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ABSTRACT 
 
Smokers attend preferentially to smoking-related cues in the environment, known as 
attentional bias. Evidence suggests that attentional bias is related to craving and relapse. 
Attentional retraining (AR) procedures have been used in laboratory studies to modify 
attentional bias and processes related to drug use, but investigations on the clinical value 
of AR in addiction are scarce. This thesis reports on two randomised controlled trials 
investigating the efficacy of AR with modified visual probe tasks in smokers. The first 
study explored the effects of varying the length of AR on attentional bias, craving, mood 
and withdrawal in current smokers. No retraining effects were observed after either a 
short, medium or long block of AR. The second study explored the efficacy of AR on 
attentional bias and smoking cessation outcomes in treatment-seeking smokers. While AR 
procedures were feasible to deliver within smoking cessation clinics, the intervention did 
not significantly reduce attentional bias, craving, withdrawal symptoms or the likelihood 
of relapse. These results and the literature in general show that there is no clear 
association between attentional bias and craving and relapse. Current AR procedures are 
not effective in smokers and should not be used in smoking cessation treatments, as they 
currently stand.  
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CHAPTER 1: INTRODUCTION  
 
1.1 Smoking cessation context 
Tobacco smoking remains a major cause of many preventable diseases and premature 
death, killing an estimated 102,000 people in 2009 in the UK alone (Peto et al., 2012). 
Since the publication of the UK government’s White Paper, Smoking Kills (Department of 
Health, 1998), which put forward a tobacco control strategy to tackle and reduce smoking 
prevalence, the incidence of smoking has steadily declined in England over the past 
decade, from 27% in 2000 to 20% in the present day (Office for National Statistics, 
2012). Contributing factors to this decline include an advertising ban on tobacco products, 
smoke-free legislation prohibiting smoking in enclosed work and public places and 
treatments provided by a network of National Health Service (NHS) Stop Smoking 
Services (SSS).   
 
The NHS SSS, which were rolled out across the UK in 2000 after being piloted in 
deprived areas, offers both cost-effective and evidence-based smoking cessation 
treatments. Since its implementation, a reported four million people have set a quit date 
with the SSS, of which two million have stopped smoking for at least four weeks 
(Department of Health, 2010). Despite these short-term success rates, approximately 75% 
of initially successful 4-week quitters relapse [defined here as a return to regular smoking 
(Hughes et al., 2003)] within one year of quitting, with relapse occurring most commonly 
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in the first six months after cessation (Judge et al., 2005). Interventions designed to 
prevent relapse may therefore be key to improving longer-term cessation rates. 
 
1.1.1 Current provision of smoking cessation and relapse prevention treatments 
within the NHS SSS 
The NHS SSS offer a routine stop smoking programme supporting service-users up to 12 
weeks during any given quit attempt. Health care practitioners are trained to support 
service-users with evidence-based guidelines for smoking cessation (National Centre for 
Smoking Cessation and Training, 2011). Effective components of the programme include 
the provision of weekly behavioural support (Lancaster & Stead, 2005) and 
pharmacotherapy in the form of nicotine replacement therapies [NRT - gum, lozenge, 
transdermal patch, nasal spray, mouth spray, inhalator and sublingual tablet (Stead et al., 
2008)], varenicline (Cahill et al., 2012) or buproprion (Hughes et al., 2007).  
 
There is currently no guidance on providing relapse prevention interventions (RPIs) in the 
SSS, on top of what is routinely offered as cessation treatment in stop smoking 
programmes (RPIs are defined here as any treatment designed to reduce rates of relapse to 
smoking at any point after quit day, in addition to that of standard cessation treatment).  A 
survey of SSS managers revealed that RPIs had been offered by some services despite 
limited evidence of efficacy at the time the survey was administered (Agboola et al., 
2010a).  A Cochrane review of relapse prevention trials in smoking cessation found 
insufficient evidence to support the use of behavioural methods to prevent relapse for 
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individuals achieving initial abstinence and only weak evidence in favour of using some 
pharmacotherapies when provided for an extended period of time after short-term 
abstinence had been achieved (Hajek et al., 2009). However, a recent updated review 
which stratified interventions by content, included abstinent smokers only and had a 
stricter criterion on the synthesis of follow up time-points across studies, found that 
behavioural self help interventions appear to be effective in preventing relapse in initially 
unaided quitters and pharmacotherapies increase long-term abstinence in abstinent 
smokers, but not behavioural support (Agboola et al., 2010b). Of particular note is that all 
included studies in the review consisted of RPIs involving pharmacotherapy, self-help 
and/or counselling only, which are predominantly extensions of what is already available 
during the initial phases of treatment. It appears as though other approaches have not been 
studied as extensively; in the following sections I shall present evidence to suggest the use 
of more novel approaches to relapse prevention in the context of what is known about the 
relapse process, and the emerging prominence of the role of implicit cognitions in models 
of relapse prevention. 
 
1.2 The relapse process 
1.2.1 Relapse and abstinence curves for untreated and treated smokers 
Despite the vast amount of empirical work to date on the study of relapse in addiction, the 
factors contributing to the relapse process are not yet fully understood. We understand 
that upon initiation of any given quit attempt, the likelihood of a lapse (defined here as a 
slip or an incident of smoking, followed by continuation of the quit attempt) occurring 
after an initial period of abstinence is high and has been shown to predict whether or not a 
CHAPTER 1 
 
 
4 
 
smoker will achieve abstinence in the longer-term (Kenford et al., 1994). It remains 
difficult, nevertheless, to ascertain why or identify when a lapse occurs and the nature by 
which it translates into full relapse to smoking. 
 
Patterns of relapse have been depicted in relapse curves derived from survival analyses of 
untreated smokers (Hughes et al., 2004a). Where ‘survival’ is defined as abstinence from 
smoking, the shape of the curve reflects the number of smokers still abstinent over time. 
In the general untreated population, the majority of smokers return to smoking within the 
first eight days of a quit attempt; thereafter, most relapses occur within three months of 
quitting (Figure 1), leaving only 3-5% abstinent at six months (Hughes et al., 2004a).  
 
 
Figure 1. True survival curves (solid lines) and line graph relapse curves (dotted 
lines) in self-quitters, taken from Hughes et al., 2004a 
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Preliminary evidence from abstinence curves of smokers treated with pharmacotherapy 
(NRT, buproprion or varenicline) and behavioural support suggests that such treatments 
delay relapse in comparison to smokers who receive no cessation support [Figure 2 
(Coleman et al., 2010)]; for NRT, the trajectory mimics the curve for untreated smokers 
where abstinence rates are highest at the onset of the quit attempt although a steadier 
decline in abstinence is observed in comparison thereafter.  For buproprion, abstinence 
rates are fairly constant throughout. For varenicline, the rate appears to increase within the 
first three months and decelerates after this point. The similarity in the late slope pattern 
for each treatment suggests that there is very little difference between treatments beyond 
three months and highlights the comparable decline in abstinence, with varenicline 
producing a higher proportion of abstinent smokers overall at 12 months (31%) in 
comparison to NRT (29%) and buproprion (22%). Thus, treatment effects observed early 
on in a quit attempt seem to have small incremental effects on the proportion of smokers 
who remain abstinent in the longer-term, although the rate of relapse after the initial 
treatment period does not vary across treatments. 
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Figure 2. Abstinence curves (shown as line graph) in treated smokers, taken from 
Coleman et al., 2010. Horizontal lines indicate the 95% CIs for the combined 
medications estimate at each pre-specified follow-up 
 
Piasecki et al. (2002) distinguished the early and late components of the relapse curve by 
coining two distinct phases: a ‘cessation attempt’ period to signify the initial attempt to 
stop smoking and a period of ‘relapse susceptibility’ to delineate later relapses in the 
process. The authors suggest that a true, effective RPI should produce significant effects 
in the relapse susceptibility phase by reducing the likelihood of later lapses. This would 
be illustrated on a relapse curve by a uniform slope with a slower decline in abstinence 
rates over time but the preliminary evidence above suggests that current smoking 
cessation treatments do not achieve this. To reduce the probability of relapse in these later 
stages, it is important to first consider the factors that potentially influence the relapse 
process so that more targeted approaches to relapse prevention can be developed. In the 
following section, I describe some of these factors including the role that implicit 
cognitions might play in the relapse process.  
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1.2.2 Relapse as a dynamic process 
Most theoretical accounts of smoking relapse focus on specific mechanisms of drug 
motivation, the most widely studied in the field being Marlatt and Gordon’s (1985) 
cognitive-behavioural model of relapse, which forms the basis of many RPIs in smoking 
cessation (Hajek et al., 2009). The original model proposes that relapse centres on ‘high 
risk situations’ and how individuals respond to these situations (Marlatt & Gordon, 1985). 
High risk situations include internal (e.g. emotional states such as negative affect) and 
external (e.g. environments where smokers are present) contexts that increase an 
individual’s vulnerability to engaging in a target behaviour (Hendershot et al., 2011). 
Whether lapses or relapse occurs depends primarily on the individual’s ability to cope 
with high-risk situations. The relapse prevention approach developed from this model 
therefore involves skills-based training, designed to encourage individuals to identify 
high-risk situations and develop coping strategies to reduce the likelihood of relapse 
occurring.  
 
The model has since been reformulated in light of numerous developments in empirical 
studies that recognise relapse as a dynamic process involving complex interactions, rather 
than being static and time-invariant (Witkiewitz & Marlatt, 2004). Arguably, much of the 
research on relapse in the last decade has focused on individual differences, enduring 
traits or characteristics that lead to relapse. For example, being younger, smoking more 
cigarettes a day, having lower self-efficacy at the point of quitting are contributing factors 
(Ockene et al., 2000). 
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The reformulated cognitive-behavioural model of relapse recognises both tonic processes 
that are stable (e.g. personality) and phasic responses which are transient (e.g. urges and 
mood that can vary over time and contexts) that interact with each other to predict relapse 
risk (Witkiewitz & Marlatt, 2004). Recent empirical studies reveal the complexity of the 
relationship of each construct to relapse in light of new methodologies like Ecological 
Momentary Assessment (EMA) which focus on real-time data collection in real-world 
environments (Shiffman et al., 2008). EMA methods have been used to capture temporal 
variations in factors associated with relapse; for example, one study found that 
participants exhibited lower self-efficacy on the day prior to a lapse and on subsequent 
days lower self-efficacy was associated with progression to relapse (Shiffman et al., 
2000). The intensity of daily urge to smoke has been found to predict smoking lapse on 
the following day (Van Zundert et al., 2012; Shiffman et al., 1997). Negative affect has 
been found to rise in the hours preceding a lapse, but not in the days prior to it (Shiffman 
& Waters, 2004a). Other components of the model have also received support from EMA 
studies, including self-control and coping (Shiffman et al., 1996) and smoking outcome 
expectancies (Gwaltney et al., 2005).  
 
Other factors of the model have received less emphasis until now. Emerging out of 
expectancy research is an increasing interest in the influence of implicit cognitive 
processes on our understanding of dynamic relapse processes (Stacy & Wiers, 2010). 
Implicit cognitions are defined as processes (e.g. attentional bias) that often occur 
automatically and can be inferred indirectly from other behaviours (e.g. measures of 
reaction time as described in section 1.3.2). In contrast to explicit cognitions - which 
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focus on the assumption that addictive behaviours are borne out of rational decision 
making - implicit cognitions are described as impulsive and lead to relatively automatic 
drug use in response to drug-related cues. Implicit measures of cognitive processes have 
been found to be correlated with relapse outcomes across several addictive behaviours, 
including alcohol (Cox et al., 2002), heroin (Marissen et al., 2006) and smoking [(Waters 
et al., 2003a) see section 1.5 for full description]. Central to this thesis and thus the focus 
of the discussion in the following sections is a closer examination of implicit cognitive 
processes, namely attentional bias and its theoretical basis, how it might relate to the 
relapse process and its potential as a target for preventing relapse in smokers who are 
attempting to quit. 
 
1.3 Attentional bias 
1.3.1 Theoretical background 
When drug users show excessive attention towards drug-related cues in the environment, 
they are said to exhibit what is known as an ‘attentional bias’. It has most often been 
explained by theories that endorse the tenets of classical conditioning. Robinson and 
Berridge’s (1993) incentive-sensitization theory proposes that through repeated drug-use, 
the dopaminergic response produced by the reward system in the brain becomes 
sensitized and increases the salience of cues related to drug-use.  Through Pavlovian 
learning, these drug-related cues become associated with drug-related rewards, even in the 
absence of the drug itself.  As a consequence, drug-related cues appear appealing to a 
drug-user, ‘grab’ their attention and becomes ‘wanted’ to the extent that their behaviour 
may be guided towards drug use (Robinson & Berridge, 1993). Cigarette smokers have 
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been reported to attend differentially to environmental cues or ‘stimuli’ by exhibiting an 
attentional bias or readiness to process smoking-related stimuli over others, triggered by 
the motivational properties associated with such stimuli (Robinson & Berridge, 1993; 
Robinson & Berridge, 2001). Studies that support the incentive-sensitization theory show 
that drug-users respond with greater activation in brain reward circuitry when exposed to 
drug-related stimuli in comparison to non-drug users (see Wilson et al., 2004 for a review 
of studies). Using functional neuroimaging techniques (Janes et al., 2010), smoking-
related stimuli have been shown to evoke greater activation in the mesolimbic reward 
circuit than neutral cues in smokers, while non-smokers show no differential response in 
activation to either stimulus-type (Rubinstein et al., 2011).  
 
Like attentional bias, subjective cravings or urges to smoke are also perceived as an 
output of the sensitized reward system according to the incentive sensitisation theory. 
More recent models (Franken, 2003; Ryan, 2002) propose that attentional bias for drug-
related cues and subjective craving may have a mutual excitatory relationship. Based on 
this assumption, a cycle ensues when drug-related cues become the focus of attention, 
craving increases and so the salience of the drug-related cues increase to the point where 
the drug is used. Moreover, increases in attentional bias are perceived as both a cause and 
consequence of high levels of craving (Franken, 2007; Franken, 2003). Thus, smokers 
with high levels of craving may be more likely to search the environment for smoking-
related cues or notice them more readily, while prolonged attentional processing of 
smoking-related cues could lead to an increase in urge to smoke. Kavanagh et al. (2005) 
suggest in their elaborated intrusion theory that internal states (e.g. withdrawal symptoms, 
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nicotine deprivation) or external cues (e.g. sight of a cigarette packet) could initiate 
intrusive thoughts about a drug. Here, the ‘intrusion’ - subjective craving - is elaborated 
on perhaps by excessive rumination about the experience of craving or by maintaining 
attentional vigilance on the cues that triggered the thought process. Further discussion on 
the role of cue-induced cravings is provided in section 1.4.1.  
 
Habit based theorists also regard drug use as automatic and ‘stimulus bound’ (Tiffany, 
1990), meaning that the sight of a drug cue has the ability to initiate a chain of action 
towards a substance. It is only when this chain of action is disrupted, for example, when 
the drug is unavailable, that craving is experienced. Thus, unlike the causal relationship 
depicted in Franken’s (2003) model described above, it could be possible that attentional 
bias leads to the pursuit of a drug, even without the experience of craving.     
 
In contrast to classical conditioning theories that describe the development of attentional 
bias, the theory of current concerns proposes that cognitive biases develop from the drug 
users’ general motivational state and their pursuit of a drug (Klinger & Cox, 2004). A 
drug-related current concern will implicitly bias cognitive processing towards drug-
related cues; because the overall goal of a drug user is to obtain their drug of choice, 
current concerns will prompt users to automatically process drug cues related to this 
pursuit and will continue to do so until the goal is reached or abandoned (Cox et al., 
2006a). Pursuit of a drug is therefore kept in focus by such cognitive biases.  
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Taken together, the aforementioned theories of attentional bias in addiction all suggest 
that drug-related cues have the ability to capture attention relatively automatically. Drug-
related cues potentially act as a driving force in drug-taking behaviour and so disrupting 
this process by reducing attentional bias, for example, could hinder the pursuit of a drug. 
These models also suggest that attentional bias and subjective craving interact with each 
other and potentially influence drug use. Understanding the nature and significance of this 
relationship is therefore necessary to understanding how relapse to smoking unfolds, and 
is one of the central objectives of this thesis. In the following sections, I will discuss what 
methods have been used to assess attentional bias (section 1.3.2) and what is known 
already about the relationship between drug-related cues, craving and relapse (sections 1.4 
and 1.5).  
 
1.3.2 Attentional bias measures 
Several paradigms have been used to measure cognitive processing biases, either directly 
(e.g. eye-tracking) or indirectly (e.g. visual probe task). These tasks typically rely on 
measuring reaction times (RTs) to relevant stimuli to infer the amount of bias exhibited 
by a participant. Different subcomponents of attention and attentional bias can be 
examined depending on the type of task used. For example, some tasks measure the rapid 
orienting of attention, while others measure the maintenance or delayed disengagement of 
attention (see Field & Cox, 2008, for a review). In the next section, I will outline the most 
commonly used tasks and focus on the procedures that are most relevant to the research 
studies described in Chapters 2 and 3.  
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1.3.2.1 The addiction Stroop task 
The modified addiction Stroop task (Cox et al., 2006b), a variant of the classic Stroop task 
(Stroop, 1935), has been used extensively to measure selective processing of drug-related 
stimuli (Drobes et al., 2006; Sharma et al., 2001; Waters et al., 2003a). In this task, 
participants are presented with neutral or drug-related words printed in colour and they 
are asked to name the colour of the words as quickly and accurately as possible while 
ignoring the semantic content of the words. Similarly pictorial presentations of drug-
related and neutral stimuli are also used in addiction Stroop paradigms (Bruce & Jones, 
2004); participants are required to name the colour of the border of pictures presented as 
quickly as possible while attempting to ignore the content of the pictures. A processing 
bias towards drug-related stimuli is indicated by slower colour naming of drug-related 
words/pictures in comparison to neutral words/pictures, suggesting that attention is 
captured by the meaning of the drug-related words/pictures and performance is thus 
impaired on the task.  
 
Smokers, in comparison to non-smokers, have been found to exhibit a processing bias for 
smoking-related stimuli than neutral stimuli (Munafo et al., 2003). Similarly, processing 
biases have been found in drug-users of other substances in comparison to non-abusers, 
including alcohol abusers (Cox et al., 2000; Sharma et al., 2001), heroin addicts (Franken 
et al., 2000), cannabis users (Field et al., 2006) and cocaine addicts (Hester et al., 2006). 
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There is some ambiguity over the mechanisms underlying the Stroop effect, which is why 
this is referred to as a ‘cognitive processing bias’ rather than an attentional bias in this 
discussion. This is because there are alternative interpretations for why the interference 
occurs and different mechanisms at play, which could give rise to the same observed 
interference. For example, attempts to avoid drug-related stimuli [termed cognitive 
avoidance in anxiety literature (Deruiter & Brosschot, 1994)] may also result in the 
slower colour-naming of drug-related words. This has been demonstrated in a study where 
abstinent alcoholics showed increased Stroop interference when they were told to 
suppress their thoughts about alcohol, in comparison to those who were not encouraged to 
do so (Klein, 2007). An interpretation of the Stroop effect therefore requires careful 
consideration; I herein refer to this effect as a processing bias throughout this thesis. 
 
The addiction Stroop task is likely to measure the maintenance or delayed disengagement 
of attention rather than the rapid orienting of attention.  Evidence for this comes from 
‘carryover’ effects noted across addiction Stroop studies (Cane et al., 2009). Carryover 
effects have been found where colour naming performance is impaired on trials of neutral 
stimuli that have been presented immediately after trials of drug-related stimuli; smokers 
have been found to respond slower to words that appear after smoking-related words than 
after neutral words (Waters et al., 2003b). Thus, this slow down in cognitive processing 
which carries over into subsequent trials suggests that there might be a rumination effect 
on drug-related stimuli that is likely to reflect a difficulty in disengaging attention.  
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1.3.2.2 The visual probe task  
Another widely used measure of attentional bias is the visual probe task (MacLeod et al., 
1986). In this task, participants are presented with stimuli consisting of a pair of words or 
pictures that are presented side by side on a computer screen. One stimulus is neutral (e.g. 
a picture of a man holding a pen) and the other is related to smoking (e.g. a picture of a 
man holding a cigarette). After a short interval, the picture pairs disappear and are 
replaced by a single probe stimulus (e.g. a square or triangle) that appears in the location 
formerly occupied by one of the pictures. The probe stimulus replaces the neutral and 
smoking-related pictures with equal frequency. Participants are then required to press 
either the up arrow or down arrow on the computer keyboard to indicate which picture has 
been replaced as quickly as possible in response to the probe.  
 
Based on the principle that detection of the probe is quicker in the location in which the 
participant is already fixated, a participant who has an implicit bias towards smoking will 
presumably be looking in the direction of the smoking-related stimuli on the outset. 
Attentional bias towards smoking is indicated by faster RTs to the probe that appears in 
the location of the smoking-related picture rather than the neutral picture. Smokers, but 
not non-smokers have demonstrated an attentional bias for smoking-related pictorial cues 
(Bradley et al., 2004; Ehrman et al., 2002). Other drug users have shown an attentional 
bias towards drug-related stimuli of their choice; for example, cannabis users have shown 
faster approach responses towards cannabis-related pictorial cues than neutral cues (Field 
et al., 2006). 
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Different stimulus presentation times are assumed to measure different components of 
attentional bias on the visual probe task. The stimulus onset asynchrony (SOA), which is 
the time in which a picture is presented on a computer screen in each trial, has been 
manipulated in visual probe task studies to investigate the initial orienting of attention or 
speeded detection of drug-related stimuli versus the maintenance or delayed 
disengagement of attention. Short SOAs, typically less than 200 milliseconds (ms), are 
likely to reflect early processes while longer SOA durations of between 500 ms and 2000 
ms reflect later slower processes. This is based on the assumption that only one shift in 
attention seems plausible when two stimuli are presented at an SOA duration of less than 
200 ms, while multiple shifts are possible at SOAs of over 500 ms (Field & Cox, 2008). 
Accordingly, shorter SOAs may indicate the rapid initial orienting of attention while 
longer SOAs may reflect maintenance or disengagement of attention; this line of 
reasoning is generally accepted in the anxiety literature (Koster et al., 2004).   
 
The differentiation between the two subcomponents has been best measured by 
combining the visual probe paradigm with eye-tracking methodology. As the visual probe 
task is limited to measuring the allocation of attention at the time of stimulus offset, eye-
tracking allows for the measurement of attention over the duration of stimulus 
presentation. Thus, eye-tracking methodology provides a more direct measurement of 
both initial orienting and delayed disengagement. Attentional bias is inferred from eye 
movements, for example by measuring the direction of first eye movements or the amount 
of time individuals maintain their gaze on drug-related stimuli versus neutral stimuli (also 
known as ‘dwell time’). In a study of heavy drinkers (Schoenmakers et al., 2008) and 
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cannabis users (Field et al., 2006), attentional bias RTs on the visual probe tasks were 
positively correlated with gaze dwell times when drug-related stimuli were presented for 
2000 ms, which lends support to the notion that longer presentation times capture the 
maintenance of attention. Similarly, smokers have a higher proportion of first eye 
movements and a longer dwell time towards smoking-related stimuli than neutral stimuli 
(Field et al., 2004; Mogg et al., 2003). Furthermore, smokers have been found to direct 
their gaze towards dynamic smoking-related cues more quickly, more often and for a 
longer duration in comparison to non-smokers (Lochbuehler et al., 2011). 
 
Arguably, these two subcomponents of attention may have state-like or trait-like qualities. 
Faster attentional processes like the initial orienting of attention may be indicative of a 
trait that has developed after years of conditioning to smoking cues and accordingly, may 
have a consistent presence in certain drug users. On the other hand, the maintenance of 
attention may be regarded as a state-like construct and may be influenced more so by 
motivational factors such as craving (LaBerge, 1995). Biases in maintained attention may 
therefore be more evident in situations of high cravings, for example when smokers are 
nicotine deprived. Although this is somewhat speculative, these trait-like and state-like 
features of attentional bias may be important when examining the relationship between 
attentional bias and craving.  
 
In summary, both Stroop and visual probe task paradigms have been used to demonstrate 
that smokers show cognitive processing biases towards smoking-related stimuli compared 
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to non-smokers. It is likely that each task taps into different subcomponents of attention; 
the Stroop task is likely to measure the maintenance or delayed disengagement of 
attention while the visual probe task appears to capture both initial orienting and delayed 
disengagement of attention, depending on the duration of stimulus presentations. Both of 
these tasks were used in the research studies described in Chapters 2 and 3. 
 
1.4 Attentional bias and craving: are they related?  
In section 1.2.2, I highlighted that attentional bias and craving feature in recent models of 
relapse and in section 1.3.1, I discussed how several theoretical models predict that 
attentional bias is associated with subjective craving. Here, I introduce how this 
relationship has been investigated in addiction and what is known so far. 
 
Firstly, it is important to distinguish between two types of craving reported in the 
addiction literature: background craving and episodic or cue-induced craving. 
Background craving perpetuates throughout the day as a steady, tonic state and reduces 
over time while episodic craving – which typically overlays background craving – occurs 
during bouts of intense craving and is usually triggered by situational cues, for example 
exposure to smoking cues or alcohol consumption (Ferguson & Shiffman, 2009; Marlatt 
& Gordon, 1985; Niaura et al., 1988; Shiffman, 1982). Some authors propose that 
background craving and episodic craving arise from separate processes (Carter et al., 
2009). For the purpose of composition, I predominantly refer to and focus on episodic 
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craving as the majority of studies mentioned below have most commonly investigated 
attentional bias in relation to cue-induced cravings. 
 
The theories proposed by Franken (2003) and others suggest that there is a reciprocal 
relationship between attentional bias and craving. One way to examine this relationship is 
to experimentally manipulate either craving or attentional bias in order to produce a 
corresponding effect, such that an increase in craving would result in an increase in 
attentional bias and vice versa. This causal relationship has been studied across several 
substances using experimental manipulations like cue exposure (Tiffany & Drobes, 1990) 
or attentional retraining procedures (Attwood et al., 2008) which are described below. 
Other experimental manipulations include priming (Schoenmakers et al., 2008), negative 
mood induction (Bradley et al., 2007) and deprivation (Waters & Feyerabend, 2000) all of 
which are described in Field and Cox’s (2008) review.  
 
It is worth noting that there are methodological differences across these studies which 
complicate the study of this association. Studies typically vary according to the attentional 
bias tasks used (e.g. visual probe task versus Stroop task), the samples used (e.g. 
treatment-seeking versus non-treatment seeking, light users versus heavy users), the type 
of substance abusers tested (e.g. cigarette smokers, alcohol users, cocaine addicts) and the 
measures of craving used (e.g. single item versus multi-item questionnaires). Taking 
account of this, a recent meta-analysis of 68 studies found a significant, although 
somewhat weak (r=0.19), positive correlation between the magnitude of attentional bias 
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and the strength of craving across users of various substances (Field et al., 2009a). In the 
sections that follow, I discuss some of the empirical studies that have attempted to 
elucidate the relationship between attentional bias and craving. I focus namely on studies 
that used experimental manipulations like cue exposure and attentional retraining, as they 
are most relevant to the studies described in Chapters 2 and 3. 
 
1.4.1 Cue-induced craving manipulations 
In cue-reactivity research, drug-related stimuli are known to produce increases in 
subjective craving and physiological arousal (Carter & Tiffany, 1999). One of the most 
commonly used procedures to evoke craving in smoking studies involves exposure to 
smoking-related stimuli (Carter & Tiffany, 2001; Tiffany & Drobes, 1990), which can 
consist of either in vivo cues (e.g. holding a lit cigarette), imagined cues (e.g. imagining 
holding a lit cigarette) or images of smoking paraphernalia (e.g. a short film of people 
smoking). For example, Field et al. (2007a) demonstrated that both subjective craving and 
processing biases for smoking-related stimuli could be increased after smokers were 
presented with a smoking cue (a lit cigarette)  in a smoking environment than a control 
cue (a pen) in a neutral environment. The study also showed that the corresponding effect 
on attentional bias was mediated in part by cue exposure effects on subjective craving. 
 
More recently, neuroimaging studies have helped establish patterns of brain activation 
associated with cue exposure, attentional bias and craving. In a study by Kang et al. 
(2012) temporarily-abstinent smokers were exposed to smoking-related and neutral visual 
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cues while undergoing functional magnetic resonance imaging (fMRI) to study changes in 
brain reactivity and eye-tracking to measure attentional bias, followed by a measure of 
craving using the Questionnaire on Smoking Urges-Brief (QSU-Brief). Smokers showed 
significantly longer gaze dwell times in response to smoking-related cues than neutral 
cues, indicating an attentional bias towards smoking cues. Attentional bias was also 
positively correlated with QSU-Brief scores in which higher craving was associated with 
greater processing of smoking-related cues. Furthermore, attentional bias to smoking cues 
was associated with greater activation in regions of the brain linked to the mesolimbic 
reward system and visuospatial attention; subjective craving was associated with 
heightened activation in areas engaged in reward-related decision-making and cognitive 
control, which lends support to incentive salience theories in addiction (Franken, 2003; 
Robinson & Berridge, 2001).   
 
1.4.2 Attentional bias manipulations 
Other studies have investigated the effect of manipulating attentional bias on subjective 
craving to test a causal association. If increases in craving increase attentional bias, then it 
should be demonstrable that increases in attentional bias lead to increases in craving if 
there is a reciprocal relationship. Attentional retraining (AR) procedures – where standard 
attentional bias tasks are modified to manipulate attentional bias – have been used in 
train-to-attend and train-to-avoid experimental manipulations. The most common AR 
procedure used in substance-related studies is a modified visual probe task which has 
shown that individuals with specific drug use patterns are able to increase or decrease 
attentional bias towards their drug of choice (Attwood et al., 2008; Field & Eastwood, 
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2005; Field et al., 2007b; Field et al., 2009b; McHugh et al., 2010; Schoenmakers et al., 
2007). In the train-to-attend manipulation, the probe replaces the drug-related stimuli 
more frequently than the neutral stimuli; by comparison in the train-to-avoid 
manipulation, the probe replaces the neutral stimuli on a greater number of occasions. 
Consequently attention is trained towards one particular stimulus type. 
 
In addiction retraining studies, the effects of AR on subjective outcomes (e.g. craving) 
and behavioural outcomes (e.g. drug consumption) have been investigated. These have 
mainly been laboratory studies in alcohol users and more recently tobacco users trained 
using a modified visual probe task. Table 1 displays the characteristics of all the published 
addiction retraining studies available at the time of writing. The first of these studies 
found that social drinkers who were trained to attend to alcohol-related stimuli showed 
increases in attentional bias for alcohol-related stimuli; these changes were also associated 
with increases in urge to drink and actual beer consumption during a post-task taste test 
(Field & Eastwood, 2005). Conversely, those who were trained to avoid alcohol-related 
stimuli showed reductions in attentional bias for alcohol-related stimuli and consumed 
less beer than the comparison group, but no changes in urge to drink were observed. Field 
et al. (2007b) replicated this study with the inclusion of a control group and found the 
predicted direction of change in attentional bias in the two experimental groups, as well as 
no change in attentional bias in the control group. Alcohol craving increased among 
participants in the attend group, but only for those who were aware of the experimental 
contingencies, i.e. participants who reported the relationship between the location of the 
probe and stimulus-presentation correctly in a post-task questionnaire. However in 
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contrast to the findings of the earlier study, there were no differences between groups in 
the volume of beer consumed. Schoenmakers et al. (2007) carried out a similar study 
where heavy social drinkers had learned to avoid alcohol-related stimuli and develop an 
attentional bias towards soft drinks, although the authors reported that training had no 
effect on post-task craving or drink choice.  
 
At the time of writing, only three laboratory studies reported outcomes for AR in current 
cigarette smokers (Attwood et al., 2008; Field et al., 2009b; McHugh et al., 2010). 
Attwood et al. (2008) found that AR increased attentional bias in participants who were 
trained towards smoking-related stimuli and decreased attentional bias in those trained 
towards neutral stimuli. Furthermore, when participants were measured on their response 
to a lit cigarette following the training procedure, greater increases in subjective craving 
were found in male participants who attended to smoking-related stimuli than those 
trained towards neutral stimuli. However, no effect of training on smoking topography 
(e.g. number of puffs taken, puff duration, etc.) was observed. Field et al. (2009b) and 
McHugh et al. (2010) replicated this study with the inclusion of a control group. Field et 
al. (2009b) found that attentional bias was greater after training in the attend group than 
the avoid and control groups, but these effects disappeared after one day. Neither the 
train-to-attend or train-to-avoid manipulations had any effect on urge to smoke, although 
unlike in the Attwood et al. (2008) study, no cue exposure task was used. Additionally, no 
group effects of retraining on motivation to smoke were observed. McHugh et al. (2010) 
compared an avoid group with a control group and found no change in attentional bias 
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and no effects of retraining on subjective craving. Unlike the Attwood et al. (2008) and 
Field et al. (2009b) studies, no behavioural measures of tobacco seeking were taken. 
 
While the relationship between attentional bias, subjective craving and behavioural 
outcomes is currently equivocal, it is important to note that inconsistencies across the 
above studies may be due to procedural differences in design. For example, across the 
alcohol retraining studies, the number of training trials varied from 600 trials to 960 trials 
while in the tobacco retraining studies, the number of trials ranged from 512 to 896. It is 
therefore unclear whether retraining effects on attentional bias, craving and drug-taking 
were contingent on the amount of retraining delivered. Chapter 2 describes a study in 
which we explored varying the length of AR on these particular outcomes.
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Table 1. Characteristics of tobacco and alcohol-related attentional retraining studies. AB=attentional bias 
Author Type of 
retrained 
substance 
cue 
Sample 
(N) 
Treatment 
seeking? 
Groups Type 
of 
task 
No.  of 
retraining 
trials 
No.  of 
test 
trials 
Effect on 
cognitive bias 
Untrained 
stimuli 
Alternative  
task measure 
Effect on 
subjective 
outcome 
measure  
Effect on 
behavioural 
outcome 
measure 
Field et al. 
(2005) 
Alcohol Heavy 
social 
drinkers 
(n= 40) 
No Attend 
& 
Avoid 
Visual 
probe 
task 
896 56 Attend: 
Increased AB                 
Avoid: 
Decreased AB 
N/A N/A Attend: 
Increased urge 
to drink only 
on one 
measure           
Avoid: No 
effect 
Attend 
group 
consumed 
more 
alcohol than 
avoid group 
during taste 
test 
             
Field et al. 
(2007b) 
Alcohol Heavy 
social 
drinkers 
(n= 60) 
No Attend, 
Avoid 
& 
Control 
Visual 
probe 
task 
960 120 Attend: 
Increased AB                 
Avoid: 
Decreased AB 
(approached 
significance)          
Control: No 
change 
Attend: 
Increased 
AB                
Avoid: 
Increased 
AB              
Control: 
No change 
No Attend: 
Increased urge 
to drink only 
in participants 
aware of 
experimental 
contingency             
Avoid: No 
effect on urge 
to drink 
No effect on 
alcohol 
consumption 
during taste 
test in any 
group 
             
Schoenmakers 
et al. (2007) 
Alcohol Heavy 
social 
drinkers 
(n=106, 
males) 
No Avoid 
& 
Control 
Visual 
probe 
task 
600 48 Avoid: 
Decreased AB                             
Control: No 
change 
No No Avoid: No 
effect on urge 
to drink               
Control: No 
effect on urge 
to drink 
No effect on 
drink 
preference 
in any group 
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Table 1 continued 
Author Type of 
retrained 
substance 
cue 
Sample 
(N) 
Treatment 
seeking? 
Groups Type 
of 
task 
No.  of 
retraining 
trials 
No.  of 
test trials 
Effect on 
cognitive bias 
Untrained 
stimuli 
Alternative 
task measure 
Effect on 
subjective 
outcome 
measure  
Effect on 
behavioural 
outcome 
measure 
Attwood et 
al. (2008) 
Tobacco Current 
smokers 
(n=55) 
No Attend 
& 
Avoid 
Visual 
probe 
task 
512 128 Attend: Increased 
AB                            
Avoid: Decreased 
AB 
N/A N/A Attend: 
Increased urge 
to smoke 
across cue 
exposure, 
only in male 
participants 
aware of 
experimental 
contingency 
(this 
approached 
significance 
only on one 
measure)          
Avoid: No 
effect on urge 
to smoke 
No effect on 
smoking 
topography 
             
Field et al. 
(2009b) 
Tobacco Current 
light 
smokers 
(n=72) 
No Attend, 
Avoid 
& 
Control 
Visual 
probe 
task 
896 160 Attend: Increased 
AB                   
Avoid: Decreased 
AB (approached 
significance)            
Control: No 
change 
No  No Attend: No 
effect on urge 
to smoke                 
Avoid: No 
effect on urge 
to smoke                
Control: No 
effect on urge 
to smoke 
No effects on 
motivation in 
any group 
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Table 1 continued 
Author Type of 
retrained 
substance 
cue 
Sample 
(N) 
Treatment 
seeking? 
Groups Type 
of 
task 
No.  of 
retraining 
trials 
No.  
of test 
trials 
Effect on 
cognitive 
bias 
Untrained 
stimuli 
Alternative 
task 
measure 
Effect on 
subjective 
outcome 
measure  
Effect on 
behavioural 
outcome 
measure 
Fadardi & 
Cox (2009) 
Alcohol Social 
drinkers 
(n=40)                      
Hazardous 
drinkers 
(n=89)               
Harmful 
drinkers 
(n=92) 
Yes Avoid 
only 
Stroop 
task 
Goal directed 
training set by 
participant                     
2 full sets of 
training in one 
session 
(duration of 
approx. 1 hour)                        
2 sessions 
(social & 
hazardous 
drinkers), 4 
sessions 
(harmful 
drinkers) 
192 Decrease in 
cognitive 
bias across 
all groups; 
significant 
reduction in 
hazardous 
and harmful 
drinkers vs. 
social 
drinkers 
N/A N/A N/A Harmful 
drinkers: 
significant 
reduction in 
weekly 
alcohol 
consumption 
from baseline 
to post-
training and 
reduction 
maintained at 
3 month 
follow-up 
             Schoenmakers 
et al. (2010) 
Alcohol Alcohol-
dependent 
patients 
(n=43) 
Yes Avoid 
& 
Control 
Visual 
probe 
task 
528 (total of 
2640 across 5 
sessions) 
96 Avoid: 
Decreased 
AB                     
Control: No 
change 
Avoid: 
Smaller 
bias than 
control 
N/A Avoid: No 
effect on urge 
to drink                   
Control: No 
effect on urge 
to drink 
Time to 
relapse longer 
in avoid vs. 
control group              
Earlier 
discharge 
from facility 
in avoid vs 
control group 
             
McHugh et al. 
(2010) 
Tobacco Current 
smokers 
(n=64) 
No Avoid 
& 
Control 
Visual 
probe 
task 
560 96 Avoid: No 
change            
Control: No 
change 
No (only 
novel 
stimuli 
used) 
N/A Avoid: No 
effect on urge 
to smoke             
Control: No 
effect on urge 
to smoke 
N/A 
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To recapitulate, there is some evidence to suggest that attentional bias is related to 
craving, although correlations are weak (Field et al., 2009a). Laboratory studies have used 
procedures like cue exposure and attentional retraining to investigate this causal 
association by experimentally increasing craving or manipulating attentional bias. 
Evidence from AR studies in non-treatment seeking substance-users demonstrates that 
increases and decreases in attentional bias are plausible but are not always consistent. 
Furthermore, increases in attentional bias may lead to increases in craving, but this has 
only been demonstrated in few or ambiguous circumstances. Laboratory retraining studies 
have failed to show retraining effects on actual drug-taking behaviour in smokers, while 
in alcohol users, the findings are inconsistent. Notably across all aforementioned studies 
discussed in this section, non-treatment seeking individuals were recruited. In sections 
1.5-1.7, I discuss the importance of examining attentional bias and AR procedures in 
those attempting to abstain or seeking treatment for their addiction. 
 
1.5 Attentional bias and drug taking behaviour - are they related? 
In section 1.4, I discussed how the relationship between attentional bias and craving has 
been explored in non-treatment seeking users. In this section, I discuss the relevance of 
investigating attentional bias in relation to drug taking behaviour, with particular 
emphasis on how it might relate to lapses and relapse in those seeking treatment for their 
addiction.   
  
There is a clear interest in exploring how attentional bias relates to behavioural outcomes 
as this could indicate how attentional bias relates to clinically relevant outcomes including 
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success or failure of a cessation attempt. The only ecologically valid way of investigating 
this is to use samples of drug users who are interested in reducing their substance-use, or 
are undergoing treatment. Arguably, most studies investigating this association have been 
small scale laboratory studies with non-treatment seeking users that have measured 
behavioural outcomes in an abstract way (Field et al., 2009b; Hogarth et al., 2008; 
Hogarth et al., 2009). For example, in the study by Field et al. (2009b) mentioned in 
section 1.4.2, behavioural effects of AR were assessed in current smokers by using three 
measures of tobacco seeking. The tasks included: a delay discounting task, in which 
participants were required to make hypothetical decisions about whether to accept a small 
number of cigarettes immediately as a reward or a larger amount after a delay; a task 
which measured the amount of time participants could abstain from smoking within a 30 
minute timeframe; and a behavioural economic measure of how much participants were 
willing to pay for a cigarette after completion of retraining, ranging from low to high 
values.  Attentional retraining had no effect on these behavioural measures of motivation 
to smoke; arguably these effects could be masked in samples of temporarily abstinent 
smokers in laboratory studies because they know that they can continue to smoke after 
leaving the testing session. This pattern of results may therefore be different in abstinent 
individuals who are motivated to reduce their substance-use.  
 
Most relevant to the discussion here are studies that investigate attentional bias and its 
relation to drug treatment outcomes (Carpenter et al., 2006; Cox et al., 2002; Marissen et 
al., 2006; Waters et al., 2003a; Waters et al., 2003c). Patients that exhibit attentional bias 
may be more at risk of relapsing than those without attentional bias; for example pre-
treatment bias has been shown to predict relapse in heroin addicts at three months post-
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treatment, even when controlling for self-reported craving (Marissen et al., 2006). 
Similarly, heightened Stroop interference effects have been associated with reduced 
attendance at treatment and cocaine toxicology in cocaine addicts (Carpenter et al., 2006). 
Another study found that processing biases increased over time in alcoholic patients who 
relapsed during or after treatment relative to control patients and in those in whom 
treatment was successful (Cox et al., 2002).  
 
In the first of the smoking cessation studies to study this relationship, 158 smokers were 
randomised to either a high-dose patch condition or placebo patch condition where the 
Stroop task was administered on the first day of quit attempts (Waters et al., 2003a). The 
authors found that smokers who showed greater selective processing towards smoking-
related words on the first day of abstinence were significantly more likely to lapse in the 
short-term with daily lapse risk increasing by 30% for every 100 ms increase. 
Additionally, Stroop effects on the first block of trials (OR = 1.58, CI = 1.12-2.23, 
p=0.009) predicted 1-week abstinence but the association was not significant between 
attentional bias measured in all assessments (OR = 1.50, CI = 0.98-2.29, p=0.06).  
 
The authors replicated the study using the visual probe task and assessed 141 smokers 
prior to stopping smoking (Waters et al., 2003c). As predicted, participants were 
significantly faster to respond to smoking-related cues than neutral cues (mean 
difference=2.9 ms, SD=16.8). Unlike the previous study (Waters et al., 2003a) attentional 
bias did not predict lapse episodes (HR=1.00, CI=0.99-1.01, p=0.66).  
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A similar study investigated whether attentional bias predicted treatment success in 
smokers receiving standard behavioural support for smoking cessation, using both the 
modified visual probe task and word-Stroop task (Spiegelhalder et al., 2011). Attentional 
bias assessed on the visual probe task did not predict relapse as found in the study by 
Waters et al. (2003c).  However, on the Stroop task, greater processing biases were 
associated with a lower risk of relapse, which is contrary to the findings in the other study 
by Waters et al. (2003a).  
 
Attentional bias has been shown to predict relapse during unaided quit attempts too 
(Powell et al., 2010). Powell et al. (2010) found that greater processing biases on the 
Stroop task predicted relapse at one week but not one month or three months after quit 
day. Cue reactivity predicted relapse at all three times. The authors were unable to find 
any correlation between attentional bias and cue reactivity, which could suggest that these 
components tap different processes, although this remains unclear.  
 
To summarise, only a handful of studies have explored the relationship between 
attentional bias and drug use in relation to relapse. In smokers attempting cessation, 
attentional bias has been found to predict lapses on one measure [Stroop task (Waters et 
al., 2003a)] but not another [visual probe task (Waters et al., 2003c)]. Furthermore, an 
association between attentional bias and relapse has been found in some cases, but again, 
this has only been found on one measure of attentional bias or through analysis of part of 
the data (Waters et al., 2003a). The nature of this relationship is unclear, as greater 
processing biases have either predicted a higher or lower risk of relapse (Spiegelhalder et 
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al., 2011; Waters et al., 2003a). Thus, in respect to smoking cessation the predictive 
validity of attentional bias is currently equivocal. Chapter 3 describes a study in which we 
re-examined the association between attentional bias, craving and relapse using Stroop 
and visual probe task measures in treatment-seeking smokers.   
 
1.6 Attentional bias in abstainers and treatment-seekers 
In the current section, I discuss how some investigators have explored differences in 
attentional bias across subgroups of individuals and how factors like abstinence and the 
treatment-seeking status of substance users might relate to attentional bias. 
 
There is some contention over whether attentional bias differs between different 
subgroups of smokers (e.g. never-smokers, ex-smokers and current smokers). The first 
study to explore this found that ex-smokers, who were enrolled in a smoking cessation 
programme and had been abstinent from smoking for at least one week, had an 
intermediate bias for smoking-related stimuli, in-between that of smokers and non-
smokers (Ehrman et al., 2002). In another study, smokers who were attempting to quit and 
smokers without such plans had similar levels of attentional bias (Cane et al., 2009). In 
contrast to these studies, two studies found that ex-smokers showed a similar level of 
processing bias as never-smokers, while smokers exhibited more bias than both other 
groups (Littel & Franken, 2007; Munafo et al., 2003).  In both of these studies, ex-
smokers had been abstinent for at least six months rather than recently abstinent from 
smoking. Thus, data are conflicting but it is possible that attentional bias persists early in 
a quit attempt and resolves with increased duration of abstinence although no study has 
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examined this. However, if attentional bias persists for many months, we might speculate 
that if there are enduring effects of smoking cues after cessation as suggested in previous 
research, abstinence could be undermined in initially successful quitters.  
 
Speculatively, it may be that substance users who are not seeking treatment or receiving 
treatment for substance abuse do not experience cognitions that are clinically relevant to a 
quit attempt. Control of attention and cognitive processes may contribute to relapse in 
smokers trying to quit, with both motivational and behavioural consequences. Abstaining 
smokers or those receiving cessation treatments may well use strategies to avoid smoking 
cues or suppress urges to smoke. Alcohol studies provide some tentative evidence of this 
in treatment-seeking alcoholics, where patients have shown attentional avoidance to 
alcohol-related stimuli compared to light social drinkers, i.e. faster RTs to neutral rather 
than alcohol-related stimuli at 500 ms stimulus presentation durations (Noel et al., 2006; 
Stormark et al., 1997; Townshend & Duka, 2007). However, this difference between 
groups is somewhat inconsistent across studies; both abstinent alcoholics and social 
drinkers have shown attentional avoidance in one study (Vollstadt-Klein et al., 2009), 
while in another, only abstinent alcoholics with low levels of craving showed attentional 
avoidance compared to controls (Field et al., 2013).  
 
Altogether, the evidence suggests that factors such as abstinence or the treatment seeking 
status of substance users might impact on attentional bias in various ways, although the 
nature in which it does is unclear. While some studies demonstrate that smokers who are 
initially abstinent from smoking or are interested in quitting show similar levels of 
CHAPTER 1 
 
 
34 
 
attentional bias towards smoking cues than continuing smokers (Cane et al., 2009), others 
indicate that attentional bias might diminish over extended periods of abstinence (Littel & 
Franken, 2007; Munafo et al., 2003). Attentional avoidance towards drug-related stimuli 
has been found in treatment-seeking alcoholics (Noel et al., 2006; Stormark et al., 1997; 
Townshend & Duka, 2007) but it is unknown whether smokers show similar patterns of 
attentional processing during smoking cessation.  
 
1.7 Attentional retraining in treatment-seeking populations 
In section 1.4, I described how AR has been used in laboratory studies to investigate the 
causal relationship between attentional bias and subjective craving. More recently, there is 
an increasing amount of interest in the efficacy of these procedures as a clinical tool as 
most standard treatments do not target attentional bias directly. This section details how 
AR procedures have been used to treat patients with several problems, from anxiety to 
addiction. 
 
The first AR procedures were developed as an experimental paradigm in the study of 
anxiety-related attentional bias and later as a treatment for clinical anxiety disorders. Also 
known as cognitive bias modification (CBM), such procedures were designed to expose 
participants to a cognitive bias task encouraging them to augment or attenuate biases 
towards threat-related stimuli (MacLeod et al., 2002). Recent meta-analyses have revealed 
small to medium effects of CBM procedures on reducing attentional bias and symptoms 
of anxiety across clinical and non-clinical populations (Hakamata et al., 2010; Hallion & 
Ruscio, 2011).  
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A few studies have used AR as a treatment for clinically diagnosed anxiety disorders.  
They trained one group to avoid their selective bias and gave placebo training to the other 
(Amir et al., 2009a; Amir et al., 2009b; Julian et al., 2012; Schmidt et al., 2009). Using a 
modified visual probe task, it has been demonstrated that people with anxiety disorders 
have lower attention to threat-related information than patients having placebo training 
(Amir et al., 2009a; Amir et al., 2009b; Schmidt et al., 2009). Significant reductions in 
symptoms of anxiety have been found as well as remission of diagnoses in those who 
received AR compared to placebo training (Amir et al., 2009a), with some studies also 
demonstrating the maintenance of these effects up to four months post-treatment (Amir et 
al., 2009b; Schmidt et al., 2009).  
 
Not all studies investigating AR found benefits for patients with anxiety disorder. In a 
replication of Amir et al. (2009b), Julian et al. (2012) did not find any retraining effects 
on attentional bias or reactivity to a stressful challenge. However, it is worth noting that 
this study only employed one session of training, unlike the multiple sessions delivered in 
the earlier studies [e.g. Amir et al. (2009a)].  A review suggested that more retraining 
sessions produces greater treatment effects (Hakamata et al., 2010).   
 
In the addiction domain, only two studies to date have examined the effects of multiple 
AR sessions on substance users’ processing biases and drug taking in people seeking to 
reduce or abstain (Fadardi & Cox, 2009; Schoenmakers et al., 2010). In an uncontrolled 
trial, Fadardi and Cox (2009) recruited hazardous and harmful drinkers interested in 
reducing their alcohol intake. They asked them to complete two or four weekly sessions 
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of AR on a modified Stroop task, respectively. After treatment was complete, processing 
biases towards alcohol-related stimuli reduced in both groups, as did alcohol consumption 
by about 10 Units/week (one Unit is equivalent to 8g of ethanol) for the harmful drinkers. 
These reductions were also maintained at the 3-month follow up. Uncontrolled trials in 
people seeking to change their behaviour are of course hard to interpret. 
 
In the only randomised trial, Schoenmakers et al. (2010) found that alcohol-dependent 
patients were more able to disengage attention from alcohol-related stimuli than control 
patients after five sessions of AR on a modified visual probe task, given in addition to 
standard treatment. Moreover, relapse was delayed by over a month in patients that 
received AR.  
 
Overall, AR procedures have largely shown success in reducing attentional bias and 
symptoms of anxiety in clinically anxious populations. These therapeutic gains have been 
observed following multiple sessions rather than a single session of AR. Preliminary 
evidence from two studies in alcohol abusers (Fadardi & Cox, 2009; Schoenmakers et al., 
2010) indicates that multiple sessions of AR may lead to reductions in attentional bias for 
alcohol-related cues and improvements in clinically relevant outcomes, including reduced 
alcohol consumption and delayed relapse. At the time of writing, AR procedures had yet 
to be tested in smokers who were seeking to quit smoking. Chapter 3 details the first 
clinical trial to test multiple sessions of AR in treatment-seeking smokers.    
 
CHAPTER 1 
 
 
37 
 
1.8 Summary of introduction 
Relapse continues to be a problem in smokers who attempt to stop smoking. Although 
NHS SSS provide effective cessation treatments to help people stop in the short-term, 
there are currently no designated interventions to prevent relapse back to smoking. Most 
relapse prevention trials have focused on behavioural methods and pharmacotherapy to 
reduce the likelihood of relapse, but these have shown mixed findings. In recent times, 
investigators have considered the role of implicit cognitions like attentional bias in the 
relapse process. Using cognitive measures like the visual probe and pictorial Stroop tasks, 
drug users have shown greater attentional bias towards drug-related cues than neutral 
cues. Associations between attentional bias, craving and behavioural outcomes have been 
explored using cue-induced craving manipulations and attentional retraining procedures in 
non-treatment seeking substance users. While the data are mixed, the best evidence that 
attentional bias is important in addiction recovery is likely to come from experimental 
interventions to change it in people who are attempting to abstain from drug use. Hence, 
attentional retraining interventions have been developed for use in clinical populations, 
some of which have shown promise in improving treatment outcomes in clinically 
anxious patients and alcohol abusers. At the time of writing, attentional retraining had yet 
to be tested as a therapeutic intervention in treatment-seeking smokers; thus, we 
developed the first clinical trial of attentional retraining for smokers attempting to quit 
with NHS SSS. 
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1.9 Overview of thesis 
The goal of this thesis is to further our understanding of attentional bias and the utility of 
attentional retraining procedures in smokers, specifically in those attempting to quit.  
 
The objectives of the research outlined in this thesis are therefore as follows: -  
1) To develop, test and evaluate attentional retraining procedures for smokers; 
2) To explore the relationship between smoking-related attentional bias, craving, 
withdrawal symptoms and relapse. 
 
1.9.1 Outline of chapters 
The following chapters in this thesis are set out in the chronological order that the 
research was carried out. 
 
Chapter 2 describes the first empirical study in this thesis. The study was designed to pilot 
the length of an AR procedure suitable for use in the clinical trial described in Chapter 3. 
In the addiction retraining studies discussed in sections 1.4.2 and 1.7, we found no clear 
guidance on the optimal amount of training trials to deliver in an AR procedure, with 
previous studies having varied the number of trials from 512 trials (Attwood et al., 2008) 
to 960 trials (Field et al., 2007b) in a single session. We therefore had a sample of current 
smokers carry out either a short, medium or long block of attentional retraining or no 
training in a single session, using a modified visual probe task. Following the training 
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task, participants completed a cue exposure task consisting of handling a lit cigarette. We 
measured the effects of each block on attentional bias, subjective craving, mood and 
withdrawal. We further examined the number of errors made during each block length to 
infer attentional fatigue. Finally, we measured generalisation of retraining effects to 
another cognitive bias measure, the pictorial Stroop task. 
 
Chapter 3 describes the protocol for a double-blind randomised controlled trial of 
attentional bias retraining in smokers attempting smoking cessation (ARTS trial, Chapter 
3). This chapter describes the objectives of the study and methods used. The design of the 
trial focused on the delivery of multiple AR sessions to patients receiving standard 
behavioural support and nicotine replacement therapy for smoking cessation within NHS 
stop smoking clinics. Participants were randomised to either five weekly sessions of AR 
or placebo training (PT) on a modified visual probe task. Urge to smoke and withdrawal 
symptoms were measured weekly using questionnaire measures. Cognitive bias 
assessments were carried out on the visual probe task and the pictorial Stroop task prior to 
quitting, at four weeks post-quit and at the follow-up sessions at eight weeks and three 
months post-quit. A cue exposure task was also administered at follow-up.  
 
Chapters 4 and 5 describe the main outcomes of the ARTS trial. As this was the first trial 
of AR delivered in a clinical setting to treatment-seeking smokers, Chapter 4 reports on 
the feasibility of running the study within NHS stop smoking clinics and the acceptability 
of the procedures to patients. Feasibility was assessed via response and recruitment rates 
at each stage of the recruitment process, in addition to attendance at clinic sessions. We 
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examined the acceptability of the trial procedures using a patient satisfaction 
questionnaire and also by looking at adherence to the training sessions. 
 
In Chapter 5, I discuss the findings from the ARTS trial data and observational data. We 
examined the efficacy of the AR intervention on attentional bias, craving, withdrawal 
symptoms and the likelihood of relapse. We also assessed generalisation of retraining 
effects in two ways, firstly by looking at the effects of retraining on another cognitive bias 
measure, the pictorial Stroop task, and secondly by measuring attentional bias towards 
novel stimuli that were not used during the training task. Finally, we addressed whether 
attentional bias was associated with measures of dependence and smoking cessation 
outcomes.  
 
Chapter 6 contains a discussion of the general conclusions from the research described in 
the previous chapters. Here, I also provide a summary of recommendations on future 
research to help advance our understanding of attentional bias and AR procedures in this 
field.
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CHAPTER 2: DEVELOPMENT OF AN ATTENTIONAL 
RETRAINING INTERVENTION – A LABORATORY STUDY 
2  
2.1 Introduction 
In section 1.3, I described how cognitive processing biases in attention towards drug-
related cues have been well-documented in tobacco smokers and users of other drug 
substances (Lubman et al., 2000; Mogg et al., 2003). Several theoretical models of 
attentional bias propose that drug-related cues are able to capture the attention of a drug 
user, with habit-driven or motivational consequences towards drug use (Robinson & 
Berridge, 1993; Franken, 2003). As I mentioned in section 1.3.2.2, the visual probe task 
has been commonly used to measure attentional bias (MacLeod et al., 1986), in which 
participants are required to respond to probes that replace either drug-related stimuli or 
neutral stimuli. In smokers, an attentional bias towards smoking is indicated by faster 
reaction times to probes that appear in the location of smoking-related stimuli rather than 
neutral stimuli. Similarly, the addiction Stroop task has been used extensively to measure 
selective processing of drug-related stimuli (Cox et al., 2006b). A processing bias towards 
smoking is characterised by slower colour-naming of smoking-related stimuli than neutral 
stimuli. Both tasks have demonstrated that drug users – compared to non-drug users - 
show a bias towards drug-related stimuli of their choice (see sections 1.3.2.1 and 1.3.2.2). 
 
In section 1.4, I reviewed the laboratory evidence on the association between attentional 
bias and craving. Using modified versions of the visual probe task, drug users have been 
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trained to increase or decrease attentional bias in train-to-attend and train-to-avoid 
experimental manipulations, while effects on craving have also been measured (Attwood 
et al., 2008; Field & Eastwood, 2005; Field et al., 2007b; Field et al., 2009b; McHugh et 
al., 2010; Schoenmakers et al., 2007). Increases in attentional bias have been associated 
with increases in craving (Field & Eastwood, 2005) but not consistently; some studies 
have found this relationship only in male participants (Attwood et al., 2008) or those 
aware of the experimental contingencies (Field et al., 2007b) or not at all (Field et al., 
2009b; McHugh et al., 2010). While decreases in attentional bias are plausible using 
attentional retraining procedures, most studies have failed to find corresponding effects on 
craving [(Attwood et al., 2008; Field & Eastwood, 2005; Field et al., 2007b; Field et al., 
2009b; McHugh et al., 2010; Schoenmakers et al., 2007) see section 1.4.2].  
 
Differences in the experimental design of these studies may have contributed to the 
discrepancies found in retraining effects. As illustrated in Table 1, section 1.4.2, the 
amount of retraining delivered across studies has varied from 512 to 960 attentional 
retraining trials. It is unknown whether changes in attentional bias are dependent on the 
length of AR given. It may be that extending the length of AR produces stronger effects 
on attentional bias and craving, where a linear dose-response relationship would be 
observed. However, an alternative possibility is that a longer AR session may have 
detrimental effects on attentional bias and craving because the risk of participants’ 
experiencing boredom and fatigue is increased. In this instance, we might find a 
curvilinear relationship with training, due to fatigue effects involved with doing a 
repetitive task. 
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The purpose of the present study was to test the acceptability an AR intervention for use 
in a forthcoming smoking cessation trial. The ARTS trial, (a double blind randomised 
controlled trial of attentional bias retraining in smokers attempting smoking cessation) 
will use the modified visual probe task described above as a treatment tool. For these 
procedures to have any clinical value in the treatment of smokers who are seeking to quit, 
it is necessary to establish how much training is needed in order to detect any effects on 
attentional bias and craving. Furthermore, it is important to develop an intervention of a 
length that is both tolerable for patients and practical for practitioners to deliver alongside 
usual care in a NHS stop smoking clinic.  
 
We therefore aimed to investigate the extent to which the length of AR mediates 
attentional bias and subjective craving in tobacco smokers. We also sought to explore the 
relationship between AR and fatigue, which was inferred from the number of errors made 
during training. We used a between-subjects design to compare participants in an AR 
group who were trained away from smoking-related stimuli with a control group who 
received no training towards any particular stimulus-type. Unlike in the previous studies 
(Attwood et al., 2008; Field et al., 2009b), we did not include a group that was trained 
towards smoking-related stimuli because our primary interest lies in the potential clinical 
translation of AR procedures.  
 
Participants were further randomised to receive a short, medium or long block of AR or 
no training, in order to examine the effects of varying the length of the procedure. We 
included a cue-exposure task to measure cue-reactivity immediately after the procedure, 
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which has consistently been shown to evoke cue-induced craving (Attwood et al., 2008; 
Carter & Tiffany, 2001; Sayette et al., 2001). Finally, we examined whether any effects of 
AR could generalize to other measures of attentional bias, namely on a pictorial Stroop 
task. The issue of generalization of retraining effects in tobacco smokers has only been 
explored in one of the earlier studies (Field et al., 2009b), but the effects of training did 
not generalise to performance on a different task.  
 
2.2 Methods 
2.2.1 Participants 
Seventy-two non-treatment seeking smokers (36 males and 36 females) were recruited 
from the general population via posters and online advertising. Inclusion criteria included 
a minimum age of 18 years and self-reported tobacco smoking of at least five cigarettes 
per day. Participants were also required to have normal or corrected-to-normal vision. 
Participants were excluded if they had a severe acute or chronic medical or psychiatric 
illness, or if they were using illicit substances (excluding cannabis).  
 
The study was approved by the Faculty of Science Research Ethics Committee at the 
University of Bristol and the Life and Health Sciences Ethical Review Committee at the 
University of Birmingham.  
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2.2.2 Materials 
Twelve pairs of smoking-related and matched neutral pictures were used, as tested and 
applied in previous research (Attwood et al., 2008; Bradley et al., 2008; Mogg et al., 
2003). Each set of pictures consisted of a colour photograph of a smoking-related 
stimulus or scene (e.g. a close-up of a pack of cigarettes) matched as closely as possible to 
another photograph containing no smoking-related content. An additional four neutral 
picture pairs were used in practice trials. 
 
The same questionnaire measures were used as in the Attwood et al. (2008) study. This 
comprised of the Fagerström Test of Nicotine Dependence (FTND) (Heatherton et al., 
1991), a six-item measure assessing severity of nicotine dependence; the Spielberger 
State-Trait Anxiety Inventory state and trait sub-scales (STAI-State and STAI-Trait) 
(Spielberger et al., 1983), each containing 20 items rated on a four-point scale ranging 
from “not at all” to “very much so” on the STAI-State and “almost never” to “almost 
often” on the STAI-Trait; the Questionnaire of Smoking Urges - Brief (QSU-Brief) (Cox 
et al., 2001), a nine-item measure of urge to smoke rated on a seven-point scale ranging 
from “strongly disagree” to “strongly agree”; and visual analogue scales (VAS) for items 
including “happy”, “drowsy”, “depressed”, “anxious”, “energetic”, “irritable”, and 
“craving a cigarette” rated on a 100 mm (millimetre) scale from “not at all” to 
“extremely”.  
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2.2.3 Procedure 
Figure 3 provides a schematic overview of the allocation of participants and procedures. 
Participants were tested between the hours of 09:00 and 12:00. Participants were asked to 
abstain from cigarette smoking for 12 hours prior to the study, as stated in the participant 
information sheet (Appendix 1). Participants provided informed consent (Appendix 2) and 
samples of expired carbon monoxide on a MicroCO Meter (Care Fusion Ltd) to confirm 
temporary abstinence from smoking upon arrival. They then completed a questionnaire 
battery where baseline measurements (FTND, STAI-State, STAI-Trait, QSU-Brief and 
VAS) were taken immediately prior to the visual probe task (Appendix 3).  
 
The visual probe task consisted of blocks of practice trials, test trials and attentional 
retraining trials. The structure of each trial was similar across trials. Each trial began with 
a fixation cross displayed in the centre of the computer screen for 500 ms. A picture pair 
of smoking-related and neutral pictures was then presented for 500 ms. This picture pair 
disappeared and a visual probe, either a circle or a square, was presented in the location 
formerly occupied by one of the pictures. Participants were required to discriminate the 
identity of the probe and respond accordingly by pressing the up or down arrow keys on 
the keyboard as quickly as possible. The probe remained on the screen until a response 
was detected by the program, after which there was a 500 ms interval before the next trial 
began. On each trial, participants’ response latencies and accuracy were recorded. Each 
block of trials was presented in a new random order for each participant, using EPrime 
version 2 (Psychology Software Tools Inc., Pittsburgh PA). 
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Figure 3. Schematic overview of participant flow and procedures 
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Participants first completed eight practice trials in which neutral picture pairs were 
presented in order to familiarize themselves with the task. This was followed by one block 
of test trials, which provided a pre-task measure of attentional bias. The test comprised a 
total of 96 trials, across which the visual probes appeared in the location of the smoking-
related and neutral pictures with equal frequency. Following the test trials, participants 
were randomized to complete either a modified version of the visual probe task designed 
to train attention away from smoking-related stimuli (attentional retraining group) or no 
training towards any stimulus-type (control group). Within each group, participants were 
randomly allocated to receive one block, two blocks or three blocks of attentional 
retraining or no training, comprising a total of 96, 192 and 288 trials, respectively. For 
participants in the AR group, the visual probes always appeared in the location of the 
neutral pictures in every block. For participants in the control group, the visual probes 
were presented in the location of the smoking-related and neutral pictures with equal 
frequency. After AR or no training, participants completed another block of 96 test trials, 
which provided a post-task measure of attentional bias.  
 
Participants then provided pre-exposure mood and urge to smoke ratings (STAI-State; 
QSU-Brief; VAS). Subsequently, participants took part in a cue-exposure task. 
Standardized instructions for the task were delivered via a digital recorder. During the 3-
minute exposure, participants were seated in front of their own brand of cigarette, a 
lighter and an ashtray. They were instructed to pick up the cigarette, light it but not smoke 
it, and imagine what it would be like to smoke the cigarette before extinguishing it in the 
ashtray. Following the task, post-exposure mood and urge to smoke ratings were taken 
(STAI-State; QSU-Brief; VAS).  
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After the cue exposure task, participants completed a pictorial Stroop task. The same 12 
picture pairs of smoking-related and matched neutral pictures that were used in the visual 
probe task were used during this task.  Each picture, which had either an outline of a red, 
blue, yellow or green border, was presented centrally on the computer screen. Participants 
were required to indicate the colour of the border, while ignoring the picture, by pressing 
one of four corresponding colour-labelled keys on the keyboard, as quickly as possible. 
Participants received eight practice trials in which neutral pictures were presented first, 
followed by 96 trials, presented in two blocks of 48 trials.  
 
At the end of the session, participants were asked a question about their awareness of the 
experimental contingencies during the visual probe task. Participants were asked whether 
they thought that the visual probes always appeared in the location of the smoking-related 
pictures, the neutral pictures or both with equal frequency. They were then debriefed and 
reimbursed £10 for their time (Appendix 4). On the next day, all participants were 
contacted for follow-up and asked when they had their first cigarette after leaving the 
session. If this was within 30 minutes of leaving the session, participants were asked to 
specify the number of minutes at 5-minute intervals (e.g. “within 10-15 minutes”). 
 
2.2.4 Data analysis 
2.2.4.1 Primary analyses  
Attentional bias scores on the visual probe task were calculated in the following way. A 
reaction time (RT) was produced for each correct response made on each trial where the 
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probe replaced either the smoking-related picture or neutral picture. A mean RT was 
calculated for all RTs produced for smoking-related pictures and all RTs produced for 
neutral pictures. A score for attentional bias was calculated by subtracting the overall 
mean RT to smoking-related pictures from the mean RT to neutral pictures, where a 
positive score indicated a bias towards smoking cues and a negative score indicated a bias 
towards neutral cues. These scores were used to examine retraining effects on attentional 
bias firstly by group and secondly by block length, in a series of analyses of covariance 
(ANCOVAs). Mixed model analyses of variance (ANOVAs) were also performed using 
mean RTs for each picture type. Where significant interactions were found, further 
analyses were performed using ANOVAs and t-tests (details provided within each sub-
section below). For all mixed model ANOVAs, Greenhouse-Geisser was used to report all 
F-values. T-tests were two-tailed and an alpha level of 0.05 was set. These analyses were 
performed using PASW Statistics 18 (SPSS, Inc., 2009, Chicago, IL, USA).  
 
In order to investigate retraining effects on subjective craving by group and block length 
over time, data were analysed using mixed effects regression models with an 
autoregressive variance-covariance structure. The reasons for choosing this approach over 
univariate methods were three-fold; firstly, mixed effects regression takes into account 
that the rate of change in craving across time varies between participants and so estimates 
are produced for each participant, while ANOVA relies on averaging across all 
participants and thus fails to capture this variation (Hedeker, 2004). Secondly, an 
autoregressive modelling structure takes into consideration that repeated craving 
measurements taken closer together in time on the same participant are likely to be more 
highly correlated than measurements that are taken further apart in time; ANOVA on the 
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other hand, assumes that all assessments are similarly correlated over time (Vittinghoff et 
al., 2004). Finally, due to the complexity of the experimental design, mixed effects 
regression modelling was the most practical way for me to examine the three-way 
interaction between group, block length and time. This modelling technique was used on 
the QSU-Brief scores and the single VAS item “craving a cigarette”. Regression 
coefficients, p-values and 95% confidence intervals (CI) were derived from the models. 
These analyses were implemented in Stata 11.0 (StataCorp, 2009, College Station, TX: 
StataCorp LP). 
 
2.2.4.2 Secondary analyses 
We investigated the effects of AR on mood and withdrawal over time using scores from 
the STAI-State and VAS measures in mixed model ANOVAs. To control for multiple 
testing and avoid the risk of making a Type 1 error, an alpha level of 0.008 was set for the 
VAS measures following a Bonferroni adjustment for six independent tests.   
 
To examine whether AR affected selective processing biases on the pictorial Stroop task, 
mean RTs to colour-naming trials of neutral pictures were subtracted from the mean RTs 
to colour-naming trials of smoking-related pictures to give an overall Stroop bias score. 
Slower RTs to smoking-related pictures indicated a processing bias towards smoking 
cues, while faster RTs to neutral pictures indicated a bias towards neutral cues. T-tests 
were used to compare Stroop bias scores between groups and at each block length. Mean 
RTs for each picture type were also examined in mixed model ANOVAs. 
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Contingency awareness was assessed using a chi-squared test and time to first cigarette 
questionnaire data were analysed using Mann-Whitney U.  
 
Error data from training trials were analysed using multilevel logistic regression to 
examine the effects of each block length on the number of errors made. Errors consisted 
of incorrect responses to the probe, including responses of <200 ms that were considered 
too quick to represent true attentional processing and responses of >1500 ms, which were 
considered too slow (including those that timed out, i.e. no response was made). Odds 
ratios (OR) and 95% confidence intervals (CI) were compared. Finally, linear regression 
was used to examine error frequency on attentional bias scores, with error treated as a 
categorical variable (0-4 errors/5+ errors). 
 
2.3 Results 
2.3.1 Data reduction 
Test trials comprising of errors were removed from visual probe task data; error rates 
were 7.4% pre-training and 4.3% post-training. All visual probe task data were missing 
from three participants and post-training data were missing for one participant due to a 
computer error. All visual probe task data were excluded for one participant based on a 
high percentage of trial errors (51%) and outlying RTs (mean <200 ms). 
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Trials with errors were also removed from pictorial Stroop task data; the error rate was 
3.8%. All pictorial Stroop task data were excluded for one participant due to a high 
percentage of trial errors (62.5%). Results are reported for n=67 participants.  
 
2.3.2 Participant characteristics 
The sample included 33 males and 34 females, aged between 18 and 49 (M=23.91, 
SD=6.22). Participants smoked between 5 and 27 cigarettes per day (M=9.97, SD=4.81) 
and started smoking between the ages of 13 and 24 (M=16.36, SD=2.40). Participants had 
an FTND score between 0 and 7 (M=2.60, SD=2.04). Table 2 shows summary data for 
baseline measures by group allocation and Table 3, Table 4 and Table 5 by length of 
block allocation.  
 
Table 2. Baseline characteristics of participants by group 
  
All                              
(n= 67) 
Attentional 
retraining                 
(n= 32) 
Control           
(n=35) 
  M (SD) M (SD) M (SD) 
Gender ratio (M:F)  33:34 17:15 16:19 
Age (years) 23.91 (6.22) 24.03 (6.07) 23.80 (6.44) 
Cigarettes smoked per day 9.97 (4.81) 10.16 (5.27) 9.80 (4.41) 
Age started smoking (years) 16.36 (2.40) 16.91 (2.61) 15.86 (2.10) 
FTND* 2.60 (2.04) 2.50 (2.14) 2.69 (1.97) 
STAI-Trait 41.60 (9.94) 42.00 (10.40) 41.23 (9.64) 
STAI-State at baseline 37.25 (8.96) 35.97 (7.03) 38.42 (10.38) 
QSU-Brief total at baseline 33.12 (12.40) 29.34 (10.74) 36.57 (12.95) 
VAS craving at baseline 42.99 (19.63) 40.06 (19.36) 45.66 (19.77) 
*Fagerstrom Test for Nicotine Dependence, scored from 0-10 
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Table 3. Baseline characteristics of participants by allocation to short block length 
Short block length 
All                   
(n= 23) 
Attentional 
retraining               
(n= 11) 
Control           
(n=12) 
  M (SD) M (SD) M (SD) 
Gender ratio (M:F)  15:8 8:3 7:5 
Age (years) 24.13 (6.15) 25.27 (7.24) 23.08 (5.04) 
Cigarettes smoked per day 10.78 (5.19) 10.82 (6.34) 10.75 (4.16) 
Age started smoking (years) 16.65 (2.27) 16.91 (2.81) 16.42 (1.73) 
FTND* 2.65 (2.19) 2.55 (2.42) 2.75 (2.05) 
STAI-Trait 38.26 (9.13) 36.55 (8.92) 39.83 (9.42) 
STAI-State at baseline 33.05 (8.43) 31.00 (4.86) 35.09 (10.79) 
QSU-Brief total at baseline 29.00 (11.80) 27.45 (10.62) 30.36 (13.74) 
VAS craving at baseline 37.39 (20.46) 35.64 (19.27) 38.00 (23.01) 
*Fagerstrom Test for Nicotine Dependence, scored from 0-10 
 
Table 4. Baseline characteristics of participants by allocation to medium block 
length 
Medium block length 
All                  
 (n= 23) 
Attentional 
retraining                
(n= 13) 
Control           
(n=10) 
  M (SD) M (SD) M (SD) 
Gender ratio (M:F)  10:13 5:8 5:5 
Age (years) 25.57 (7.56) 23.69 (5.82) 28.00 (9.10) 
Cigarettes smoked per day 9.35 (5.30) 9.15 (5.08) 9.60 (5.84) 
Age started smoking (years) 16.83 (2.33) 17.15 (1.95) 16.40 (2.80) 
FTND* 2.48 (2.13) 2.23 (2.24) 2.80 (2.04) 
STAI-Trait 43.61 (11.02) 43.85 (11.97) 43.30 (10.26) 
STAI-State at baseline 40.70 (9.65) 39.55 (8.07) 42.11 (11.66) 
QSU-Brief total at baseline 33.30 (13.79) 31.18 (11.09) 36.67 (15.08) 
VAS craving at baseline 43.57 (21.71) 44.45 (18.26) 43.56 (24.25) 
*Fagerstrom Test for Nicotine Dependence, scored from 0-10 
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Table 5. Baseline characteristics of participants by allocation to long block length 
Long block length 
All                  
 (n= 21) 
Attentional 
retraining                   
(n= 8) 
Control           
(n=13) 
  M (SD) M (SD) M (SD) 
Gender ratio (M:F)  8:13 4:4 4:9 
Age (years) 21.86 (3.97) 22.88 (5.11) 21.23 (3.14) 
Cigarettes smoked per day 9.76 (3.82) 10.88 (4.29) 9.08 (3.50) 
Age started smoking (years) 15.52 (2.50) 16.50 (3.46) 14.92 (1.55) 
FTND* 2.67 (1.85) 2.88 (1.73) 2.54 (1.98) 
STAI-Trait 43.05 (9.01) 46.40 (6.59) 40.92 (9.86) 
STAI-State at baseline 38.38 (7.28) 37.88 (3.83) 38.69 (8.91) 
QSU-Brief total at baseline 37.43 (10.31) 31.75 (9.87) 40.92 (9.25) 
VAS craving at baseline 48.48 (15.00) 43.63 (19.24) 51.46 (11.57) 
*Fagerstrom Test for Nicotine Dependence, scored from 0-10 
 
2.3.3 Attentional bias at baseline  
A one-sample t-test against zero indicated that there was no significant attentional bias 
towards smoking cues in the sample at baseline (t[66]=0.46, p=0.65). Although the AR 
group exhibited a higher attentional bias (mean difference=2.42), this was not statistically 
significant (t[65]=0.22, p=0.83). As can be seen in Table 6, mean RTs for smoking-
related pictures across both groups were lower than mean RTs for neutral pictures at 
baseline, suggesting that participants were responding faster in the predicted direction (for 
mean RTs by block length, see Appendix 5).  
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Table 6. Pre-training and post-training attentional bias scores by group 
  
Attentional 
retraining           
(n=32) 
Control           
(n=35) 
    
  M (SD) M (SD) 
Mean  
difference t p 95% CI 
Pre-training 
660.50 (124.64) 676.56 (128.25) -16.06 -0.52 0.61 (-77.87, 45.75)   RT for smoking stimuli 
  RT for neutral stimuli 664.27 (129.20) 677.90 (129.41) -13.63 -0.43 0.67 (-76.80, 49.53) 
  Attentional bias 3.77 (51.39) 1.34 (38.39) 2.42 0.22 0.83 (-19.59, 24.43) 
Post-training 
611.56 (127.69) 603.93 (102.82) 7.63 0.27 0.79 (-48.71, 63.98)   RT for smoking stimuli 
  RT for neutral stimuli 619.59 (130.62) 611.21 (117.41) 8.38 0.28 0.78 (-52.14, 68.90) 
  Attentional bias 8.03 (32.31) 7.29 (45.62) 0.75 0.08 0.94 (-18.71, 20.20) 
Change score attentional 
bias 4.27 (64.02) 5.94 (52.95) -1.68 -0.12 0.91 (-30.25, 26.89) 
RT - reaction time (milliseconds) 
 
2.3.4 Association between attentional bias and subjective craving at baseline 
To examine whether the visual probe task measure of attentional bias was correlated with 
subjective craving measures at baseline, Pearson’s correlations were performed between 
the baseline attentional bias scores, QSU-Brief scores and VAS score for the item 
“craving a cigarette” on all participants. A strong positive correlation was found between 
both craving measures (r=+0.87, p<0.001), but neither measure was correlated with the 
attentional bias scores (ps>0.52, rs<-0.05). 
 
2.3.5 Effects of attentional retraining on attentional bias  
A one-way between-groups analysis of covariance (ANCOVA) was performed using pre-
training attentional bias scores as the covariate.  
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After adjusting for pre-training attentional bias scores, no significant differences were 
found between groups in post-training attentional bias scores (F[2,64]=0.004, p=0.95). 
Similarly, in a 2 x 2 between-groups ANCOVA with participant gender as an additional 
factor, there were no significant main effects or interactions (Fs<0.27, ps>0.61).  
 
The analyses were re-run in a 3 x 2 ANCOVA with the inclusion of block length (short, 
medium, long) but no significant main effects or interactions were found (Fs<2.39, 
ps>0.10).  
 
To examine whether there were group differences between pre and post training RT 
scores to each picture type, data were analysed using a 2 x 2 x 2 mixed model ANOVA 
with group (attentional retraining/control) as the between-subjects factor and picture type 
(smoking-related pictures/neutral pictures) and time (pre-training/post-training) as the 
within-subjects factors. There was a significant effect of time (F[1,65]=22.22, p<0.001, 
partial η2=0.26) but there were no other significant main effects or interactions (Fs<1.83, 
ps>0.18). Within-subjects t-tests, performed separately on each group, indicated that 
participants in the AR group responded significantly faster to both smoking-related 
pictures (t[31]=2.17, p<0.04) and neutral pictures (t[31]=2.61, p<0.01) post-training, as 
did the control group for smoking-related pictures (t[34]=4.18, p<0.001) and neutral 
pictures (t[34]=4.26, p<0.001) post-training, which may reflect practice effects (Figure 4).  
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a) 
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b) 
 
Figure 4. Pre-training and post-training mean reaction time scores (in milliseconds) 
to neutral and smoking-related pictures. Data are shown separately for a) control 
group (n=35) and b) attentional retraining group (n=32) 
 
When block length (short, medium, long) was added as an additional between-subjects 
factor in the mixed model ANOVA described above, there was a significant main effect 
of time (F[1,61]23.21, p<0.001, partial η2=0.28) and a 3-way interaction of group x block 
length x picture type (F[2,61]3.41, p<0.04, partial η2=0.10). There was also a significant 
block length x time interaction (F[2,61]3.63, p<0.03, partial η2=0.11). No other 
significant main effects or interactions were observed (Fs<3.10, ps>0.09). 
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We investigated the source of this interaction by conducting a 2 x 2 x 2 mixed model 
ANOVA by block length. There was a significant group x picture type interaction effect 
at the medium block length (F[1, 21]6.70, p<0.02, partial η2=0.24) and main effects of 
time at the medium block length (F[1, 21]13.13, p<0.002, partial η2=0.39)  and long block 
length (F[1, 21]19.26, p<0.001, partial η2=0.50). No significant main effects or 
interactions were found at the short block length (ps>0.25). 
 
Within subjects t-tests revealed that participants in the AR group who were allocated to 
the medium block length responded significantly faster to both smoking-related pictures 
(t[12]=4.92, p<0.001) and neutral pictures (t[12]=5.18, p<0.001) post-training. While the 
AR group responded faster to both picture types overall, participants were quicker to 
respond to neutral pictures than smoking-related pictures (mean difference=-6.33 ms). In 
contrast, the control group were quicker to respond to smoking-related pictures than 
neutral pictures (mean difference=18.43 ms).  
 
2.3.6  Effects of attentional retraining on subjective craving  
2.3.6.1 Statistical modelling of QSU-Brief and VAS scores 
Two independent, fully specified, mixed-effects regression models of subjective craving 
with QSU-Brief scores and VAS “craving a cigarette” scores as outcome variables against 
the explanatory variables, group (attentional retraining/control), time (baseline/pre-
exposure/post-exposure) and block length (short/medium/long) were constructed. In all 
models, the reference categories were the control group, time at baseline and the short 
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block length. Participant ID was treated as the random effects part of the models. 
Participant gender was entered in the model as a covariate since this was found to be a 
moderator of retraining effects on craving in a previous study (Attwood et al., 2008).  
 
The fully specified models included all main effects, lower order two-way interactions 
and a three-way interaction between group, time and block length. Stepwise regression 
was carried out using backward elimination to remove sets of interactions that failed to 
reach the significance threshold (p<0.05) and thus had little influence on the outcome 
variable. Additionally, model comparisons were performed using chi squared to assess 
goodness of fit and qualify the removal of any interactions. The overall aim was to 
produce the most parsimonious model of QSU-Brief scores and VAS scores to best 
explain the data. 
 
The fully specified models were used to produce linear combinations of the coefficients in 
order to estimate the overall effect of AR on QSU-Brief scores and VAS craving scores 
between groups at each time point and block length. 
 
At each step of modelling, diagnostic checks were carried out on the residuals of each 
model using scatter plots to check normality (see Appendix 6).  Box and whisker plots 
were constructed to check the distribution of scores (see Appendix 7).   
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2.3.6.1.1 QSU-Brief 
Figure 5 and Figure 6 illustrate the mean scores for the QSU-Brief by group and block 
length, respectively. In both groups and at each block length, there was a general increase 
in craving over time. The change in craving was greater in the AR group compared to the 
control group from baseline to pre-exposure (mean difference=5.56) but not from pre-
exposure to post-exposure, where the difference was smaller in the AR group compared to 
the control group (mean difference=-1.71, see Figure 7). A similar pattern was observed 
across each block length apart from the medium block length, where the change in 
craving from pre-exposure to post-exposure was marginally greater in the AR group 
compared to the control group (mean difference=1.35, see Appendix 8 for details). 
Figure 5. Mean (95% CI) QSU-Brief craving scores at baseline, pre-exposure and 
post-exposure in the attentional retraining group (n=32) and control group (n=35) 
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Figure 6. Mean (95% CI) QSU-Brief craving scores at baseline, pre-exposure and 
post-exposure in the attentional retraining group (n=32) and control group (n=35) 
by short, medium and long block length 
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Figure 7. Mean (95% CI) change in QSU-Brief scores from baseline to pre-exposure 
and post-exposure in the attentional retraining group (n=32) and control group 
(n=35) 
 
The most parsimonious mixed-effects model of QSU-Brief scores was reached through 
elimination of non-significant interactions between group, time and block length, time by 
block length and group by block length (Table 7). The inclusion of participant gender did 
not significantly improve the fit of the model nor alter the coefficients substantially; 
therefore this was discarded during initial modelling steps. Model comparisons indicate 
that the parsimonious model was similar to the fully specified model because there was no 
 
CHAPTER 2 
 
 
65 
 
significant difference in fit; while there were fewer degrees of freedom in the 
parsimonious model, there was no significant loss in the log-likelihood (Table 8). 
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Table 7. Mixed-effects models of QSU-Brief scores over time by group and block length 
  Model 1 Model 2 Model 3 Model 4 Model 5 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Fixed effects 
            Group₁ -3.13 0.54 -2.96 0.56 -5.58 0.25 -5.50 0.26 -6.80 0.03 
  Gender₂ -1.20 0.68 
          Time (pre-exosure)₃ 3.08 0.12 3.08 0.12 1.78 0.28 2.34 0.05 2.34 0.05 
  Time (post-exposure)₃ 8.92 0.001 8.92 0.001 6.43 0.003 6.46 0.001 6.46 0.001 
  Block length (medium)₄ 7.98 1.53 7.88 0.13 5.53 0.27 5.29 0.28 4.66 0.17 
  Block length (long)₄ 10.84 2.19 10.51 0.03 8.94 0.06 9.36 0.04 8.18 0.02 
Intercept 30.92 
 
30.42 
 
31.67 
 
31.58 
 
32.2 
 Interactions 
            Group x Time (pre-exposure) 2.92 0.31 2.92 0.31 5.64 0.001 5.56 0.001 5.56 0.001 
  Group x Time (post-exposure) -1.19 0.75 -1.19 0.75 4.01 0.07 3.86 0.08 3.86 0.08 
  Group x Block length (medium) -5.57 0.44 -5.88 0.42 -1.31 0.85 -1.31 0.85 
    Group x Block length (long) -6.27 0.40 -6.21 0.41 -2.78 0.69 -2.78 0.69 
    Time (pre-exposure) x Block length (medium) -1.48 0.61 -1.48 0.61 0.47 0.82 
      Time (pre-exposure) x Block length (long) -0.85 0.76 -0.85 0.76 1.17 0.58 
      Time (post-exposure) x Block length (medium) -5.52 0.14 -5.52 0.14 -0.70 0.79 
      Time (post-exposure) x Block length (long) -2.38 0.50 -2.38 0.50 0.61 0.82 
      Group x Time (pre-exposure) x Block length (medium) 3.87 0.34 3.87 0.34 
        Group x Time (pre-exposure) x Block length (long) 4.60 0.27 4.60 0.27 
        Group x Time (post-exposure) x Block length (medium) 9.33 0.07 9.33 0.07 
        Group x Time (post-exposure) x Block length (long) 6.53 0.23 6.53 0.23 
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Table 7 continued 
 
            Model 1 Model 2 Model 3 Model 4 Model 5 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Random effects 
           Participant ID, intercept (SD) 8.89 
 
8.91 
 
8.22 
 
8.23 
 
    8.28 
 -2*log likelihood -704.56   -704.64   -706.5 
 
-706.8 
 
-706.88 
Model 1: craving score by group, gender, time, block length and interaction terms group x time x block length, group x time, group x block length, time x block length 
Model 2: craving score by group, time, block length and interaction terms group x time x block length, group x time, group x block length, time x block length 
Model 3: craving score by group, time, block length and interaction terms  group x time, group x block length, time  x block length 
Model 4: craving score by group, time, block length and interaction terms group x time, group x block length 
Model 5: craving score by group, time, block length and interaction term group x time  
  ₁ Reference category is control group, ₂Reference category is males, ₃Reference category is time (baseline), ₄Reference category is block  
length (short) 
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Table 8. Difference in fit between models of QSU-Brief scores over time 
  LL₁ LL₂ Chi squared df p 
         Model 1 to 2 -704.56 -704.64 0.08 1 0.78 
         Model 2 to 3 -704.64 -706.50 1.86 4 0.76 
         Model 2 to 4 -704.64 -706.80 2.16 8 0.98 
         Model 2 to 5 -704.64 -706.88 2.24 10 0.99 
         
 
Model 1: craving score by group, gender, time, block length and interaction terms group x time x block 
length, group x time, group x block length, time x block length  
Model 2: craving score by group, time, block length and interaction terms group x time x block length, 
group x time, group x block length, time x block length 
Model 3: craving score by group, time, block length and interaction terms group x time, group x block 
length, time x block length 
Model 4: craving score by group, time, block length and interaction terms group x time, group x block 
length  
Model 5: craving score by group, time, block length and interaction term group x time  
LL₁ - loglikelihood of hierarchically superior model; LL₂ - loglikelihood of comparison model  
 
The only significant interaction found in the parsimonious model was a group by time 
(pre-exposure) interaction (β=5.56, p<0.001). The absence of any significant interactions 
by block length suggests that effects of group or time on craving were not mediated by 
block length; as can be seen in Figure 6, there was no difference in trend across blocks. 
 
Linear combinations of the coefficients derived from the fully specified model indicated 
that there was a non-significant reduction in craving at pre-exposure and post-exposure at 
each block length in the AR group compared to the control group (Table 9). Irrespective 
of block length, craving scores at pre-exposure were 0.05 points less in the AR group than 
in the control group and 4.15 points less at post-exposure, although these differences did 
not reach statistical significance at either time point (ps>0.05).  
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Table 9. Linear combinations of coefficients for QSU-Brief scores at pre-exposure 
and post-exposure by short, medium and long block length 
 
2.3.6.1.1 VAS 
Mean scores for the VAS item “craving a cigarette” indicate that cue-induced craving 
increased from baseline to pre-exposure in both groups (Figure 8) and at each block 
length (Figure 9). There was a decrease in VAS scores from pre-exposure to post-
exposure across both groups and at each block length. While the change in craving from 
baseline to pre-exposure was greater in the AR group compared to the control group 
(mean difference=5.52), the change in craving was less from pre-exposure to post-
exposure (mean difference=3.46, see Figure 10). This was also evident across block 
lengths (Appendix 9).  
                      Time 
  Pre-exposure   Post-exposure 
 
Regression 
coefficient p CI   
Regression 
coefficient p CI 
Short -0.05 0.99 (-10.03, 9.94) 
 
-4.15 0.42 (-14.14, 5.84) 
Medium -2.05 0.69 (-12.12, 8.01) 
 
-0.70 0.89 (-10.76, 9.36) 
Long -1.65 0.76 (-12.41, 9.10) 
 
-3.84 0.48 (-14.59, 6.92) 
CHAPTER 2 
 
 
70 
 
 
Figure 8. Mean (95% CI) VAS craving scores at baseline, pre-exposure and post-
exposure in the attentional retraining group (n=32) and control group (n=35) 
 
 
Time 
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Figure 9. Mean (95% CI) VAS craving scores at baseline, pre-exposure and post-
exposure in the attentional retraining group (n=32) and control group (n=35) by 
short, medium and long block length 
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Figure 10. Mean (95% CI) change in VAS craving scores from baseline to pre-
exposure and post-exposure in the attentional retraining group (n=32) and control 
group (n=35) 
 
The mixed-effects model fitted to the data indicated that there were no significant three-
way interactions between group, time and block length or two-way interactions of group 
by block length or group by time (Table 10). The most parsimonious model of VAS 
scores contained a significant time (post-exposure) by block length (long) interaction 
only, which suggests that there was no difference in trend across groups (Figure 9).
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Table 10. Mixed-effects models of VAS craving scores over time by group and block length 
  Model 1 Model 2 Model 3 Model 4 
  
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
  Fixed effects 
            Group₁ -3.36 0.65 -2.93 0.60 -5.11 0.25 -0.41 0.87 
    Time (pre-exosure)₂ 6.17 0.41 7.08 0.25 7.08 0.25 9.74 0.07 
    Time (post-exposure)₂ -18.00 0.01 -18.32 0.003 -18.32 0.003 -14.26 0.007 
    Block length (medium)₃ 7.10 0.35 8.55 0.16 6.62 0.21 6.21 0.24 
    Block length (long)₃ 12.46 0.08 11.90 0.05 10.59 0.05 11.04 0.04 
  Intercept 39.00 
 
38.79 
 
39.83 
 
37.59 
   Interactions 
            Time (pre-exposure) x Block length (medium) 1.03 0.93 -2.00 0.79 -2.01 0.79 -1.52 0.84 
    Time (pre-exposure) x Block length (long) -1.55 0.88 -1.67 0.83 -1.67 0.83 -2.22 0.78 
    Time (post-exposure) x Block length (medium) -12.10 0.26 -13.35 0.07 -13.35 0.08 -12.61 0.09 
    Time (post-exposure) x Block length (long) -19.08 0.06 -17.25 0.02 -17.25 0.03 -18.07 0.01 
    Group x Time (pre-exposure) 7.47 0.49 5.55 0.38 5.56 0.38 
      Group x Time (post-exposure) 7.82 0.46 8.50 0.18 8.50 0.18 
      Group x Block length (medium) -1.12 0.92 -3.75 0.53 
        Group x Block length (long) -4.47 0.68 -2.89 0.64 
        Group x Time (pre-exposure) x Block length (medium) -5.67 0.71 
          Group x Time (pre-exposure) x Block length (long) 0.16 0.99 
          Group x Time (post-exposure) x Block length (medium) -2.10 0.89 
          Group x Time (post-exposure) x Block length (long) 4.63 0.77 
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Table 10 continued 
 
 
 
   
 
Model 1 Model 2 Model 3 Model 4 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Random effects 
         Participant ID, intercept (SD) 1.23E-10 
 
1.51E-10 
 
1.12E-11 
 
9.42E-11 
 -2*log likelihood -864.83   -864.99   -865.2     -866.15 
      Model 1: craving score by group, time, block length and interaction terms group x time x block length, group x time,  
group x block length, time x block length 
Model 2: craving score by group, time, block length and interaction terms  group x time, group x block length,  
time x block length 
   Model 3: craving score by group, time, block length and interaction terms group x time, time x block length 
     Model 4: craving score by group, time, block length and interaction term time x block length 
      ₁ Reference category is control group, ₂ Reference category is time (baseline), ₃ Reference category is block length (short) 
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Linear combinations of the coefficients indicated that at pre-exposure, there was a non-
significant increase in craving for participants who received the short block length in the 
AR group compared to the control group, while a non-significant reduction was found in 
those that received the medium and long block lengths (Table 11). At post-exposure, 
across all block lengths, there was a non-significant increase in craving in the AR group 
compared to the control group, although the confidence intervals were again wide, 
indicating some degree of imprecision in the estimates. 
 
Table 11. Linear combinations of coefficients for VAS craving scores at pre-
exposure and post-exposure by short, medium and long block length 
                      Time 
  Pre-exposure   Post-exposure 
 
Regression 
coefficient p CI   
Regression 
coefficient p CI 
Short 4.11 0.58 (-10.53, 18.74) 
 
4.45 0.55 (-10.18, 19.09) 
Medium -2.68 0.72 (-17.43, 12.06) 
 
1.23 0.87 (-13.52, 15.98) 
Long -0.20 0.98 (-15.96, 15.55)   4.61 0.57 (-11.14, 20.37) 
 
2.3.7 Effects of attentional retraining on mood and withdrawal  
Mood and withdrawal scores for STAI-State anxiety and VAS items “happy”, “drowsy”, 
“depressed”, “anxious”, “energetic” and “irritable” were analysed using mixed model 2 x 
3 ANOVAs with group (attentional retraining/control) as the between-subjects factor and 
time (baseline/pre-exposure/post-exposure) as the within-subjects factor. There were 
significant main effects of time on VAS scores for the items “happy” (F[2,130]=12.12, 
p<0.001, partial η2=0.16), “depressed” (F[2,130]=50.29, p<0.001, partial η2=0.44), 
“anxious” (F[2,130]=6.23, p<0.008, partial η2=0.09) and “irritable” (F[2,130]=6.75, 
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p<0.006, partial η2=0.09). Scores for the items “anxious” and “irritable” increased over 
the three time-points, where as scores for “happy” decreased over time. Scores for 
“depressed” decreased from baseline to pre-exposure but increased from pre-exposure to 
post-exposure. No other main effects or interactions were significant (Fs<5.42, ps>0.01). 
 
When block length was included as an additional between-subjects factor in the model 
above, there were significant main effects of time for the items “happy” (F[2,122]=13.07, 
p<0.001, partial η2=0.18), “depressed” (F[2,122]=501.06, p<0.001, partial η2=0.45), 
“anxious” (F[2,122]=6.83, p<0.005, partial η2=0.10) and “irritable” F[2,122]=6.33, 
p<0.008, partial η2=0.09) and a time x block length interaction for “happy” 
F[2,122]=7.49, p<0.001, partial η2=0.20). There was a general decrease over time for 
ratings of “happy” across block length, apart from at the long block length where there 
was an increase from pre-exposure to post-exposure. Mean scores for “depressed”, 
“anxious” and “irritable” increased over time. 
 
For STAI-State anxiety scores, there was a significant increase over time 
(F[2,110]=27.77, p<0.001, partial η2=0.34) but no other significant main effects or 
interactions were found (Fs<0.60, ps>0.51). With the inclusion of block length (short, 
medium, long) as a between-subjects factor in the ANOVA above, there were main 
effects of time (F[2,102]=27.32, p<0.001, partial η2=0.35) and block length 
(F[2,51]=3.51, p<0.04, partial η2=0.12), while all other interactions were not significant 
(Fs<1.42, ps>0.25). Post-hoc tests revealed that anxiety scores were higher for those who 
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received the long block length than those who received the short block length (mean 
difference=7.19) and this difference approached significance (p=0.07).  
 
2.3.8 Effects of attentional retraining on pictorial Stroop task performance  
An independent sample t-test revealed that there was no significant difference between 
groups in Stroop bias scores post-training (t[65]=1.25, p=0.22). See Table 12 for 
summary data. 
 
To examine whether there were group differences in colour-naming RT scores to each 
picture type, data were analysed using a 2 x 2 mixed model ANOVA with group 
(attentional retraining/control) as the between-subjects factor and picture type (smoking-
related pictures/neutral pictures) as the within-subjects factor. No significant main effects 
or interactions were observed (Fs<1.57, ps>0.22), which suggests that attentional 
retraining had no effect on Stroop task performance. This was also the case when block 
length (short, medium, long) was added as an additional between-subjects factor in the 
ANOVA above (Fs<2.62, ps>0.08). 
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Table 12. Pre-training and post-training Stroop bias scores by group 
  
Attentional 
retraining            
(n= 32) 
Control           
(n=35) 
    
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
RT for smoking 
stimuli 735.55 (160.66) 692.11 (155.09) 43.43 1.13 0.26 (-33.63, 120.50) 
RT for neutral 
stimuli 707.66 (135.35) 694.03 (110.25) 13.63 0.45 0.65 (-46.39, 73.64) 
Stroop bias 27.89 (75.40) -1.91 (113.75) 29.80 1.25 0.22 (-17.75, 77.36) 
RT - reaction time (milliseconds) 
 
2.3.9 Effects of attentional retraining on time to first cigarette after laboratory session 
The majority of participants reported having a cigarette within 5 minutes of leaving the 
laboratory session; this number was higher in the control group (60%) than the AR group 
(43.8%, see Figure 11). Overall, there were no significant differences between groups in 
the time to first cigarette (U=472.50, p=0.24, r=0.15). 
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Figure 11. Time to first cigarette following laboratory session in the attentional 
retraining group (n=32) and control group (n=35) 
 
2.3.10  Contingency awareness 
In total, 14 participants (20.9%) were ‘aware’ of the experimental contingency (i.e. they 
had correctly identified the relationship between the location of the probe and picture type 
or lack thereof in the case of the control group). The remaining 53 participants (79.1%) 
were ‘unaware’ of the experimental contingency (i.e. they had incorrectly identified the 
relationship between the location of the probe and picture type or were unsure). There was 
a significant association between group and contingency awareness (χ2=11.70, p<0.001), 
where significantly fewer participants in the AR group (n=1, 3.1%) were ‘aware’ of the 
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experimental contingency in comparison to the control group (n=13, 37.1%). Due to the 
low number of participants who were aware of the experimental contingencies in the AR 
group, we were unable to carry out any further analyses on the role of contingency 
awareness on the effects of AR. 
 
2.3.11  Effect of block length on error rate 
Table 13 shows summary data for the number of errors made during training trials by 
each block length. Multilevel logistic regression indicated that compared to those who 
received the short block length, participants were more likely to make errors if they 
received the medium block length (OR 1.55, 95% CI=0.72, 3.35). The risk of making an 
error increased if participants received the long block length (OR 2.03, 95% CI=0.93, 
4.42). However, statistical significance was not reached in either case (ps>0.07). 
 
Table 13. Number of errors made by short, medium and long block length 
 
Short 
(n=2208*) 
Medium 
(n=4416*) 
Long 
(n=5526*) 
Incorrect responses (% of total) 68 (0.6) 195 (1.6) 243 (2.0) 
<200 RT 13 (0.1) 51 (0.4) 26 (0.2) 
>1500 RT 18 (0.1) 26 (0.2) 50 (0.4) 
*Total number of trials across all participants 
 
2.3.12  Error frequency on attentional retraining effects 
To examine whether error frequency was a mediator of retraining effects, linear 
regression was carried out with error as an explanatory variable and post-training 
attentional bias score as the outcome variable. Pre-training attentional bias scores were 
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controlled for in the analysis. Prior to analysis, a categorical variable was created for 
errors made because the distribution of errors was positively skewed. Error was split into 
two categories: 0-4 errors and >5 errors. There were too few participants in each category 
to explore interactions by block length, therefore block length was omitted from the 
model and the subsequent analysis was performed by group only. 
 
In participants who made less than five errors during training trials, a reduction in post-
training attentional bias scores was found in the AR group compared to the control group 
(β=-4.00, p=0.77, 95% CI=-31.32, 23.32), while an increase was found in those who 
made more than five errors (β=2.43, p=0.86, 95% CI=-25.87, 30.72). Attentional 
retraining effects appeared to decrease as the frequency of errors made during training 
trials increased (Figure 12), however we should note that there were no significant main 
effects or interactions (ps>0.39) and the reported coefficients were small and 
encompassing confidence intervals wide. 
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Figure 12. Attentional bias scores (ms) by error frequency in the attentional 
retraining group (n=32) and control group (n=35) 
 
2.3.13  Sub-group analyses 
As the sample did not exhibit an attentional bias towards smoking-related stimuli at 
baseline, we explored whether retraining effects were seen in those who did exhibit an 
attentional bias at baseline. A categorical variable was created which specified whether 
attentional bias was absent or present at baseline; a positive RT score indicated that 
attentional bias was present (RT>0), while a negative score indicated that attentional bias 
was absent (RT<0). As block length had little influence on treatment outcome as 
demonstrated in the primary analysis, this variable was omitted from the sub-group 
analyses.  
 
-30.00 
-20.00 
-10.00 
0.00 
10.00 
20.00 
30.00 
40.00 
A
tt
e
n
ti
o
n
a
l 
b
ia
s
 s
c
o
re
s
 (
m
s
) 
Attentional Retraining                Control                 
0-4 errors 
>5 errors 
Error  
category 
CHAPTER 2 
 
 
83 
 
2.3.13.1 Effect of attentional bias absence/presence on post-training attentional bias 
scores 
Linear regression was performed with attentional bias absent/present as an explanatory 
variable to predict post-training attentional bias scores. The analysis indicated that post-
training attentional bias scores were 24.36 ms higher in participants who did not have an 
attentional bias at baseline in the AR group compared to the control group (p=0.09).  In 
participants who had an attentional bias at baseline, there was an 18.47 ms reduction in 
post-training attentional bias scores in the AR group compared to the control group 
(p=0.15, see Figure 13).  
 
 
 
Figure 13. Post-training attentional bias scores (ms) by attentional bias 
absence/presence at baseline in the attentional retraining group (n=32) and control 
group (n=35) 
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2.3.13.2 Effect of attentional bias absence/presence on subjective craving 
To explore the influence of baseline attentional bias on subjective craving, an attentional 
bias absent/present variable was added to the parsimonious model of QSU-Brief scores. 
This model was used in preference to the fully specified model to reduce the risk of over-
fitting and making the model unstable. Three-way and two-way interactions between 
group, time and attentional bias absent/present were included. This model was used to 
produce linear combinations of the coefficients to compare groups.   
 
The analysis indicated that there were no significant three-way or two-way interactions 
(p>0.77). At pre-exposure, QSU-Brief scores were 3.79 points less in participants who 
had an attentional bias at baseline in the AR group compared to the control group, while 
an increase of 5.06 points was found in those who had no attentional bias at baseline. A 
similar pattern was found at post-exposure in those with attentional bias (β=-4.76) and 
without attentional bias (β=0.35). However, at neither time point were these coefficients 
significant (ps>0.2), most probably due to the lack of statistical power. 
 
2.4 Discussion 
2.4.1 Summary of principal findings 
This laboratory study evaluated the impact of varying the length of AR on attentional bias 
and subjective craving in current smokers. Contrary to the findings of the previous study 
(Attwood et al., 2008), the AR intervention did not produce a significant decrease in 
attentional bias for smoking-related cues irrespective of the length of training given.  
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Both QSU-Brief and VAS craving measures were highly correlated with each other, 
although neither measure correlated with attentional bias scores. There was no significant 
difference in subjective craving between groups at each block length on either measure, 
however there was some indication of an overall reduction in QSU-Brief scores in the AR 
group following cue exposure.  
 
There was no difference in mood and withdrawal ratings between groups. Across block 
lengths, anxiety scores were higher in participants who received the long block length in 
comparison to those that received the short block length, although this only approached 
significance.  
 
We observed no retraining effect on other measures of cognitive bias (the pictorial Stroop 
task), either by group or block length. There were no effects of training on indirect 
behavioural measures, i.e. the time it took participants to have their first cigarette after 
leaving the laboratory session.  
 
We found that the likelihood of making an error during training trials increased as the 
length of the training block increased. We further found tentative evidence that retraining 
effects on attentional bias were influenced by the number of errors made during training 
trials. Post-training attentional bias scores were lower among trained participants who 
made fewer errors during training trials compared to control participants; the reverse was 
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true for trained participants who made more errors, with bias scores being higher relative 
to control participants.  
 
Perhaps the most unexpected finding was that the sample did not exhibit a significant 
attentional bias at baseline. There was some indication that retraining effects were 
contingent on whether participants exhibited an attentional bias at baseline; we found 
tentative evidence of a reduction in attentional bias among trained participants who had an 
attentional bias at baseline compared to control participants. The effects of retraining in 
this subgroup of participants extended to non-significant reductions in craving 
immediately after retraining and following cue exposure. We should note, however, that 
these findings are exploratory in nature and should be interpreted with some caution, as 
discussed below. 
 
2.4.2 The findings in the context of previous studies  
While we were unable to replicate the findings of the Attwood et al. (2008) study, this 
study provides partial support for other tobacco-related retraining studies (Field et al., 
2009b; McHugh et al., 2010). In the study by Attwood et al. (2008), significant reductions 
in attentional bias towards smoking cues were observed in a train-to-avoid group, while 
increases in attentional bias and craving were found in a train-to-attend group. Field et al. 
(2009b) replicated the study with the inclusion of a control group and found a decrease in 
attentional bias in the avoid group, but this failed to reach statistical significance; in fact, 
training effects appeared to be more robust in the group trained to attend to smoking cues. 
Furthermore, no effects on urge to smoke were found in either group. Perhaps most 
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similar to the findings of our study is the study by McHugh et al. (2010) who found no 
retraining effects on attentional bias or craving in participants trained to avoid smoking 
cues. We found that AR did not significantly reduce attentional bias for smoking cues or 
induce an attentional bias away from smoking cues in the AR group.   
 
There are several possible reasons why this study and the aforementioned studies were 
unable to detect a significant reduction in attentional bias from train-to-avoid 
experimental manipulations. Primarily, this could be because most retraining studies 
differ in design and the groups used for comparison. In both tobacco and alcohol-related 
retraining studies carried out in non-clinical samples, successful retraining effects have 
been reported in studies that compared attend with avoid manipulations (Attwood et al., 
2008; Field & Eastwood, 2005) or where larger samples have been used (Schoenmakers 
et al., 2007). Studies that used a control comparison, like our study, have either found no 
retraining effect on attentional bias in the avoid group (McHugh et al., 2010) or weaker 
effects in the avoid groups in comparison to the attend groups (Field et al., 2007b; Field et 
al., 2009b). Given that it is likely that attentional bias occurs after long-term exposure to 
drug-related stimuli (Robinson & Berridge, 1993; Robinson & Berridge, 2001), it is 
perhaps more difficult for smokers to break a conditioned response to smoking cues with 
a train-to-avoid manipulation than it is to train individuals to attend to an existing bias. 
Moreover, as discussed by Wiers et al. (2006), the difference in attentional bias scores 
between two experimental manipulations (i.e. attend and avoid) is larger than the 
difference between a control comparison and an experimental manipulation. Taken 
together, it would seem that retraining effects are harder to achieve in avoid groups rather 
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than attend groups and where comparisons are made with a control group. If the effect of 
AR is indeed small, larger sample sizes may be required to detect a robust effect.  
 
Consistent with the findings from other studies (Field et al., 2009b; McHugh et al., 2010; 
Schoenmakers et al., 2007), retraining effects on subjective craving were small in this 
study. Although there was some suggestion that craving reduced over cue exposure, the 
effects were negligible. Causal associations between attentional bias and subjective 
craving are often described as weak and inconsistent across tobacco and alcohol-related 
studies (Field et al., 2009a); any observed effects of retraining have been constrained to 
participants with certain characteristics, i.e. in males (Attwood et al., 2008) and those only 
aware of the experimental contingency (Field et al., 2007b). Again, retraining effects on 
subjective outcomes were only seen in the attend groups and did not extend to the avoid 
groups. We did not find any differential retraining effects by gender, or awareness of the 
experimental contingency. In fact, the number of ‘aware’ participants was too small to 
investigate this. This finding is similar to the Field et al. (2009b) study in that very few 
participants were contingency aware and so it remains to be explored whether making 
people aware of the experimental contingency could enhance the training effect. Future 
studies should investigate this possibility as awareness of the training manipulation has 
been particularly relevant in observing the predicted changes in subjective craving 
(Attwood et al., 2008; Field et al., 2007b).  
 
Unexpectedly, VAS craving scores decreased across both groups during cue exposure. 
Previous studies have found that VAS craving scores generally increase over time 
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(Attwood et al., 2008), although we are unable to explain why this pattern was not 
observed in this study. 
 
Another major difference between this study and others is that the amount of AR given to 
participants was much less than what has been provided in other retraining studies (see 
Table 1). Retraining effects were observed in studies where twice as many trials were 
used during training than in the present study. For example, Attwood et al. (2008) used a 
total of 512 retraining trials to detect significant effects between their groups, while in our 
study the shortest length consisted of 96 trials and the longest length, 196 trials. 
Additionally, the longest block length of training was no more effective than the shortest 
block length. We might consider from our findings that a single session of AR at the 
block lengths explored in this study may not have been sufficient to produce the desired 
change in attentional bias or subjective craving.  
 
We initially opted for shorter training blocks in view of using this procedure in a clinical 
setting where practitioners not only have time-constraints on the duration of consultations, 
but patients may not adhere well to treatments given in lengthy sessions.  Indeed, we 
found in the present study that increasing the block length increased the likelihood of 
errors being made during training trials, suggesting that participants experienced boredom 
or attentional fatigue as the length of training increased. Arguably, this may not be the 
case in patients that are actively seeking treatment, as they may be more engaged in the 
task if they thought that it was helping them overcome their addiction. There was some 
indication from our findings that making more errors may have reduced the effectiveness 
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of AR as evidenced in post-training attentional bias scores, although we were unable to 
explore this association by block length due to the low number of participants. It may be 
of interest in future investigations to explore the impact of error frequency on retraining 
effects at longer block lengths and in larger samples.   
 
It is important to note, however, that simply increasing the number of training trials may 
not be sufficient to affect clinical outcomes. Previous studies that have used a single 
session of training have often been unable to detect retraining effects on behavioural 
outcomes; for example, Attwood et al. (2008) found no retraining effects on smoking 
topography and Field et al. (2009b) found no effect on tobacco-seeking motivation or 
smoking rate. Similarly, effects have been inconsistent across alcohol-related retraining 
studies (Field et al., 2007b). However, studies using multiple sessions of AR have found 
some evidence for effects on drug-seeking behaviour. In Schoenmakers et al. (2010) 
alcohol-dependent patients who were trained to avoid alcohol cues over an extended 
period of time in five sessions were not only discharged from their treatment facility 
sooner than the control group, but they also remained abstinent for longer than their 
counterparts. In Fadardi and Cox (2009), harmful drinkers significantly reduced their 
weekly alcohol consumption after receiving four sessions of training and these reductions 
were maintained three months later. To this end, several authors suggest that increasing 
the frequency of training sessions may be necessary to produce long-lasting changes in 
attentional bias, rather than task-specific changes (Field et al., 2009b; McHugh et al., 
2010). For AR to be clinically effective, global changes in attentional bias are required if 
attentional bias does in fact underpin subjective craving and tobacco-seeking behaviour; 
multiple sessions may be the way forward to acheive this.  
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Studies that used multiple sessions in their design also differed from this study in respect 
of the samples recruited. As this was a laboratory study designed to inform our clinical 
trial, we recruited a sample of non-treatment seeking smokers. There may be differential 
effects of training by the population group targeted; preliminary evidence for this comes 
from Fadardi and Cox’s (2009) study, where harmful and hazardous drinkers – who were 
interested in reducing their consumption - demonstrated a bigger reduction in cognitive 
bias following training than social drinkers. Retraining may have more of an effect in 
smokers who are motivated to abstain or seeking smoking cessation. Additionally, we 
found some indication that retraining effects on attentional bias were contingent on 
whether attentional bias was present in participants at baseline. A further consideration is 
that participants were relatively light smokers (as evidenced by their low FTND scores) 
and so it is unclear whether the effects of retraining are more pronounced in heavier 
smokers. Taken together, it may be that attentional bias is only present in individuals who 
possess certain characteristics or that retraining effects are mediated by factors such as 
smoking status, nicotine dependence or smoking rate. Identifying these individual 
characteristics and the potential moderators of AR are therefore of particular importance 
in large-scale studies, in order to establish who would be most receptive of and benefit 
from this type of treatment.    
 
Finally, we found no effect of AR on selective processing biases assessed on a different 
task measure – participants were not slower to identify the colour of the border of the 
neutral pictures compared to the smoking-related pictures on the Stroop task. This is 
consistent with other studies that have assessed generalisation to the Stroop task (Field et 
al., 2007b; Field et al., 2009b). We should perhaps be cautious in our interpretation of this 
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finding as no pre-training measure of Stroop bias was taken, and so future studies that 
assess generalisation should include this as a baseline assessment.   
 
2.4.3 Implications for the ARTS trial  
The purpose of the present study was to explore how much attentional retraining would be 
required to produce an effect on attentional bias and craving for use in a clinical setting as 
a therapeutic intervention. Another purpose was to explore whether boredom/fatigue 
occurred with more training given, characterised by the number of errors made, and if the 
number of errors made had any impact on retraining effects. 
 
Taking these preliminary findings from this study into consideration, as well as the points 
from the discussion above and the context in which the intervention will be delivered, we 
have made the following recommendations on the design of our clinical trial. 
 
1) We considered that the AR intervention needed to be of a length that was both 
acceptable to patients and practical for stop smoking practitioners to deliver within 
a reasonable time-frame in a typical stop smoking clinic. A single session of AR at 
either of the three block lengths explored in this study did not produce a 
significant reduction in attentional bias or subjective craving, and so our decision 
was made on other factors. As there was some indication that anxiety was higher 
in those who received the long block length and that more errors were made as the 
length of the training block increased, the long block length was subsequently 
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disregarded. There appeared to be little difference in retraining effects between 
one block and two blocks of training; a decision was made to use two blocks of 
training, with the condition that this was separated by a break in which the 
practitioner would deliver behavioural support between blocks to minimize 
attentional fatigue.  
 
2) Successful retraining effects on attentional bias and drug-seeking behaviour have 
been found in cases where multiple sessions of training were used in dependent 
populations (Fadardi & Cox, 2009; Schoenmakers et al., 2010). We have similarly 
chosen to use multiple sessions of training, which was considered a more practical 
way of increasing the ‘dose’ of training given to patients, and avoided the need to 
extend the length of each stop smoking clinic session. Five sessions of AR were 
chosen to be delivered weekly, to fit in line with the standard 7-week NHS stop 
smoking programme. 
 
3) Although retraining effects in this study did not generalize to the Stroop task, we 
decided to re-assess this in our clinical trial, in this case with a baseline assessment 
included (see Chapter 3 for description).  
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CHAPTER 3: A DOUBLE BLIND RANDOMISED 
CONTROLLED TRIAL OF ATTENTIONAL BIAS 
RETRAINING IN CIGARETTE SMOKERS ATTEMPTING 
SMOKING CESSATION (ARTS) – PROTOCOL  
3.1 Introduction 
The reporting of the ARTS trial spans Chapters 3, 4 and 5. The present chapter describes 
the protocol for the trial, which has been published (Begh et al., 2013; Appendix 10). It 
specifically outlines the objectives of the study and the methods undertaken.   
 
3.1.1 Rationale for the trial 
As discussed in section 1.1, resumption of smoking by initially successful quitters is 
arguably the greatest public health challenge in smoking cessation. While there are few 
interventions at present that are known to reduce the risk of relapse to smoking (Hajek et 
al., 2009), the development of new approaches like attentional retraining could be 
worthwhile. Despite evidence from laboratory studies indicating that attentional bias can 
be modified in cigarette smokers using AR procedures (Attwood et al., 2008; Field et al., 
2009b) and the success of such tasks on improving clinical outcomes in other addictions 
(Schoenmakers et al., 2010) and psychopathologies (Amir et al., 2009a), at the time of 
writing no study had yet examined the clinical application of such procedures in 
treatment-seeking smokers. 
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We therefore carried out a pilot double-blind randomised controlled trial of multiple 
sessions of attentional bias retraining in smokers attempting smoking cessation (ARTS). 
This translational study offered the ability to both examine the benefits of AR on users of 
NHS stop smoking services and provide data to aid our understanding on the phenomenon 
of attentional bias and its relation to craving, withdrawal symptoms, lapses and relapse in 
smokers attempting to quit. The trial was designed as a pilot study to test both the 
feasibility and acceptability of the ARTS intervention, upon which to inform a larger trial.   
 
3.1.2 Objectives 
1) To investigate the feasibility of delivering an attentional retraining intervention 
within NHS stop smoking services and explore the acceptability of the procedures 
to service-users; 
2) To investigate the efficacy of an attentional retraining intervention on attentional 
bias and smoking cessation outcomes; 
3) To investigate the association between attentional bias, urges to smoke, 
withdrawal and relapse in smokers. 
 
In the following section I describe the study questions that were developed to answer the 
main objectives of the study, in light of the literature reviewed in Chapter 1.   
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3.1.3 Study questions 
1) Are attentional retraining procedures feasible to deliver within NHS stop smoking 
services and are they acceptable to smokers seeking cessation support? 
While the primary objective of many attentional retraining studies has been to examine 
the efficacy of AR, most have often neglected to report on the processes involved in 
delivering these procedures in a clinical setting. Additionally, very little is known on 
whether patients themselves accept and adhere to this form of treatment. As the ARTS 
trial involved a new intervention being delivered in an established service, it was 
necessary to examine the feasibility of running the trial in practitioner-led NHS stop 
smoking clinics and to also assess the acceptability of the procedures to NHS patients.  
 
2) Can attentional retraining diminish attentional bias in smokers during cessation; 
are the effects evident across different cognitive bias tasks and different types of 
stimuli? 
As evidenced in the laboratory studies discussed in section 1.3, individuals with specific 
drug use patterns have shown increases or decreases in attentional bias towards their drug 
of choice by using modified versions of the visual probe task (Attwood et al., 2008; Field 
& Eastwood, 2005; Field et al., 2007b; Field et al., 2009b; Schoenmakers et al., 2007). 
Attentional retraining has led to reductions in attentional bias towards alcohol cues and 
delayed time to relapse in alcohol-dependent patients seeking treatment for alcohol abuse 
(Schoenmakers et al., 2010). Evidence from two laboratory studies in non-treatment 
seeking smokers demonstrated that a train-to-avoid manipulation of smoking cues could 
reduce attentional bias in non treatment-seeking smokers in a single session (Attwood et 
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al., 2008; Field et al., 2009b). We thus chose to investigate whether AR – using multiple 
sessions - could lead to similar reductions in attentional bias in smokers who were 
attempting cessation. If retraining were successful, participants would be able to 
demonstrate that they can divert their attention away from smoking cues on the visual 
probe task. We would expect AR to reduce the degree to which smokers notice smoking 
cues in their environment because they are trained away from attending to them.  
 
Similarly, if AR showed material reductions on one cognitive bias task, it is plausible that 
a reduction may be seen on another task measure - such as the pictorial Stroop task - if 
similar attentional processes were involved. Finally, if AR were able to produce a global 
change in attentional bias and not just a task-specific change in bias towards smoking 
cues, then smokers should be able to transfer their ability to disengage their attention to 
other smoking cues that are not featured in the retraining procedure.  
 
3) Does attentional retraining affect urges to smoke, cue-induced craving or 
withdrawal symptoms in smokers during cessation? 
Previous studies have revealed mixed findings on the effects of AR on craving and 
withdrawal. As I reviewed in section 1.4.2, some experimental paradigms have 
successfully increased attentional bias towards smoking-related cues or alcohol-related 
cues and found a corresponding increase in cue-induced craving (Attwood et al., 2008) or 
urge to drink (Field & Eastwood, 2005; Field et al., 2007b), respectively. On the other 
hand, AR has often had no effect on craving, mood and withdrawal in train-to-avoid 
manipulations (Attwood et al., 2008). However, as highlighted in section 1.6, 
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motivational processes could differ between continuing smokers and treatment-seeking 
smokers. Therefore, we investigated the effects of AR on urges to smoke, cue-induced 
craving and withdrawal symptoms in smokers during their cessation attempt. If AR 
procedures are capable of reducing exposure by diverting attention away from smoking 
cues, this in turn could reduce the capacity of these cues to invoke craving and symptoms 
of withdrawal.   
 
4) Do the effects of attentional retraining on attentional bias persist up to 6 months 
after cessation? 
The durability of AR remains unclear at present. Field et al. (2009b) found the predicted 
changes in attentional bias immediately after smokers were trained in a single session to 
attend or avoid smoking-related cues, but found that these effects disappeared in a second 
assessment session conducted one day later. One marker for the success of these 
procedures is to evaluate whether they produce enduring effects; this is particularly 
pertinent if the presence of attentional bias undermines abstinence (Powell et al., 2010). 
Accordingly, we investigated whether retraining effects were evident in smokers after 
their cessation attempt at follow-up assessments. 
 
5) Does attentional retraining reduce the likelihood of relapse in smokers attempting 
cessation? 
Preliminary investigations in alcohol-dependent populations have revealed clinically 
relevant effects of AR including earlier treatment discharge and delayed time to relapse 
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[(Schoenmakers et al., 2010) see section 1.7]. We therefore questioned whether retraining 
could reduce the likelihood of relapse in smokers attempting to quit. If the ability to train 
attention away from smoking-related cues during retraining translated to a smoker’s 
natural environment, s/he might experience less exposure to the environmental cues that 
would normally trigger smoking; in time, this could weaken the stimulus-response 
association between smoking cues and smoking behaviour, thus reducing the likelihood of 
a lapse occurring. Alternatively, if attentional avoidance leads to less instances of craving 
(as hypothesised in the second study question) this also may in turn reduce the likelihood 
of relapse, given that craving predicts relapse (Waters et al., 2003a; Killen & Fortmann, 
1997; Shiffman et al., 1997). 
 
6) Do smokers who are attempting to quit exhibit an attentional bias towards 
smoking-related cues? 
It is well-documented that drug-users show an attentional bias towards drug-cues of their 
choice (Field & Cox, 2008) but as I have discussed in section 1.7, some evidence from 
alcohol studies on attentional bias indicate that treatment-seekers or abstainers display 
attentional avoidance, that is, a bias away from alcohol-related cues (Noel et al., 2006; 
Townshend & Duka, 2007). To facilitate our understanding of the underlying mechanisms 
of attentional bias in smokers seeking to quit, we investigated whether treatment-seeking 
smokers show an attentional bias towards or away from smoking-related cues at baseline.  
   
7) Is attentional bias related to the severity of nicotine dependence; is it also related 
to the severity of urges to smoke and withdrawal prior to and after quitting?  
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There is some evidence to suggest that the severity of dependence could be a modulating 
factor of attentional bias, although the direction of this relationship is currently unclear. 
On the one hand, some studies have found that heavily dependent smokers show greater 
reactivity to smoking-related cues than less dependent smokers (Vollstadt-Klein et al., 
2011), while others have shown the opposite; for example Hogarth et al. (2003) found that  
light smokers (who smoked less than 20 cigarettes a day) had greater attentional bias than 
heavier smokers. In the former case, it is plausible that heavier smokers are more reactive 
to smoking cues as predicted by incentive salience theories (Robinson & Berridge, 1993) 
because greater exposure to cigarettes should lead to greater activation in the reward 
circuitry in the brain, in turn increasing sensitisation to smoking cues. In the latter case, 
less dependent smokers who consume fewer cigarettes may be more reactive as a result of 
developing greater stimulus control, presumably due to smoking in response to a narrower 
set of stimuli than heavier smokers (Hogarth et al., 2003; Watson et al., 2010). We chose 
to clarify these contradictory findings by examining the association between attentional 
bias and the severity of dependence in our sample of treatment-seekers. 
 
In section 1.4, I described how several studies have attempted to explore the relationship 
between attentional bias and craving. The causal relationship between the two processes 
has been described as weak at best (Field et al., 2009a) with many experimental 
manipulations of attentional bias failing to find corresponding effects on craving (Field et 
al., 2009b; Schoenmakers et al., 2007). The design of the current study permitted us to 
explore this relationship by examining whether attentional retraining away from smoking-
related cues could lead to reductions in craving. 
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Another aspect of this relationship that remains unclear is the association between 
attentional bias and the severity of craving and withdrawal. Evidence from alcohol studies 
indicates that higher levels of craving are predictive of higher levels of attentional bias in 
abstinent alcoholics (Field et al., 2012). In non treatment-seeking smokers, positive 
correlations have been found between attentional bias and craving (Kang et al., 2012). In 
treatment-seeking smokers, Waters et al. (2003c) found that those with higher craving at 
baseline had greater attentional bias than those with lower levels of craving, but this 
association was found on one half of the task but not on the other. In light of these 
tentative findings in treatment-seeking smokers, we chose to examine whether attentional 
bias was related to the severity of cravings and withdrawal during quit attempts. 
 
8) Is attentional bias associated with an increased probability of relapse? 
As discussed in section 1.5, there is some evidence indicating that attentional bias predicts 
relapse during quit attempts. Some tobacco-related studies have found that greater 
processing biases are associated with an increased risk of lapsing (Waters et al., 2003a) 
and relapse (Powell et al., 2010) while others have not (Spiegelhalder et al., 2011; Waters 
et al., 2003c). To clarify these findings and understand the prognostic value of attentional 
bias on the success of quitting, we investigated this association in our sample of smokers. 
 
Questions 1-5 were addressed using the data from the study as trial data across both the 
trial arms, while questions 6-8 were explored by using the data as observational data. 
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3.2 Methods 
3.2.1 Trial design 
This was a pilot double blind randomised controlled trial. Participants attending a 7-
session weekly NHS stop smoking clinic were randomised to either an intervention group 
consisting of a modified visual probe task with attentional retraining (AR) or a control 
group with placebo training (PT). Five sessions of AR or PT were delivered.  
 
3.2.2 Inclusion criteria 
Participants were required to meet the following inclusion criteria to be eligible for 
enrolment into the trial: 
1. Aged 18 years or over. 
2. Smoked at least 10 cigarettes per day or 12.5 grams of tobacco or had a value of at 
least 10 parts per million (ppm) for exhaled carbon monoxide (CO). 
3. Had normal or corrected-to-normal vision. 
4. Showed evidence of a signed and dated informed consent document indicating that 
s/he had been informed of all aspects of the study and consented to participate and 
be randomised to either group. 
5.  Were able and willing to complete all study procedures. 
 
3.2.3 Exclusion criteria 
Participants were excluded if they presented with any of the following: 
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1. A medical condition that prevented them from seeing the computerised images 
properly, attending to the task, or pressing the keyboard buttons on the computer 
accurately, or completing any other study procedures. 
2. Were currently using nicotine replacement therapy (NRT), bupropion, 
nortriptyline, mecamylamine, reserpine, or varenicline, or undergoing any 
treatment for tobacco dependence (e.g. acupuncture) that they were not willing to 
cease using and instead use study medication (i.e. nicotine patches as described in 
section 3.2.9.3.1). 
3. Had previously had severe skin reactions to nicotine patches or severe eczema or 
other skin diseases that made patch use hazardous or undesirable. 
4. Had a severe acute or chronic medical or psychiatric condition or previously 
diagnosed clinically important renal or hepatic disease, which could have 
increased the risk associated with study participation or could have interfered with 
the interpretation of study results and, in the judgment of the investigator, would 
make the participant inappropriate for entry into this study. 
 
3.2.4 Withdrawal criteria 
It is standard practice in smoking cessation trials to treat those who fail to attend 
appointments as having relapsed (West et al., 2005). Therefore, failure to attend was not 
defined as withdrawal from the trial; we considered that the only withdrawals would be 
those in which the participant had asked to be withdrawn. We expected this in less than 
5% of participants. This is standard procedure in smoking cessation studies. 
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3.2.5 Participant recruitment  
Participants were recruited from West Midlands NHS SSS. A letter of invitation 
(Appendix 11) and a patient information sheet about the study (Appendix 12) were sent 
from GP practices to patients that were registered on their databases as smokers. The 
letters asked those patients who wished to take part in the trial to respond to the study 
team. In our experience, we anticipated that 5–10% would respond. In our later 
recruitment approaches described in Chapter 4, we approached staff within the NHS SSS 
to write to smokers on their database that had a history of failed quit attempts. Preliminary 
eligibility to participate was assessed during telephone screening (Appendix 13) and 
potential participants were booked in for an assessment session at the clinic site, similar to 
that arranged by the NHS SSS.  
 
Written informed consent was obtained from all participants at the first session (Appendix 
14), which took place two weeks prior to quit day. As there may have been circumstances 
in which participants wanted to delay their quit day, for example, owing to a family 
bereavement, participants were allowed to delay their quit attempt by a maximum of 14 
days. Similarly, as it is not uncommon for people to miss their scheduled weekly 
appointments, participants were able to have their appointment rescheduled within 14 
days of their last visit. Participants wishing to delay their quit attempt by more than 14 
days or were unable to attend a rescheduled appointment within 14 days of their last visit 
were classified as abandoning their quit attempt and the participant was advised to contact 
their local stop smoking service at a time when they were ready to set a new quit date. 
Participants were provided with the name and number of their local stop smoking service.  
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3.2.6 Staff training 
Over the lifetime of the study, nine research nurses and three stop smoking advisors (SSAs) 
were trained to deliver the intervention. All staff completed a 2-day NHS stop smoking 
advisor course. They also attended a training day in which they were briefed on the clinical 
procedure on how to deliver each task (Appendix 15), and on use of the trial database. Prior 
to running a clinic, each member of staff observed a baseline session and week -1 
(randomisation) session delivered by the chief investigator. In turn, the chief investigator 
observed the first two sessions delivered by each nurse/SSA involved in the study. Regular 
site visits were conducted to check that the intervention was being delivered as per protocol. 
 
3.2.7 Trial Procedures 
Figure 14 provides an overview of the study procedures and clinic sessions. Participants 
in both trial arms were seen weekly in clinics from two weeks prior to quit day up to four 
weeks post quit day. There were ten clinic sessions in total. Randomisation took place at 
the second clinic session (see section 3.2.8) which initiated the first of the five weekly 
AR/PT sessions. Follow up visits took place at eight weeks and three months post quit 
day, with a final visit arranged at six months. Participants were reminded to attend their 
appointments by telephone or text message. Staff completed a case report form (CRF) at 
each clinic visit, which contained a checklist of the trial procedures (Appendix 16). 
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Figure 14. Timeline of procedures and clinic visits. V=visit; VP=visual probe task; AR=attentional retraining; PT=placebo training; 
AB=attentional bias; CO=carbon monoxide; MPSS=Mood and Physical Symptoms Scale; VAS=visual analogue scale; 
mg=milligrams 
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3.2.7.1 Clinic measures 
At the first session, demographic and clinical characteristics of participants were collected 
using a baseline questionnaire (Appendix 17). Participant age, gender, ethnicity, 
education and employment status were classified using UK Census 2011 categories 
(Office for National Statistics, 2011). The questionnaire also contained information on 
smoking history including the Fagerström Test of Nicotine Dependence (FTND) 
(Heatherton et al., 1991), a six-item measure assessing the severity of nicotine 
dependence.  
 
Urge to smoke and withdrawal were measured at the beginning of every session using the 
Mood and Physical Symptoms Scale (MPSS). A modified version of the MPSS was used 
in which each of the nine items was rated on a scale from 1-7 (Appendix 18). Items 
relating to the strength and frequency of urges can be combined to produce a composite 
score (MPSS-C); this is also the case for combined mood items (MPSS-M). The MPSS 
was preferred over other measures such as the Questionnaire of Smoking Urges because 
of its superiority in predicting treatment outcomes (West, 2006; West & Ussher, 2010).  
 
Exhaled carbon monoxide (CO) measurements were taken at the beginning of each 
session to biochemically verify smoking status. Attentional bias assessments were carried 
out using the visual probe task and pictorial Stroop task described in sections 3.2.7.3.1 
and 3.2.7.3.2. Cue-induced craving was measured at the beginning of the second session 
and following attentional bias assessments (Appendix 19).  The task is described in detail 
in section 3.2.7.3.3. A visual analogue scale (VAS) was used to measure craving on a 100 
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mm scale from “Not At All” to “Extremely” prior to and after the task. Lapses were 
recorded in the CRF at each clinic session. Knowledge on group allocation was measured 
in a questionnaire given at the end of the +4 week visit (Appendix 20). At eight weeks 
post-quit, acceptability of the training tasks was measured using a patient satisfaction 
questionnaire developed by the study team (Appendix 21). 
 
3.2.7.2 Materials 
Eighteen picture pairs of smoking-related and matched neutral pictures were used across 
attentional bias assessment and training tasks (picture pairs 1-18). These stimuli have 
been tested and applied in previous research (McClernon et al., 2007; McClernon et al., 
2008). Each set of pictures consisted of a colour photograph of a smoking-related 
stimulus or scene (e.g. a close-up of a cigarette) matched on age, sex, complexity and 
ethnicity to another photograph containing no smoking-related content (example provided 
in Appendix 22). In the assessment version of the visual probe task and pictorial Stroop 
task, twelve picture pairs were used (picture pairs 1-12). Similarly in the AR and PT 
versions of the visual probe task, the twelve picture pairs consisted of six picture pairs 
featured in the assessment version of the task (picture pairs 7-12) in addition to six new 
picture pairs (picture pairs 13-18). An extra four neutral picture pairs were used for 
practice trials before each task.  
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3.2.7.3 Clinic Tasks 
3.2.7.3.1 Visual probe task  
At the baseline session and again at four weeks post-quit, eight weeks, three months and 
six months, all participants completed the assessment version of the visual probe task. The 
assessment version, which was used to measure attentional bias, comprised a total of 192 
trials, presented in two blocks. Each trial began with a fixation cross displayed in the 
centre of the computer screen for 500 ms. A picture pair of smoking-related and neutral 
pictures was then presented side-by-side on the screen for 500 ms. After this picture pair 
disappeared, a visual probe was presented in the location formerly occupied by one of the 
pictures. This probe was either a circle (●) or square (■). Participants were required to 
discriminate the identity of the probe and respond accordingly by pressing the up or down 
arrow keys on the keyboard as quickly as possible. There was a 500 ms interval before the 
next trial. Presentation of each picture-pair and probe location was counterbalanced. In all 
trials, the visual probe replaced the smoking-related and neutral pictures with equal 
frequency. At the start of the task, participants carried out eight practice trials in which 
neutral picture pairs were presented first, to allow them to become familiar with the 
procedure.  
 
Each block of trials were presented in a new random order for each participant, using 
EPrime version 2 (Psychology Software Tools Inc., Pittsburgh PA). The task took 
approximately 16 minutes to complete. Attentional bias scores were calculated from 
reaction time (RT) data; an attentional bias towards smoking cues was characterized by 
faster reaction times towards smoking-related pictures than neutral pictures. 
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3.2.7.3.2 Pictorial Stroop task 
All participants carried out a pictorial Stroop task as an additional measure of cognitive 
bias. The pictorial Stroop task was given after the visual probe task at the baseline session 
and again at four weeks post-quit, eight weeks, three months and six months. The task 
comprised a total of 192 trials, presented in four blocks of 48 trials, with each block 
consisting of smoking-related pictures or neutral pictures only. Each picture was 
presented centrally on a computer screen, with either an outline of a red, blue, yellow or 
green border. Participants were required to indicate the colour of the border, while 
ignoring the picture, by pressing one of four corresponding labelled keys on the keyboard, 
as quickly as possible. Participants received eight practice trials in which neutral pictures 
were presented first, to allow them to become familiar with the procedure. A short break 
between blocks was permitted.  
 
Each block of trials was presented in a new random order for each participant, using 
EPrime version 2 (Psychology Software Tools Inc., Pittsburgh PA). The task took 
approximately 12 minutes to complete. Stroop bias scores were calculated from RT data; 
selective processing towards smoking cues was characterized by slower reaction times 
towards smoking-related pictures than neutral pictures.  
 
3.2.7.3.3 Cue exposure task 
At one week prior to quit day, four weeks post-quit and follow-up sessions at eight weeks, 
three months and six months, participants in both groups were given a cue exposure 
procedure to measure cue-induced craving immediately after completion of the visual 
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probe task and pictorial Stroop task. This is a common procedure in cue-reactivity 
research (Sayette & Hufford, 1994; Shiffman et al., 2003). Showing a strong craving 
response to cue-exposure has been shown to predict relapse risk (Abrams et al., 1988). 
Prior to attending the session at week -1, participants were instructed to abstain from 
smoking for at least one hour. We chose an abstinence period of one hour to avoid floor 
effects in craving ratings, commonly found immediately after smoking (Schuh & Stitzer, 
1995). 
 
In order to standardize the procedure, instructions for the cue exposure task were recorded 
on a digital recorder, which was then played to participants in the relevant clinic sessions. 
Before the instructions were played, participants provided a single rating of their urge to 
smoke on the VAS. The therapist placed a box that concealed a cigarette and a lighter in 
front of the participant. The recording was then played, which instructed the participant to 
lift up the box and handle the cigarette and lighter contained within. The task lasted three 
minutes. Following the task, participants provided another rating of their urge to smoke 
on the VAS.  
 
3.2.7.4 Reimbursement to participants 
Participants were paid £15 to complete assessments at the three month and six month 
follow-up sessions, as these were not therapeutic encounters.  
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3.2.8 Randomisation 
Participants were randomised 1:1 to either AR or PT using a computer generated simple 
randomisation scheme, ordered in random permuted blocks of four. The sequence were 
generated by the trial statistician and entered on to a dedicated online trial database by an 
independent programmer in the Primary Care Clinical Research and Trials Unit 
(PCCRTU) at the University of Birmingham. At one week prior to quit day, at the start of 
the clinic session, the therapist accessed the randomisation section of the trial database 
and clicked on a button that revealed a letter (‘A’ or ‘B’) to reveal the training task to 
which the participant was allocated. The training tasks were contained within two folders 
labelled ‘Training A’ or ‘Training B’ on the study laptop, which concealed whether the 
procedure was AR or PT. These folders were labelled by an independent researcher prior 
to the start of the trial. Thus the participants, therapists and study staff were blinded to 
allocation, to minimize the risk of bias. 
 
3.2.9 Treatments 
3.2.9.1 Control group  
Participants allocated to the control group carried out five weekly sessions of PT, starting 
one week prior to their designated quit day. During each session, participants carried out 
eight practice trials of neutral picture pairs followed by 192 trials of PT, presented in two 
blocks. Between each block, participants were permitted to have a short break if required. 
The task took approximately 16 minutes to complete. On each PT trial, the visual probes 
always replaced smoking-related and neutral pictures with equal frequency.  
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3.2.9.2  Intervention group 
Participants allocated to the intervention group carried out five weekly sessions of the 
modified visual probe task, AR, starting one week prior to their designated quit day. Eight 
practice trials of neutral picture pairs were presented prior to the first block of AR trials. 
A total of 192 training trials were presented in two blocks, where participants had the 
opportunity to have a break in between. The task took approximately 16 minutes to 
complete. 
 
The AR program differed from the PT program only in the location of the visual probes. 
During each training trial, visual probes always appeared in the location of the neutral 
pictures. Thus, participants always had their attention directed away from smoking-related 
pictures.   
 
3.2.9.3 NHS stop smoking support 
Systematic reviews have shown that some behavioural and pharmacological interventions 
increase people’s chances of successfully stopping smoking (Stead et al., 2008; Lancaster 
& Stead, 2005). All participants were therefore given NRT in the form of transdermal 
nicotine patches and received standard withdrawal orientated behavioural support (Hajek, 
1989).  
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3.2.9.3.1 Trial Medication 
Participants in this trial were offered 21mg/24 hour nicotine patches as the only choice of 
treatment.  This was because:  
1) All participants were regular smokers for whom the 21mg dose was deemed 
appropriate. 
2) The study aimed to examine the effects of attentional retraining on urge to smoke. 
Short-acting NRT e.g. inhalator or gum affect cue-induced urges to smoke and 
reduce their intensity (Ferguson & Shiffman, 2009). It would have thus been 
difficult to assess the effects of the attentional retraining if short-acting NRT was 
used. Participants were also not permitted to use varenicline for the same reason 
(Aubin et al., 2008). Investigators have found that nicotine patches do not protect 
against cued craving (Waters et al., 2004), therefore we considered that patch-use 
was unlikely to mask the potential effects of retraining. 
3) The patch is the best tolerated form of NRT and has the highest adherence (Hajek 
et al., 1999; Jorenby et al.,1995). 
 
3.2.9.3.2 Dose alteration procedure 
Nicotine patches are well tolerated in the large majority of regular smokers and so we 
expected that most people would continue with the standard dose. However, there are 
circumstances when the form or dose of the preparation needs to be changed. This 
variation reflects pragmatic behaviour in the NHS stop smoking services and was 
expected to be equal in both arms. We anticipated the following occurrences: 
CHAPTER 3 
  
  
115 
 
1) Minor skin irritation to the patch is one of the most common problems with use.  
This is commonly eased by swapping from one form of patch to another, because 
it is usually intolerance to the glue. If the skin reaction was worse, such as causing 
blisters that could not be remedied by emollients and hydrocortisone cream, patch 
use was stopped and the participant was swapped to an equivalent dose of oral 
NRT. 
2) Sleep disturbance or vivid dreaming is also one of the most common problems 
with use of the nicotine patch.  This can usually be eased by removing the nicotine 
patch an hour or so before bedtime and so this was advised.  There is no good 
evidence that 16 hour patch use is less effective than 24 hour patch use. 
3) Possible symptoms that dose is too high are uncommon problems, but possible.  
Nausea is the earliest symptom of overdose, but it is also a common symptom 
experienced by people often enough.  Nicotine has a short half life, meaning that 
by about 10 hours after first applying a patch, nicotine has reached a steady state.  
Therefore nausea occurring for the first time days after starting treatment is 
unlikely to be due to the patch.  More definite symptoms are as follows, muscular 
twitching, dizziness, confusion, rapid pounding heart, high blood pressure, 
vomiting, and weakness. However, 21mg/24 hour patch systems come as 14mg/24 
hours and 7mg/24 hours, which can be used in a step down system. If the therapist 
thought that an overdose was likely, the precaution taken was to step down the 
dose to the next step i.e. from 21mg to 14mg, or from 14mg to 7mg.  
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3.2.9.3.3 Duration of treatment and instructions for use 
Treatment with NRT started either on the evening prior to quit day or the morning of quit 
day, depending on personal preference. Patches were dispensed accordingly during the 
second visit, which was one week prior to quit day. Instructions for patch use included 
changing it every 24 hours, using a different area of skin for the new patch. Participants 
were advised to continue using the patch for at least eight weeks or stop if they abandoned 
their quit attempt before the 8 weeks. The therapist in consultation with the patient may 
have chosen to step down the patch as discussed above. Step down was not necessary as 
there is no evidence to suggest that it enhances efficacy, but it is commonly perceived as 
helpful by patients. Step down towards the end of treatment was not permitted to 
commence until at least four weeks after quit day. The therapist was instructed not to 
suggest stepping down in people who had recent lapses. Some PCTs that were involved in 
the trial did not allow treatment for longer than 8 weeks, but, in those that did, the 
therapist consulted the participant about longer courses of treatment up to 12 weeks 
duration. This decision was at the discretion of the therapist in consultation with the 
patient.  
 
Behavioural support started two weeks prior to quit day, and lasted up to four weeks after 
quit day. This followed the typical 7-session withdrawal orientated therapy programme 
offered in existing NHS stop smoking services (Hajek, 1989).  
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3.2.9.3.4 Reporting of adverse events 
This was not a trial of an investigational medical product. Indeed we used a licensed 
medical product within the terms of its license and in accord with clinical guidelines. We 
therefore expected relatively few problems and so no special reporting requirements were 
made. The therapist leading the sessions managed problems within his/her own 
competence. Clinical advice was sought from the trial doctor. Between them, the therapist 
and trial doctor decided how to manage unexpected problems and whether to report a 
suspected unexpected serious adverse reaction (SUSAR) to the Medicines and Health 
Care Regulatory Authority using the yellow card system (this is a standard system for 
reporting unusual reactions to medication). 
 
However, for the purposes of the trial, we recorded clinically significant adverse events 
that led to a change in medication management or was otherwise so significant that it was 
odd not to record them. This allowed us to track changes in medication instruction, such 
as swapping to 16 hour use or dose alterations. The CRF was used to record the date, the 
nature of the adverse event/symptoms, and the action taken (Appendix 16). 
 
3.3 Trial Outcomes 
3.3.1 Primary trial outcomes 
 Measure of attentional bias during assessment trials of the visual probe task, as 
measured by the difference in median reaction time taken (in ms) to respond to 
probes replacing smoking-related stimuli versus probes replacing neutral stimuli. 
CHAPTER 3 
  
  
118 
 
This was assessed at four weeks post-quit in abstinent and non-abstinent smokers 
across both trial arms, following recommendations of Shiffman et al. (2004b).  
 Strength of weekly urge to smoke on the MPSS, measured up to four weeks post-
quit in abstinent and non-abstinent smokers across both trial arms. 
 
3.3.2 Secondary trial outcomes 
 Strength of withdrawal symptoms on the MPSS, measured up to four weeks post-
quit in abstinent and non-abstinent smokers across both trial arms. 
 Prolonged abstinence measured and biochemically validated at four weeks post-
quit and each follow-up using the Russell standard (West et al., 2005). Criteria for 
the Russell standard includes a two week grace period from quit day, followed by 
smoking no more than five cigarettes and verification by means of exhaled CO, 
with a cut-off point of <10ppm.  
 Time to first lapse, with a lapse episode defined here as any smoking, even a puff 
(West et al., 2005).  
 
3.3.3 Other trial outcomes  
 Feasibility of running the ARTS trial within NHS SSS assessed on the basis of: 
- Rates of response to patient invitation letters; 
- Rates of recruitment at telephone screening; 
- Rates of attendance at clinic sessions;  
- Rates of drop out prior to and after randomisation.  
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 User acceptability as measured by ratings of perceived usefulness on a patient 
satisfaction questionnaire. 
 Change in cue-induced cravings measured on the VAS prior to and at the end of 
the cue-exposure task at four weeks, eight weeks, three months and six months 
post-quit day in abstinent and non-abstinent smokers across both trial arms. 
 Measure of cognitive processing bias on the pictorial Stroop task, to assess 
generalization of attentional retraining effects at four weeks post-quit in abstinent 
and non-abstinent smokers across both trial arms. Stroop bias was measured by the 
difference in median reaction time taken to respond to colour-naming of smoking-
related stimuli versus colour-naming of neutral stimuli.   
  Measure of attentional bias towards novel untrained stimuli on the visual probe 
task at four weeks post-quit in abstinent and non-abstinent smokers across both 
trial arms. 
 Measure of attentional bias on the visual probe task and pictorial Stroop task at 
eight weeks, three months and six months to assess long term effects of attentional 
retraining. 
 Strength of urge to smoke and withdrawal symptoms on the MPSS, measured up 
to eight weeks, three months and six months to assess long term effects of 
attentional retraining. 
 
3.4 Observational Study Outcomes 
 Association between attentional bias and nicotine dependence 
 Association between attentional bias and urges to smoke 
 Association between attentional bias and withdrawal symptoms 
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 Association between attentional bias and smoking abstinence  
 
3.5 Trial Statistics 
The sample size was based on the following calculations. In these calculations, we 
assumed that only quitters would continue to attend clinic and that the measures were 
analysed only in abstinent smokers, as is standard practice with withdrawal phenomena 
(Shiffman et al., 2004b).  
 
We assumed that the effect of five sessions of attentional retraining would be no greater 
than the effect of a single session. From the findings of the Attwood et al. (2008) study, to 
detect a mean reduction of 26 ms (SD=43 ms) with 80% power and a type 1 error rate of 
5%, 42 participants in each group were required. We revised this calculation to adjust for 
baseline attentional bias scores. In our laboratory study of AR (Chapter 2), we found an 
estimated correlation coefficient of -0.13 between baseline and post-training 
measurements. Thus, to detect a reduction of 26 ms with the same standard deviation, 
power and type 1 error stated above, 42 participants were still required in each group. We 
expected that at least 50% of participants would reach the Russell standard abstinence 
criteria at 4 weeks, as the NHS services achieve greater than this, providing about 50 
abstinent participants in each arm, sufficient to test this hypothesis.  
 
The trial was an exploratory study but was powered to detect differences in urge to 
smoke. One study on smokers quitting on pharmacotherapy found that the mean change in 
urge strength between quit day and week one was about 0.5 points measured with the 
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MPSS and had a SD of 1.2 (Aveyard et al., 2008). Another study reported that glucose 
reduced urge strength by 1.0 points, although this was immediately after dosing (West et 
al., 1999). In both of these studies, MPSS urge strength was scored from zero to five 
(West & Hajek, 2004). We assumed that if AR could reduce urge strength by 0.6 points, 
then 62 participants in each group would have been needed to detect this with 80% power 
and a type 1 error rate of 5%. From the earlier study (Aveyard et al., 2008) we used an 
estimated correlation coefficient of 0.41 between quit day and post-training urge strength 
to adjust this power calculation. This meant that to detect a 0.6 point reduction in urge 
strength (SD=1.2) with 80% power and a type 1 error rate of 5%, 53 participants would be 
required in each group. In the first four weeks, when withdrawal is at its height, this 
implied that about 200 smokers were needed, assuming that 60% would achieve 
abstinence in the first four weeks.  
 
3.5.1 Loss to follow-up 
Participants who failed to attend clinic and did not respond to our telephone calls were 
classed as smokers for the analysis of smoking abstinence, as is standard (West et al., 
2005). We had expected to make contact with more than 90% of people at the six month 
follow-up, based on experiences of a recent trial (Aveyard et al., 2008). We anticipated 
that the effects of attentional retraining on attentional bias and withdrawal phenomena 
would be analysed primarily in abstinent smokers, as recommended by Shiffman et al. 
(2004b), so defaulting from routine clinic appointments by failed quitters was not 
considered a threat on the integrity of the trial. We therefore did not require those 
participants who failed to maintain abstinence and abandoned their quit to continue to 
attend clinics except for reasons detailed below.  
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We considered that this study could give valuable information on what happens to 
attentional bias over time, how it is affected by training, how it is affected by resuming 
smoking, and whether the training effect is contingent on continued abstinence. 
Accordingly, we asked all participants regardless of smoking status to attend the follow-
up sessions and compensation was provided to increase the likelihood of attendance 
(section 3.2.7.4). 
 
3.6 Regulatory Procedures 
3.6.1 Definition of end of trial 
End of trial was defined as the final six month follow-up assessment of the last participant 
undergoing the trial. 
 
3.6.2 Monitoring and audit 
The progress of the trial was monitored by quarterly review of records. We checked that 
consent information was available for all participants and that the inclusion and exclusion 
criteria were being adhered to. Data cleaning took place by a series of checks on the trial 
database, for example, a participant could not be recorded as a prolonged abstinent 
smoker at eight weeks if they had not been recorded abstinent at four weeks. 
Discrepancies on the trial database were checked with the source documents (e.g. CRFs 
and data stored on the study laptops) and amended where necessary. 
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3.6.3 Data management 
The trial was conducted as part of the portfolio of trials in the Primary Care Clinical 
Research and Trials Unit (PCCRTU), a National Institute for Health Research (NIHR) 
recognised trials unit in Primary Care Clinical Sciences at the University of Birmingham. 
The data management followed standard operating procedures, which were fully 
compliant with the Data Protection Act and International Conference on Harmonisation 
(ICH) Good Clinical Practice (GCP). The source documents for the trial were stored in 
the trials unit, in a locked cabinet, in a locked office. The PCCRTU maintained the trial 
database.  
 
Upon completion of the trial and analyses of all data, we transferred the source documents 
to a secure archiving facility at the University of Birmingham. Here, they will be held for 
15 years and then destroyed. The PCCRTU anonymised the trial database. 
 
3.6.4 Data protection and confidentiality 
Data were kept in accordance with the Data Protection Act. The trial was registered with 
the Data Protection Act website at the University of Birmingham. As mentioned in 
section 3.6.3, the standard operating procedures of the trials unit were followed, which 
were designed to protect patient confidentiality. Patient identifiable data were shared only 
within the immediate study team on a need-to-know basis. This was to ensure the 
provision of adequate clinical care and appropriate follow-up. Participants gave consent 
for their data to be shared with their general practitioner, or approved auditors from the 
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Research Ethics Committee or NHS Research and Development, where necessary. No one 
outside of the study team had access to the source documents or the trial database. 
 
3.6.5 Ethics and Research Governance 
The trial was conducted in compliance with the principles of the Declaration of Helsinki 
(1996), the ICH-GCP, the EU Clinical Trials Directive and all applicable regulatory 
requirements. The study protocol and other documentation were approved by the National 
Research Ethics Committee (10/H1206/34) and local NHS Research & Development 
offices. Subsequent protocol amendments were submitted to the Research Ethics 
Committee for approval, and the other bodies where necessary. We provided the Research 
Ethics Committee with annual progress reports, in addition to a final study report. 
 
3.7 Funding 
The study was funded by the National Institute for Health Research (NIHR). Service 
support costs were claimed via the Comprehensive Clinical Research Network. Treatment 
costs were covered by the NHS SSS. 
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CHAPTER 4: ASSESSING THE FEASIBILITY AND 
ACCEPTABILITY OF ATTENTIONAL RETRAINING IN 
PRACTICE –FINDINGS FROM THE ARTS TRIAL 
4.1 Introduction 
As described in Chapter 3, our first objective of the ARTS trial was to explore the 
feasibility of delivering the AR intervention within NHS stop smoking clinics and assess 
the acceptability of AR procedures to NHS patients. No study has yet investigated the use 
of computerized interventions like these in practitioner-led NHS stop smoking clinics. 
Chapter 4 therefore describes how we assessed the feasibility of the intervention by 
examining the study processes and outcomes that include: the rates of response to patient 
invitation letters, recruitment at telephone screening, attendance at clinic sessions and 
rates of drop out prior to and after randomisation. Acceptability of the trial procedures 
was assessed further by adherence to the tasks and patient satisfaction.  
 
4.2 Study processes  
4.2.1 NHS regulatory approvals 
There were delays in obtaining NHS permissions to run the trial. We initially applied for 
NHS permission to run the trial in seven Primary Care Trusts (PCTs): Birmingham East 
and North (BEN), Heart of Birmingham (HoB), South Birmingham (SB), Dudley, 
Sandwell, Warwickshire and Worcestershire PCTs. 
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Although all applications were submitted concurrently in March 2010, ethical approval 
was granted from Birmingham East, North and Solihull Research Ethics Committee in 
May 2010 (REC reference number 10/H12006/34), while R&D approvals for BEN, HoB, 
SB and Sandwell PCTs were obtained in August 2010 (Appendix 23). Honorary contracts 
that allowed research staff to access NHS premises were issued in October/November 
2010; research activity could only commence at these sites from this point forward. 
 
We did not gain approval to run the trial in Dudley PCT because two other smoking 
cessation trials were already operating within the Trust and they would not fund the NRT 
treatment costs. Similarly, Warwickshire PCT did not agree to fund the excess treatment 
costs. At the time of applying for permissions, Worcestershire PCT were undergoing a 
major change to the delivery of their stop smoking services and for this reason, did not 
take on the trial.  
 
We later sought further ethical approval to run the trial from additional sites including 
Walsall Teaching (Wt) PCT and community venues within Birmingham Community 
Healthcare Trust (BCHCT) in an attempt to improve our recruitment rates (see section 
4.2.3.1.2).  
 
4.2.2 Stage 1 recruitment strategy 
We initially identified and recruited GP practices within BEN, HoB and Sandwell PCTs; 
the study was later rolled out in Wt PCT.  
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Each practice identified potential participants through electronic searches of their patient 
databases. Search criteria included patients who were registered as current smokers and 
over the age of 18. The practice staff checked the patient lists for any exclusions prior to 
invitation letters being sent out (e.g. if a patient was deceased). Letters were typically sent 
in batches of 200, based on response rates to the previous mail shot. Referrals were also 
sought from the GPs, who gave contact details of our research team to potential 
participants during consultations. 
 
4.2.2.1 Outcome of stage 1 recruitment strategy 
4.2.2.1.1 Response and recruitment rates by PCT 
Figure 15 shows response and recruitment rates to the stage 1 recruitment strategy. In 
BEN PCT, four GP practices identified a total of 3598 smokers from their patient 
database searches; 1872 letters were sent out to potential participants of which 26 (1.4%) 
contacted the research office and were screened for eligibility. Of these respondents, 17 
(1.0%) were booked for a baseline session and were enrolled in the study.  
 
In HoB tPCT, three practices identified 723 smokers from their patient searches and sent 
invitation letters to all potential participants, of which 9 (1.2%) responded and 8 (1.1%) 
were booked for a baseline session.  
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Three practices in Sandwell PCT identified and sent invitation letters to a total of 1873 
smokers on their patient databases; 55 (2.9%) potential participants responded and were 
screened for eligibility, of which 48 (2.6%) were booked for a baseline session.  
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Figure 15. Response and recruitment flow by PCT and practice during stage 1 
recruitment  
STAGE 1  
RECRUITMENT STRATEGY 
GP PRACTICE 
RECRUITMENT 
BEN PCT 
 
Practice 1 
Letters sent  n=200 
Response n=4 
Booked n=1 
 
Practice 2 
Letters sent n=600 
Response n=8 
Booked n=5 
 
Practice 3 
Letters sent n=445 
Response n=8 
Booked n=5 
 
Practice 4 
Letters sent n=627 
Response n=6 
Booked n=6 
HOB PCT 
Practice 5 
Letters sent  n=200 
Response n=5 
Booked n=5 
DNA=1 
Practice 6 
Letters sent n=187  
Response n=1 
Booked n=1 
Practice 7 
Letters sent n=337  
Response n=3 
Booked n=2 
SANDWELL PCT 
Practice 8 
Letters sent n=1200 
Response n=28 
Booked n=25 
DNA=2 
Practice 9 
Letters sent n=521  
Response n=3 
Booked n=3 
Practice 10 
Letters sent  n=152 
Response n=24 
Booked n=20 
DNA=2 
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4.2.2.2 Challenges of stage 1 recruitment strategy 
Although an additional two practices in HoB tPCT expressed an interest in the study, we 
did not pursue patient recruitment any further at this site for three reasons. Firstly, given 
the poor response rate from the existing three practices - which was considerably less than 
the 5-10% estimated – it was clear that we would not meet the desired recruitment rate of 
3/4 patients per week to reach the target sample size within our timescale. Secondly, our 
resources were limited; the additional cost and time associated with setting up these 
practices as well as the lack of staff availability outweighed the likelihood of recruiting an 
adequate number of participants from these practices to make this approach worthwhile. 
Thirdly, HoB tPCT covers an area of Birmingham with a diverse, ‘hard-to-reach’ 
population. Other smoking cessation studies have reported difficulties with recruitment 
from practices within HoB tPCT because of its demographic profile. After discussing the 
trial with the practice staff at these two practices, concerns were raised as to whether their 
patients would understand the trial procedures and stop smoking programme, as at least 
70% were of Black or Asian ethnicity, and English was not the first spoken language for 
the majority. All trial materials were written in English and none of our staff could speak 
the languages required (e.g. Punjabi, Urdu, Guajarati). For these reasons, we deemed it 
impractical to recruit further from HoB tPCT and there were no other practices that could 
be approached in BEN PCT. This led to the decision to begin practice recruitment in 
Sandwell PCT. 
 
Despite an improved response rate in Sandwell PCT compared to BEN PCT and HoB 
tPCT, we had exhausted the list of potential practices we could approach and thus our 
recruitment strategy required revision.  
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We had NHS regulatory approval to deliver in SB PCT; however we did not recruit 
practices at this site for two reasons. Firstly, we considered that participant recruitment 
may have reached saturation in the practices within this area as many practices had 
recently taken part in other smoking cessation trials using the same recruitment strategy. 
Another reason was that several practices had signed up to a Local Enhanced Service 
(LES) scheme in which they had their own in-house stop smoking service and were paid 
for service provision; the tobacco-control lead at SB PCT did not want the study to be 
carried out at these practices as it was thought that doing so would complicate the way 
that payments were made for patients seen by our study team.  
 
4.2.3 Stage 2 recruitment strategies  
In light of the poor response rate from our approved sites and the restrictions posed on 
practice recruitment in SB PCT, we implemented a number of changes in an attempt to 
increase our recruitment rate including: 
a) Increasing the number of sites  
b) Targeting a new population group  
c) Increasing reach of study via new advertising methods 
Substantial amendments were submitted to the Birmingham East, North and Solihull 
Research Ethics Committee in order to proceed with these changes and approvals were 
received.  
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4.2.3.1 Changes to recruitment approach 
4.2.3.1.1 Increasing the number of sites  
We had exhausted practice recruitment in our existing sites; it was therefore necessary to 
recruit from a) different venues and b) a different geographical area that other smoking 
cessation studies had not recently operated in.  
 
While we were unable to recruit any practices in SB PCT, we attempted to recruit from 
within the community by holding a clinic at the University of Birmingham. As this was 
classed as a community venue, we obtained approval to carry out the study within 
BCHCT. The clinic was advertised locally, on the University website, in staff newsletters, 
staff payslips, the University magazine and later through social media (see section 
4.2.3.1.3). 
 
From April 2010, eight PCTs in the West Midlands opted into a new tariff-based scheme 
in which organisations were commissioned by the PCT to provide stop smoking services 
via a payment on results contract (Department of Health, 2011). We identified Wt PCT – 
which was part of the consortium that opted into the scheme - as a potential area for 
recruitment. We gained NHS regulatory approvals for this additional site, but were unable 
to start recruitment unless our organisation (the University of Birmingham) became a 
registered provider of stop smoking services. The application to become a stop smoking 
service provider was accepted in January 2012. 
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4.2.3.1.2 Targeting a new population group  
We approached BCHCT in order to target smokers who had a history of failed quit 
attempts. The SSS at BCHCT searched all residents of South Birmingham, over the age of 
18, who had accessed the stop smoking services from April 2010 - April 2012 and were 
classed as non-abstinent at four weeks post-quit.  
 
We increased the flexibility of our clinics beyond the normal weekday working hours to 
include weekend clinics and appointment times after 7pm on weekdays. We also secured 
another community venue to increase access to the services, in addition to offering the 
University as the main venue for clinics. 
 
4.2.3.1.3 Increasing reach of study via new advertising methods  
We initially advertised the University clinic to staff and students of the university through 
posters and leaflets (Appendix 24). To boost the number of recruits into the clinic, we 
advertised more widely through an online social media campaign via the website 
Facebook (Appendix 25). The advert was publicised to people living within a 16 
kilometre radius of Birmingham, and was released from 22/03/2012 - 01/04/2012 and 
20/06/2012 - 09/07/2012. The cost we incurred depended on the number of times the 
advert was viewed, with each viewing capped at a charge of £0.59. 
 
4.2.3.2 Outcome of stage 2 recruitment strategy 
Figure 16 shows response and recruitment rates to the stage 2 recruitment strategy. 
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4.2.3.2.1 Response and recruitment rates according to the increase in the number of 
sites 
From August 2011 – March 2012, the University clinic yielded 42 respondents of which 
37 participants were booked in for a baseline session. This equated to a monthly average 
of five respondents, out of which four people were booked in for a baseline session per 
month.  
 
One practice in Walsall identified and sent invitation letters to 1204 smokers, of which 15 
(1.2%) were screened for eligibility and 14 (1.2%) were booked for a baseline session. 
 
4.2.3.2.2 Response and recruitment rates according to new population targeted 
A total of 1424 smokers were identified and sent invitation letters to take part in the study 
from the BCHCT database, of which 37 (2.6%) contacted the research office and 36 
(2.5%) were booked in for a baseline session. 
 
4.2.3.2.3 Response and recruitment rates according to online social media campaign 
The advert was clicked on 837 times, of which 27 (3.2%) expressed an interest in the 
study, 12 (1.4%) of whom left contact details and were screened for eligibility and 9 
(1.1%) booked for a baseline session. Over the lifetime of the advert, an average of three 
people per week were booked in for a baseline session. The total cost of advertising was 
£490.31. 
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Figure 16. Response and recruitment flow by site during stage 2 recruitment 
STAGE 2  
RECRUITMENT STRATEGY 
NEW SITE 
RECRUITMENT 
GP PRACTICE 
RECRUITMENT 
WALSALL 
Practice 11 
Letters sent 124 
Response rate n=15 
Booked n=14 
DNA=2 
COMMUNITY CLINIC 
RECRUITMENT 
BCHCT DATABASE 
Letters sent 1424 
Response rate n=37 
Booked n=36 
DNA=14 
RECRUITMENT VIA 
SOCIAL MEDIA 
CAMPAIGN 
Reach (no. of clicks on 
advert) n=837 
Expressed interest n=27 
Booked n=9 
Response to local 
advertising n=42 
Booked n=37 
DNA=4 
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4.2.3.3 Challenges of stage 2 recruitment strategy 
Recruiting from the University of Birmingham provided a steady stream of participants 
into the study, but did not allow us to recruit quickly enough to catch up with our 
forecasted recruitment rate.  
 
Carrying out the study in a tariff area meant that our organisation was in competition with 
other providers who were also seeking to provide their services to GP practices, many of 
whom were already operating within several practices. As a result, we only gained access 
to one practice in Wt PCT within our timescale.  
 
Of the 27 respondents that expressed an interest in the study from the Facebook 
advertisement, a large proportion did not leave their contact details (55.6%). Arguably, 
non-smokers as well as smokers could have clicked on the advert, meaning that the 
response rate could be somewhat higher than stated if only those who were interested in 
stopping smoking were used in this calculation. While it may seem counterintuitive that 
non-smokers clicked on the advert (as this would have led to an increase in advertising 
costs) we cannot rule out that they could have passed on the study details to smokers who 
were interested in quitting. The advantage of the campaign was that it could reach a large 
number of people within a short timeframe, so much so that this strategy enabled us to 
meet the anticipated recruitment rate of 3/4 people per week. Despite this improvement, 
we did not have the resources to continue this method of recruitment.  
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4.2.4 Participant flow 
The recruitment period spanned from April 2011 and October 2012; recruitment was 
stopped before reaching the target sample size of 200, due to lack of resources and time 
constraints. Figure 17 depicts the flow of participants through the trial. Of the 196 
assessed for eligibility, 137 attended a baseline session and 119 went on to be randomised 
at the second session.  
 
4.2.4.1 Attrition rates 
Eighteen (13.1%) participants dropped out of the study prior to randomisation, the 
majority of whom said this was because they had abandoned their quit attempt (33.3%). 
Of the 119 participants that were randomised, 23 (19.3%) dropped out of treatment and 
subsequent follow-up visits after randomisation. The most commonly cited reason for 
drop out was that participants had abandoned their quit attempt (69.6%). There was no 
difference in the risk of drop out between groups (RR=0.99, 95% CI=0.83, 1.19, p=0.89).  
 
4.2.4.2 Attendance rates 
The median number of clinic visits attended by all participants was 8 out of a possible 9 
visits; there was no difference between trial arms (t[116]=0.12, p=0.91). The median 
number of training sessions attended was 4.5, which was the same across both groups 
(t[116]=0.24, p=0.81). 
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Figure 17. Flow of participants through the trial 
  
Analys ed  at 4  weeks   
   40 visual probe task; 5 lost due to computer error   
   42 Stroop task; 3 lost due to computer error   
   45 CO verified   
Analys ed at 8  weeks   
   43 visual p robe task   
   41 Stroop task; 2 lost due to computer error   
   43 CO verified   
Analys ed  at 3 months   
   40 visual probe task    
   40 pictorial Stroop task   
   40 CO verified   
  
Analys ed at 4  weeks   
   46 visual probe task; 1 lost due to computer error   
   46 Stroop task; 1 lost due to computer error   
   47 CO verified   
Analys ed at 8  weeks   
   45 visual probe task    
   44 Stroop task; 1 lost due to computer error    
   45 CO v erified   
Analysed at 3 months   
   42 visual probe task ; 3 lost due to computer error   
   42 pictorial Stroop task ; 3 lost due to computer  
error   
   45 CO verified   
  
45 attended at 4 weeks   
   1 3   lost to follow - up  (6 abandoned quit ;  1 unable to  
contact; 1   reason not stated ; 3 other reasons given ;  
2  non - attendances )   
43 attended at 8 weeks   
   4   lost to follow - up a t 8 - weeks ( 4  non - attendances )   
40 attended at 3 month s   
   7   lost to follow - up at 3 months ( 7  non - attendances )   
  
  
  
196  Assessed for eligibility   at  
scre ening    
59  Excluded    
 
    13 D id n ot meet   inclusion criteria  at  
screening    
 
    7 Did not meet inclusion  criteria    at    
first  appointment   
 
    14 S creened but unable to contact  
again for   first appointment booking    
 
     25 D id  not attend first appointment   
  
47 attended at 4 weeks   
   13   l o st  to follow - up   ( 1 0   abandoned quit ;  1   unable  
to contact ;  1 other reasons given ; 1 non - 
attendance )   
45 attended at 8 weeks   
  3   lost to follow - up  ( 3 non - attendances )   
45 attended at 3 months   
   3   lost to follow - up  ( 3  non - attendances )   
60  A llocated to intervention   
   60  Recei ved allocated intervention     
59  Allocated to control   
   58  Rece ived allocated  control ; 1 patient death   
(excluded   from   thi s point forward)   
Allocation   
Analysis   
Follow - Up   
119  Randomized    
Enrollment   
18  Dropped out after first  a ppointment   
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4.3 Acceptability of ARTS intervention to patients 
Acceptability of the training procedure was assessed by a patient satisfaction 
questionnaire given to all participants at the eight week post-quit follow up visit 
(Appendix 21). Two items related to how difficult the task was to understand and carry 
out, while a further two items assessed the convenience of task. Items were rated on a 5-
point scale ranging from “not at all difficult” to “extremely difficult” and “very 
convenient” to “very inconvenient”. Adverse events were recorded by stop smoking 
advisors at each clinic visit. 
 
4.3.1 Patient satisfaction 
Of the 118 participants who were randomised (one participant excluded from subsequent 
analyses due to death), 95 (80.5%) responded to the patient satisfaction questionnaire 
(Figure 18). Most participants did not find the task instructions difficult to understand or 
difficult to carry out. Most found the length of the task convenient or expressed 
indifference; similarly the majority found the task convenient to carry out each week. 
Overall, approximately half (51.7%) of respondents said that they would use attentional 
retraining if it helped them stop smoking; 22.9% responded that they would use the task 
but had some reservations; 3.4% said that they would use the task but had a lot of 
reservations and 2.5% said they would not use the procedure at all. The most common 
reasons stated among the 34 participants who said that they would not use the task or had 
reservations in using it included boredom (23.5%) and the task being too long (20.6%).  
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Figure 18.  Patient satisfaction questionnaire responses (n=95)
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4.3.2 Adverse Events  
There was one serious adverse event that resulted in the death of one participant, which 
was unrelated to the study. Six participants experienced adverse events that were related 
to the study medication; most commonly cited were vivid dreams and disturbed sleep 
from overnight patch-use (n=5), and soreness/heavy arm at the site of the patch (n=1). 
Twelve participants experienced adverse events that were unrelated to the study e.g. flu-
like symptoms, bacterial infections. 
 
4.4 Discussion 
It took seven months to gain the necessary NHS regulatory approvals to run the trial, in 
addition to five months to identify practices and train the study team. A response rate of 
2.9% was achieved with an overall recruitment rate of 2.5%. In total, 137 participants 
were enrolled into the study, of which 119 were randomised. Delays with NHS regulatory 
approvals meant that there was insufficient time to recruit the desired 200 participants into 
the study. Moreover, the response rate was lower than the 5-10% originally forecast by 
recruiting through GP practices. While efforts were made to improve recruitment by 
increasing the number of sites, targeting a new population group and using new 
advertising methods, it was not possible to reach the target sample size within the 
available timescale.  
 
Attrition rates were similar across groups, with most people dropping out early in the 
treatment programme because they had abandoned their quit attempt. Attendance rates 
were high, as were the number of retraining sessions adhered to, indicating that the 
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intervention was feasible to carry out within stop smoking clinics despite initial barriers to 
recruitment.  
 
There is limited evidence on what recruitment strategies are effective for enrolling 
participants into smoking cessation programmes (Belisario et al., 2012) and into 
randomised controlled trials in general (Treweek et al., 2013). The former review found 
that tailored, proactive and more intensive methods of recruitment are more effective than 
less personal, reactive and less intensive strategies. For example, personal telephone calls 
are more effective than invitation letters (RR=40.73, 95% CI=2.53, 654.74) as are more 
phone call attempts (RR=1.87, 95% CI=1.61, 2.18). Similarly, Treweek et al. (2013) 
found that telephone reminders to non-responders were effective in increasing recruitment 
of participants into trials (OR=1.95, 95% CI=1.04, 3.66), in addition to ‘opt-out’ versus 
‘opt-in’ procedures (RR=1.39, 95% CI=1.06, 1.84) in which participants are enrolled 
automatically unless they request otherwise. While these methods may improve 
recruitment rates, increasing the number of calls and reminders has clear cost implications 
and opt-out procedures are ethically controversial. 
  
Although we did not achieve the desired number of participants, this study is larger than 
the other smoking attentional retraining studies (e.g. Attwood et al. (2008) n=55, Field et 
al. (2009b) n=72, McHugh et al. (2010) n=64].   
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Regarding the acceptability of the intervention, most participants reported that they would 
use AR procedures if it helped them stop smoking, although some commented that the 
length of the task was too long and boring. As found in the laboratory study in Chapter 2, 
it is difficult to ascertain what constitutes a tolerable length of training as this must be 
determined in part by its ability to produce a retraining effect. The Alcohol Attention-
Control Training Program (AACTP) procedure developed by Fardardi and Cox (2009) 
that trained harmful and hazardous drinkers to attend away from alcohol-related stimuli 
had an interactive component to its program, in which participants were able to play an 
active role in the design by choosing which neutral soft drinks to be trained towards. 
Participants also received feedback on the number of correct responses and were 
encouraged to be quicker on subsequent trials. Both active participation and positive 
feedback may increase engagement in AR procedures and reduce the effects of boredom. 
Furthermore, many of the tasks used in smoking retraining studies rely on somewhat 
outdated visual graphics created over a decade ago; in light of technological 
advancements there is scope to upgrade the displays, which might enhance the visual 
appeal of such tasks.  
  
The intervention was both feasible and acceptable to deliver within NHS stop smoking 
clinics. Initial delays in obtaining NHS regulatory approvals and the poor response rate to 
our recruitment methods meant that we were unable to recruit enough people in the time 
available. Attendance at clinic sessions was high and patients completed most training 
sessions. Overall, most participants were satisfied with the computer task, despite some 
experiencing boredom. If attentional retraining procedures are clinically effective in 
treating addictions, compliance with such tasks - that use a computer interface - may be 
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enhanced by incorporating active user-involvement or by improving visual features of the 
design. 
  CHAPTER 5 
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CHAPTER 5: A DOUBLE BLIND RANDOMISED 
CONTROLLED TRIAL OF ATTENTIONAL BIAS 
RETRAINING IN CIGARETTE SMOKERS ATTEMPTING 
SMOKING CESSATION (ARTS) – TRIAL FINDINGS 
5.1  Introduction 
The penultimate chapter of this thesis meets the second and third objective of the ARTS 
trial: to report on the efficacy of an AR intervention on attentional bias and smoking 
cessation outcomes; and to investigate the association between attentional bias, urges to 
smoke, withdrawal and relapse in smokers.  
 
The following trial outcomes (as discussed in the protocol, section 3.3) were assessed and 
compared across each trial arm, using an intention-to-treat analysis: 
 Post-training attentional bias on the visual probe task and pictorial Stroop task; 
 The strength of weekly urge to smoke and withdrawal symptoms; 
 Abstinence rates; 
 Time to first lapse;  
 Change in cue-induced craving; 
 The strength of weekly urge to smoke and withdrawal symptoms at follow-ups; 
 Post-training bias on the visual probe task and pictorial Stroop task at follow-ups 
 Post-training attentional bias towards untrained novel stimuli; 
Across all participants, the following observational outcomes were assessed: 
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 The association between baseline attentional bias and nicotine dependence  
 The association between baseline attentional bias and urges to smoke   
 The association between baseline attentional bias and withdrawal symptoms 
 The association between attentional bias and smoking abstinence  
 
Data for the six month follow-up outcome have been omitted as these were not available 
at the time of writing; therefore the results that follow include analyses up to the three 
month follow-up. 
 
5.2 Statistical analyses 
5.2.1 Primary analyses  
Attentional bias scores on the visual probe task were calculated in the following way. An 
RT was produced for each correct response made on each trial where the probe replaced 
either the smoking-related picture or neutral picture. A median RT was calculated for all 
RTs produced for smoking-related pictures and all RTs produced for neutral pictures. A 
score for attentional bias was calculated by subtracting the overall median RT to smoking-
related pictures from the median RT to neutral pictures, with positive scores indicating a 
bias towards smoking cues and negative scores indicating a bias towards neutral cues. 
Median RTs were used because distributions of mean RTs are often reported as skewed 
(MacLeod et al., 2002; Schoenmakers et al., 2010); therefore we did not need to set 
parameters for outlying RTs. Bias scores, as measured at four weeks post-quit, were used 
to examine retraining effects on attentional bias firstly by trial arm and secondly by 
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abstinence status using ANCOVA. An alpha level of 0.05 was employed. Bias scores 
were analysed as a complete case in the first instance and secondly, after imputation of 
missing RTs via regression of available data points. This was carried out by fitting a 
quadratic term of time and time² to each participants’ observed RT scores, where the 
predicted value from the regression was used if there was a missing measurement. Values 
were only imputed if the missing RT was between time points with an observed value in 
order to avoid extrapolating beyond the observed data, i.e. imputation was not carried out 
if the baseline RT was missing or if the participant had no measurements after the four 
week visit or eight week follow-up. These analyses were performed using PASW 
Statistics 18 (SPSS, Inc., 2009, Chicago, IL, USA).  
 
To investigate retraining effects on weekly urge to smoke, data were analysed using 
mixed effects regression models with an autoregressive variance-covariance structure, to 
allow for variations in craving between participants. This enabled all weekly time points 
to be included and modelled simultaneously. This modelling technique was used for 
MPSS scores; as mentioned in section 3.2.7.1, composite scores for urge to smoke 
(MPSS-C) and withdrawal symptoms (MPSS-M) were calculated. Regression 
coefficients, p-values and 95% confidence intervals (CI) were derived from the models. 
These analyses were undertaken using Stata 11.0 (StataCorp, 2009, College Station, TX: 
StataCorp LP). 
 
Intention-to-treat analyses were performed to account for people who dropped out of 
treatment.  
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5.2.2 Secondary analyses 
To examine the effects of AR on withdrawal symptoms, the same modelling technique as 
mentioned in section 5.2.1 for MPSS-C scores was used for MPSS-M scores.  
 
To determine the proportion of people achieving abstinence by trial arm, risk ratios (RRs) 
were calculated with corresponding 95% CIs. Those reported as lost-to-follow up were 
counted as non-abstinent, as is standard in the reporting of smoking cessation trials 
(Hughes et al., 2004b; West et al., 2005).  
 
Proportional hazards modelling was used to analyse the median time to lapse by trial arm; 
hazard ratios (HRs) are reported with corresponding 95% CIs. These analyses were 
performed using Stata 11.0 (StataCorp, 2009, College Station, TX: StataCorp LP). 
 
5.2.2.1 Statistical modelling of MPSS-C and MPSS-M scores 
Two independent, fully specified, mixed-effects regression models of craving (MPSS-C) 
and withdrawal (MPSS-M) as outcome variables against the explanatory variables of 
time, group (attentional retraining/control) and abstinence status (non-
abstainers/abstainers) were constructed. Time was kept as a continuous variable. In all 
models, the reference categories were the attentional retraining group and abstainers. 
Participant ID was treated as the random effects part of the models. Missing values for 
MPSS-C and MPSS-M scores were imputed as last observation carried forward, where 
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the last known value for a given item on the weekly questionnaire was used to fill in a 
subsequent missing data point (e.g. if a rating for craving had been completed at three 
weeks post-quit but not at four weeks, this last rating was “carried forward”). 
 
For MPSS-C scores, post-quit raw urge scores were modelled without inclusion of 
baseline scores as suggested by West and Hajek (2004) because urges to smoke 
experienced during ad lib smoking are likely to be different to those experienced during 
abstinence. The time points for assessments therefore included quit day, one week post-
quit, two weeks post-quit, three weeks post-quit and four weeks post-quit.   
 
As quit-related withdrawal differs from the general anxiety often felt by some smokers 
prior to quit day, baseline scores for the MPSS-M were included as a covariate in the 
model for withdrawal symptoms, which also allowed for correction of variations in scores 
between subjects (Shiffman et al., 2004b). Baseline MPSS-M scores measured prior to 
quit day on two measurement occasions were totalled, averaged and then entered as a 
covariate into the model.  
 
In order to examine the effects of AR on urge to smoke and withdrawal over time, it was 
necessary to include interaction terms involving time. The model was checked by 
comparing the plots of the observed and predicted means. If a large difference was found 
between the observed and predicted means, a time squared term and time cubed term was 
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added to see if the fit of the model was significantly improved. Quadratic models have 
been found to best fit models of craving and withdrawal (Piasecki et al., 2003). 
  
The fully specified models of MPSS-C and MPSS-M scores included all main effects, 
lower order two-way interactions and a three-way interaction between time, group, and 
abstinence status. Stepwise regression was carried out using backward elimination to 
remove interactions that failed to reach the significance threshold (p<0.05). Additionally, 
model comparisons were performed using chi squared to assess goodness of fit and 
qualify the removal of any interactions. These steps were followed to produce the most 
parsimonious models of MPSS-C and MPSS-M scores to best explain the data. 
 
The parsimonious models of the MPSS-C and MPSS-M were used to produce linear 
combinations of the coefficients in order to estimate the overall effect of AR on urge to 
smoke and withdrawal symptoms between groups and by abstinence status over time. As 
per protocol, the overall treatment effect is reported in abstainers initially and reported in 
non-abstainers separately. 
 
To minimize over-fitting, the most parsimonious models were used in all exploratory 
analyses. At each step of modelling, diagnostic checks were carried out on the residuals of 
each model using scatter plots to check normality.  Box and whisker plots were 
constructed to check the distribution of scores.   
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5.2.3 Ancillary analyses 
We examined the effects of AR on attentional bias, MPSS-C scores and MPSS-M scores 
at eight weeks and three months post-quit to investigate longer-term retraining effects. 
The same modelling technique was used as in the analysis of the four week post-quit data, 
unless otherwise stated in the corresponding sections.  
 
We adjusted the analyses of attentional bias scores, MPSS-C scores and MPSS-M scores 
for potential moderators of attentional bias, urge to smoke and withdrawal symptoms. 
Demographic and clinical characteristics were entered as covariates into linear regression 
models of attentional bias scores and into the most parsimonious model of urge to smoke 
and withdrawal to examine any interaction effects. These included age, gender and FTND 
across all analyses. Pre-quit urge to smoke was also examined in the model of attentional 
bias scores and pre-quit attentional bias in the models of MPSS-C and MPSS-M. 
 
To examine retraining effects on cue-induced craving, VAS scores were analysed in a 
mixed-effects regression model; the same modelling technique that was used for MPSS-C 
and MPSS-M scores (section 5.2.2.1) was carried out again in this instance.  
 
Visual analogue scale scores were calculated from measurements taken from a 0-100 mm 
scale before and after the cue exposure task, which was administered one week before 
quit day and again at four weeks, eight weeks and three months post-quit. The difference 
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between pre and post measurements was calculated and the change in cue-induced 
craving over time is reported.   
 
Generalization of AR to other cognitive bias measures was assessed using RT scores from 
the pictorial Stroop task. Stroop bias scores were calculated by subtracting median RTs to 
probes that replaced neutral pictures from median RTs to probes that replaced smoking-
related pictures. Slower RTs towards smoking-related pictures indicated a bias towards 
smoking cues. Again, parameters for outlying RTs did not need to be defined as median 
rather than mean RTs were used. Bias scores, as measured at four weeks post-quit, were 
used to examine retraining effects on Stroop bias firstly by trial arm and secondly by 
abstinence status using ANCOVA. 
 
Similarly, we assessed whether AR could generalize to untrained novel stimuli that only 
appeared in the assessment versions of the visual probe task and not during training 
sessions. Attentional bias scores for the trained and untrained stimuli were therefore 
analysed separately using ANCOVAs. 
 
Finally, we compared the number of participants who correctly identified their group 
allocation by trial arm, based on whether participants thought that they were allocated to 
the training group/allocated to no training group/unsure of group allocation. 
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5.2.4 Observational data analyses 
To facilitate our understanding of attentional bias, we further examined whether 
attentional bias was associated with measures of nicotine dependence, including FTND 
and smoking rate (cigarettes per day), using linear regression. Similarly, we investigated 
associations between attentional bias and our clinical outcomes of interest; mixed-effects 
linear regression models were constructed to examine urge to smoke and withdrawal 
symptoms as outcome variables prior to and post quitting, with period of quit attempt 
treated as a categorical variable (pre-quit/post-quit). Logistic regression was used to 
examine the predictive validity of attentional bias measures on four weeks abstinence. 
Odds ratios (OR) and 95% confidence intervals (CI) are reported in these cases. In all 
analyses outlined in this section, we tested associations using both cognitive task 
measures (visual probe task and pictorial Stroop task) to examine the predictive utility of 
each measure.  
 
5.3 Results 
5.3.1 Baseline characteristics 
Of the 196 participants who were initially screened, 119 were randomly allocated to either 
AR or control. One randomised participant died during the trial; data were subsequently 
excluded for this participant as recommended in intention-to-treat analyses for outcomes 
in cessation trials (West et al., 2005). Demographic and clinical characteristics are 
therefore reported for n=118 participants.  
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The sample was predominantly female, white British and middle-aged (Table 14). 
Approximately half were in employment. Less than half had a higher level professional 
qualification. Participants were moderately dependent and smoked approximately 20 
cigarettes a day (Table 15). As expected from a RCT design, there were no group 
differences in baseline characteristics.  
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Table 14. Demographic characteristics of participants 
  
All                                                                                             
(n=118) 
Attentional retraining                                        
(n=60) 
Control                                                                       
(n=58) 
Age in years mean (SD) 44.8 (12.7) 46.5 (12.7) 43.0 (12.7) 
Gender ratio (M:F) 49:69 26:34 23:35 
Ethnicity n (%) 
   White-British 92 (78.0) 46 (76.7) 46 (79.3) 
White-Irish 3 (2.5) 3 (5.0)  -  
White-other 1 (0.8) 1 (1.7)  -  
White & Black Caribbean  7 (5.9) 4 (6.7) 3 (5.2) 
White & Black African  -  -   -  
White & Asian 1 (0.8)  -  1 (1.7) 
Mixed-other 4 (3.4) 1 (1.7) 3 (5.2) 
Indian 1 (0.8)  -  1 (1.7) 
Pakistani 1 (0.8) 1 (1.7)  -  
Bangladeshi  -  -   -  
Asian other 1 (0.8) 1  -  
Caribbean 4 (3.4) 1 (1.7) 3 (5.2) 
African  -  -   -  
Black-other 2 (1.7) 2 (3.3)  -  
Chinese 1 (0.8)  -  1 (1.7) 
Any other ethnic group  -  -   -  
Employment n (%) 
   Employed 61 (51.7) 27 (45.0) 34 (58.6) 
Unemployed 17 (14.4) 9 (15.0) 8 (13.8) 
Looking after home or family 11 (9.3) 4 (6.7) 7 (12.1) 
Student 3 (2.5) 1 (1.7) 2 (3.4) 
Retired 14 (11.9) 10 (16.7) 4 (6.9) 
Long-term sick or disabled 9 (7.6) 6 (10.0) 3 (5.2) 
Other 3 (2.5) 3 (5.0)  - 
Highest Education n (%)  
  No formal qualifications 32 (27.1) 12 (20.0) 20 (34.5) 
Other qualifications below ‘A’ 
level/vocational level 3 36 (30.5) 19 (31.7) 17 (29.3) 
‘A’ levels/vocational Level 3 and 
above 23 (19.5) 14 (23.3) 9 (15.5) 
Degree, or equivalent/above 21 (17.8) 11 (18.3) 10 (17.2) 
Other Qualifications  6 (5.1) 4 (6.7) 2 (3.4) 
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Table 15. Clinical characteristics of participants 
  
All                                             
(n=118) 
Attentional 
retraining      
(n=60) 
Control           
(n=58) 
  M (SD) M (SD) M (SD) 
Cigarettes smoked per day 20.83 (9.24) 21.80 (9.88) 19.83 (8.49) 
Age started smoking (years) 16.49 (4.35) 16.62 (4.03) 16.35 (4.69) 
FTND* 5.52 (2.26) 5.33 (2.44) 5.72 (2.06) 
MPSS-C at baseline 10.67 (2.29) 10.73 (2.10) 10.62 (2.49) 
MPSS-M at baseline 20.10 (8.62) 21.53 (8.60) 18.64 (8.45) 
VAS craving at baseline 40.40 (28.65) 37.33 (28.88) 43.70 (28.30) 
*Fagerstrom Test for Nicotine Dependence, scored from 0-10. 
 
5.3.2 Data reduction 
Of the 118 participants, 98% contributed to visual probe task data at the baseline 
assessment; 73% at four weeks; 75% at eight weeks and 69% at three months. Data from 
2, 6, 0 and 3 participants were lost due to computer/experimenter error at baseline, four 
weeks, eight weeks and three months respectively. The remaining participants who did 
not contribute to follow-up data dropped out of treatment (see section 4.2.4, Participant 
flow, Figure 17). 
 
A total of 118 (100%) participants completed pictorial Stroop assessments at baseline; 
75% at four weeks; 72% at eight weeks and 69% at three months. Due to 
computer/experimenter error, data were lost from 0 participants at baseline, 4 at four 
weeks, 3 at eight weeks and 3 at three months. Trials with errors were also removed from 
pictorial Stroop task data; the error rate was 2.1% at baseline, 2.3% at 4 weeks, 2.3% at 
eight weeks and 2.2% at three months.  
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Imputation was carried out in cases where data were either lost due to 
experimenter/computer error or absent due to missed clinic visits between follow-up 
assessments. Visual probe task data were imputed in 9 cases at four weeks, 7 cases at 
eight weeks and 13 cases at three months. For Stroop task data, 8 cases were imputed at 
four weeks, 10 cases at eight weeks and 13 cases at three months. These analyses are 
reported separately in section 5.3.5.1 and 5.3.14.3. 
 
5.3.3 Attentional bias at baseline  
Participants across both groups did respond faster in the predicted direction towards 
smoking-related pictures than neutral pictures at baseline (mean difference=3.21). 
However, a one-sample t-test against zero indicated that this difference was not 
significant (t[115]=1.16, p=0.25).  
 
5.3.4 Effects of attentional retraining on attentional bias  
Mean attentional bias RT scores by trial arm are shown in Table 16. To examine whether 
there were any group differences in attentional bias scores at 4 weeks post-quit, a one-way 
between groups ANCOVA was performed while adjusting for pre-training attentional bias 
scores. No significant differences were found between groups in post-training attentional 
bias scores (F[2,81]=2.66, p=0.12). Similarly, when a 2 x 2 between-groups ANCOVA 
was performed with abstinence status included, there were no significant main effects or 
interactions (Fs<3.08, ps>0.1).  
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Table 16. Pre-training and post-training attentional bias scores at 4 weeks, 8 weeks 
and 3 months by trial arm 
  
Attentional 
retraining           
(n= 58) 
Control           
(n=58)         
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 684.36 (153.52) 684.71 (130.59) -0.34 -0.01 0.99 (-52.77, 52.08) 
  RT for neutral stimuli 685.33 (158.84) 690.16 (133.81) -4.84 -0.18 0.86 (-58.86, 49.19) 
  Attentional bias 0.97 (24.28) 5.46 (34.49) -4.49 -0.81 0.42 (-15.46, 6.48) 
Post-training +4 week 
        RT for smoking stimuli 688.54 (134.43) 655.01 (136.50) 33.53 1.15 0.26 (-24.68, 91.74) 
  RT for neutral stimuli 683.02 (125.99) 658.26 (141.04) 24.75 0.86 0.39 (-32.50, 82.02) 
  Attentional bias  -5.52 (28.05) 3.25 (21.04) -8.77 -1.62 0.11 (-19.54, 1.99) 
Post-training +8 week 
        RT for smoking stimuli 672.13 (129.73) 657.15 (117.12) 14.98 0.57 0.57 (-37.47, 67.44) 
  RT for neutral stimuli 672.87 (125.15) 651.78 (116.82) 21.09 0.82 0.42 (-30.28, 72.45) 
  Attentional bias 0.73 (24.96)  -5.37 (24.42) 6.11 1.16 0.25 (-4.37, 16.58) 
Post-training 3 months 
        RT for smoking stimuli 683.57 (155.95) 666.68 (135.54) 16.90 0.52 0.60 (-47.45, 81.25) 
  RT for neutral stimuli 683.00 (156.53) 668.80 (135.26) 14.20 0.44 0.66 (-50.23, 78.63) 
  Attentional bias  -0.57 (29.93) 2.13 (22.91) -2.70 -0.46 0.65 (-14.45, 9.06) 
RT - reaction time (milliseconds) 
 
While no statistical significance was found, an analysis within abstainers and non-
abstainers across groups was also performed. Closer inspection of the point estimates for 
only abstainers indicated that attentional bias scores were lower in the AR group than the 
control group post-training (β=-4.15, p=0.56, 95% CI=-18.29, 10.00). Similarly in non-
abstainers, bias scores were 16.37 points less in the AR group compared to the control 
group (p=0.07, 95% CI=-34.23, 1.50; see Figure 19). 
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Figure 19. Attentional bias scores (ms) with 95% CI by abstinence status in the 
attentional retraining group (n=58) and control group (n=58) 
 
5.3.4.1 Effects of attentional retraining on attentional bias – imputed dataset  
Using imputed scores for missing RT data, group differences in attentional bias scores at 
four weeks post-quit were assessed again in a one-way between groups ANCOVA 
adjusted for pre-training attentional bias scores. As found previously, no significant 
differences were found between groups in post-training attentional bias scores 
(F[2,92]=2.01, p=0.16). Similarly, in a 2 x 2 between-groups ANCOVA with abstinence 
status included, no significant main effects or interactions were found (Fs<2.23, ps>0.14).  
 
 
-35 
-30 
-25 
-20 
-15 
-10 
-5 
0 
5 
10 
15 
20 
25 
A
tt
e
n
ti
o
n
a
l 
b
ia
s
 s
c
o
re
s
 (
m
s
) 
Attentional retraining                       Control     
Abstainers 
Non-abstainers 
Abstinence  
status 
  CHAPTER 5 
 
 
160 
 
5.3.4.2 Effects of attentional retraining on attentional bias at 8 weeks and 3 months 
post-quit 
The t-test results for the 8-week and 3-month post-training attentional bias scores in Table 
16 revealed no significant differences in bias scores by trial arm at either follow-up; as 
non-significant effects were seen at four weeks post-quit in the ANCOVAs performed in 
section 5.3.4, it was unlikely that any effects would be observed at later time points. 
Therefore further analyses of these data have been omitted here, and in the analyses of 8-
week and 3-month pictorial Stroop bias scores in section 5.3.13. 
 
5.3.5 Effects of attentional retraining on craving  
5.3.5.1 MPSS-C at 4 weeks post-quit 
Mean scores for the MPSS-C by trial arm and abstinence status over time are illustrated in 
Figure 20. In abstainers across both groups, there was a general decrease in craving over 
time. In non-abstainers, scores were higher than in abstainers and were relatively stable 
over time.  
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Figure 20. Mean MPSS-C scores by trial arm and abstinence status from quit day to 
4 weeks (n=118) 
 
The means and standard deviations of the basic model of MPSS-C scores - according to a 
linear function of time by trial arm - indicated that there was a difference between the 
observed and predicted means, which warranted the inclusion of a time squared term and 
time cubed term (Appendix 26). Visual inspection of the plots revealed that the predicted 
scores fitted better to the observed data with the addition of time squared (Appendix 27a) 
but not time cubed (Appendix 27b); as the difference between the coefficients and shape 
of the curves was minimal, time cubed was discarded from all subsequent models to avoid 
the risk of overfitting.  
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The most parsimonious mixed-effects model of MPSS-C scores was reached through 
elimination of non-significant three-way and two-way interactions between trial arm, 
abstinence status and time; a three-way interaction of trial arm, abstinence status and time 
squared; and a two-way interaction of trial arm by time squared (Table 17). Chi-squared 
tests indicated that there was no significant difference in the log likelihood values 
between the fully specified model and parsimonious model (Table 18). 
 
Figure 21 illustrates a U-shaped pattern for the fixed-effects portion of predicted MPSS-C 
scores over time. Linear combinations of the coefficients indicated a 0.19 point reduction 
in craving among only abstainers in the AR group compared to the control group, 
although this difference was small and not statistically significant (p=0.74, 95% CI=-1.30, 
0.93).  
 
In a sub-group analysis of only non-abstainers, craving was significantly higher in the AR 
group compared to the control group (β=1.91, p=0.003, 95% CI=0.67, 3.16). 
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Table 17. Mixed-effects models of MPSS-C scores over time by trial arm and abstinence status 
  Model 1 Model 2 Model 3 Model 4 
 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
 Fixed effects 
           Time -1.86 0.08 -1.47 0.003 -1.36 0.005 -1.30 0.006 
   Time² 0.17 0.19 0.12 0.03 0.12 0.03 0.12 0.03 
   Treatment arm₁ -1.69 0.53 0.74 0.52 1.52 0.09 1.10 0.003 
   Abstinence status₂ -0.27 0.91 0.43 0.70 1.13 0.20 1.13 0.20 
 Intercept 12.76 
 
12.09 
 
11.68 
 
11.47 
  Interactions 
           Treatment arm x Abstinence status 2.48 0.48 -0.77 0.61 -2.12 0.01 -2.10 0.01 
   Time x Abstinence status 0.09 0.94 -0.32 0.17 -0.50 0.002 -0.50 0.002 
   Time x Treatment arm 1.78 0.23 0.31 0.22 0.11 0.51 
     Time x Treatment arm x Abstinence status -2.30 0.22 -0.35 0.29 
       Time² x Abstinence status -0.05 0.76 
         Time² x Treatment arm -0.18 0.31 
         Time² x Treatment arm x Abstinence status 0.25 0.30 
       Random effects 
           Participant ID, intercept (SD) 1.66 
 
1.65 
 
1.64 
 
1.64 
   -2*log likelihood -1054.20   -1054.98   -1055.55   -1055.76   
 Model 1: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, 
time x treatment arm, time x treatment arm x abstinence status, time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status 
Model 2: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, 
time x treatment arm, time x treatment arm x abstinence status     
Model 3: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, 
time x treatment arm  
Model 4: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status 
₁ Reference category is attentional retraining group, ₂Reference category is abstainers 
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Table 18. Difference in fit between models of MPSS-C scores over time 
 
Model 1: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm 
x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x abstinence status, 
time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status 
Model 2: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm 
x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x abstinence status 
Model 3: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm 
x abstinence status, time x abstinence status, time x treatment arm  
Model 4: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm 
x abstinence status, time x abstinence status         
LL₁ - loglikelihood of hierarchically superior model; LL₂ - loglikelihood of comparison model 
 
 
 
 
 
Figure 21.  Predicted MPSS-C scores (95% CI) by trial arm and abstinence status 
from quit day to 4 weeks (n=118) 
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   LL₁  LL₂ Chi squared df p 
Model 1 to 2 -1054.20 -1054.98   0.78 3 0.85 
Model 1 to 3 -1054.20 -1055.55 1.35 4 0.85 
Model 1 to 4 -1054.20 -1055.76 1.56 5 0.91 
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5.3.5.1.1 Re-modelling of MPSS-C 
The urge to smoke profiles depicted in Figure 21 assume that there was no change in the 
abstinence status of participants during the 4-week period from quit day, as only the four 
week post-quit outcome for abstinence was used in the model. We re-analysed this data to 
take into account that a) the abstinence status of participants was likely to change during 
the course of their quit attempts and b) non-abstainers experienced higher levels of 
craving because they were still attempting to quit. Weekly abstinence (on quit day, one 
week post-quit, two weeks post-quit, three weeks post-quit and four weeks post-quit) was 
calculated from CO readings; a participant was deemed abstinent if their CO reading was 
recorded as <10 at each clinic visit.   
 
A mixed-effects model of MPSS-C scores with three-way and two-way interactions 
involving trial arm, weekly abstinence status, time and time squared was constructed; 
only a two-way interaction between time and abstinence status remained in the model 
following backward elimination of all non-significant interactions (Appendix 28).  
 
It is important to note that unlike the analysis of MPSS-C scores reported in section 
5.3.5.1, different individuals were involved in this model at each time point because 
abstinence status was allowed to vary over time; however Figure 22 demonstrates that 
urge to smoke remained higher in those who were non-abstinent at each time point after 
quit day than in those who were abstinent.  
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Figure 22. Predicted MPSS-C scores (95% CI) by trial arm and weekly abstinence 
status from quit day to 4 weeks (n=118) 
 
5.3.5.2 MPSS-C at 8 weeks post-quit 
A mixed-effects model of MPSS-C scores at eight weeks post-quit indicated that across 
abstainers only, a 0.24 point non-significant reduction in craving was found in the AR 
group compared to the control group (p=0.70, 95% CI=-1.46, 0.99; Figure 23).  
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Figure 23. Predicted MPSS-C scores (95% CI) by trial arm and weekly abstinence 
status from quit day to 8 weeks (n=118) 
 
5.3.5.3 MPSS-C at 3 months post-quit 
Unlike the parsimonious models to predict MPSS-C scores at four weeks and eight weeks 
post-quit, the model to predict MPSS-C scores at three months post-quit only contained a 
significant two-way interaction between time and abstinence status. Linear combinations 
of the coefficients indicated a significant 0.90 point increase in craving in the AR group 
compared to the control group (p=0.02, 95% CI=0.12, 1.68; Figure 24). 
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Figure 24. Predicted MPSS-C scores (95% CI) by trial arm and weekly abstinence 
status from quit day to 3 months (n=118) 
 
5.3.6 Effects of attentional retraining on withdrawal symptoms 
5.3.6.1 MPSS-M at 4 weeks post-quit 
The trajectory for withdrawal symptoms followed an inverted U-shaped pattern in both 
trial arms and among abstainers and non-abstainers. Withdrawal was generally higher in 
the AR group than the control group and in non-abstainers compared to abstainers. In 
abstainers, withdrawal scores declined steadily over time in contrast to an increase found 
in non-abstainers. Mean MPSS-M scores by trial arm and abstinence status are illustrated 
in Figure 25. 
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Figure 25. Mean MPSS-M scores by trial arm and abstinence status from quit day to 
4 weeks (n=118) 
 
As found in the mixed-effects model of MPSS-C scores, the predicted scores for the 
MPSS-M (Appendix 29) fitted better to the observed scores when time squared was 
included in the model (Appendix 30a) but not time cubed (Appendix 30b). 
 
After adjusting for pre-quit MPSS-M scores, the fully specified model of MPSS-M scores 
revealed no significant three-way interactions or two-way interactions between trial arm, 
time or abstinence status (Table 19). Backward elimination of all interactions did not 
significantly reduce the log-likelihood of the model (Table 20). The most parsimonious 
model contained only a significant main effect of time squared, suggesting no difference 
in trend across trial arm or abstainers versus non-abstainers (Figure 26). The overall 
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treatment effect was a non-significant increase in withdrawal in the AR group compared 
to the control group (β=0.77, p=0.50, 95% CI=-1.45, 2.98). 
 
Figure 26. Predicted MPSS-M scores (95% CI) by trial arm and abstinence status 
from quit day to 4 weeks (n=118) 
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Table 19. Mixed-effects models of MPSS-M scores over time by treatment arm and abstinence status 
 
Model 1: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status, time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status  
Model 2: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status  
Model 3: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm 
Model 4: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status 
Model 5: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms time x abstinence status    
Model 6: Withdrawal scores by time, time², treatment arm, abstinence status; ₁ Reference category is attentional retraining group, ₂Reference category is abstainers
  Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Fixed effects 
              Baseline MPSS-M score 0.58 0.00 0.58 0.00 0.58 0.00 0.58 0.00 0.60 0.00 0.60 0.00 
  Time 3.95 0.13 1.85 0.13 2.26 0.06 2.45 0.04 2.43 0.04 2.07 0.08 
  Time² -0.55 0.09 -0.29 0.05 -0.29 0.05 -0.29 0.05 -0.28 0.05 -0.29 0.05 
  Treatment arm₁ -2.58 0.70 -1.83 0.52 1.10 0.62 2.43 0.16 0.78 0.49 0.77 0.50 
  Abstinence status₂ 6.69 0.28 0.65 0.81 3.26 0.14 3.26 0.14 1.86 0.33 -0.57 0.63 
Intercept 0.40 
 
3.97 
 
2.39 
 
1.67 
 
2.11 
 
3.47 
 Interactions 
              Time x Abstinence status -3.51 0.30 0.04 0.94 -0.63 0.10 -0.64 0.10 -0.64 0.10 
    Treatment arm x Abstinence status 3.07 0.72 2.04 0.59 -2.98 0.19 -2.91 0.21 
      Time x Treatment arm 1.62 0.66 1.13 0.06 0.36 0.35 
        Time x Treatment arm x Abstinence status -1.97 0.68 -1.31 0.09 
          Time² x Abstinence status 0.45 0.28 
            Time² x Treatment arm -0.06 0.89 
            Time² x Treatment arm x Abstinence status 0.08 0.89 
          Random effects 
              Participant ID, intercept (SD) 4.77 
 
4.76 
 
4.77 
 
4.79 
 
4.85 
 
4.77 
  -2*log likelihood -1484.51   -1485.91   -1487.34   -1487.77   -1488.57   -1489.88   
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Table 20. Difference in fit between models of MPSS-M scores over time 
 
   LL₁  LL₂ Chi squared df p 
Model 1 to 2 -1484.51 -1485.91 1.40 3 0.71 
Model 1 to 3 -1484.51 -1487.34 2.83 4 0.59 
Model 1 to 4 -1484.51 -1487.77 3.26 5 0.66 
Model 1 to 5 -1484.51 -1488.57 4.06 6 0.67 
Model 1 to 6 -1484.51 -1489.88 5.37 7 0.61 
Model 1: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms 
treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status, time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status 
Model 2: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms 
treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status 
Model 3: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms 
treatment arm x abstinence status, time x abstinence status, time x treatment arm 
Model 4: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms 
treatment arm x abstinence status, time x abstinence status 
Model 5: Withdrawal scores by time, time², treatment arm, abstinence status and interaction terms time x 
abstinence status    
Model 6: Withdrawal scores by time, time², treatment arm, abstinence status 
LL₁ - loglikelihood of hierarchically superior model; LL₂ - loglikelihood of comparison model  
  
         
5.3.6.2 MPSS-M at 8 weeks post-quit 
Only a significant two-way interaction between time and abstinence status remained in 
the most parsimonious mixed-effects model of MPSS-M scores at eight weeks post-quit; 
the overall treatment effect was a non-significant increase in MPSS-M score of 1.32 
points in the AR group compared to the control group (p=0.22, 95% CI=-0.80, 3.45; 
Figure 27).  
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Figure 27. Predicted MPSS-M scores (95% CI) by trial arm and abstinence status 
from quit day to 8 weeks (n=118) 
 
5.3.6.3 MPSS-M at 3 months post-quit 
Similar to the model of MPSS-M at four weeks post-quit, the model of MPSS-M at three 
months post-quit contained no significant three-way or two-way interactions between trial 
arm, abstinence status or time. As illustrated in Figure 28, the overall treatment effect was 
a non-significant increase of 1.59 points in the AR group compared to the control group 
(p=0.14, 95% CI=-0.50, 3.69). 
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Figure 28. Predicted MPSS-M scores (95% CI) by trial arm and abstinence status 
from quit day to 3 months (n=118) 
 
5.3.7 Effects of attentional retraining on abstinence 
There was no significant difference between groups in the proportion of smokers 
achieving prolonged abstinence at four weeks post-quit; 30/60 achieved abstinence in the 
AR group and 29/58 in the control group (RR=1.00, 95% CI=0.70, 1.43). Quit rates were 
higher in the AR group compared to the control group at eight weeks, with 23/60 
achieving abstinence in the AR group compared to 18/58 in the control group  (RR=1.24, 
95% CI=0.75, 2.04). At three months post-quit, 19/60 achieved abstinence in the AR 
group compared to 13/58 in the control group (RR=1.41, 95% CI=0.77, 2.59). 
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5.3.8 Effects of attentional retraining on time to lapse 
Figure 29 illustrates the time to first self-reported lapse by trial arm. Censored 
observations included those who dropped out of treatment and were assumed to have 
returned to smoking. The median time to lapse was two weeks post-quit in both the AR 
group (95% CI=0, 8) and control group (95% CI=1, 4). Cox regression analyses revealed 
that there was no significant difference between trial arms in time to lapse (HR=0.92, 
p=0.71, 95% CI=0.57, 1.47). 
 
 
 
Figure 29. Kaplan Meier curve of survival time to first lapse from two weeks prior to 
quit day to 3 months post-quit 
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5.3.9  Exploratory analyses of potential moderators of attentional bias 
Linear regression analyses were performed in all cases presented below, with post-
training attentional bias score as the outcome variable and trial arm and abstinence status 
as explanatory variables. 
 
5.3.9.1 Demographic variables 
We investigated whether retraining effects were influenced by demographic variables 
including participant age at randomisation and gender. These were adjusted for in the 
analysis of post-training attentional bias scores. The analyses revealed no additional effect 
of age (β=0.03, p=0.91, 95% CI=-0.41, 0.46) or gender (β=4.62, p=0.42, 95% CI=-6.78, 
16.02) on post-training attentional bias scores. 
 
5.3.9.2 Pre-quit attentional bias 
To assess whether the degree of attentional bias exhibited at baseline had any effect on 
post-training attentional bias scores, a three-way interaction and two-way interactions 
between baseline attentional bias score, trial arm and abstinence status were examined. 
Elimination of all non-significant interactions revealed no additional effect of baseline 
attentional bias on post-training attentional bias scores. The model indicated a reduction 
of 0.02 points with a one unit increase in baseline attentional bias score (p=0.81, 95% 
CI=-0.20, 0.16). 
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5.3.9.3 Nicotine dependence 
To examine whether retraining effects were moderated by the severity of nicotine 
dependence measured at baseline, FTND score was added as a covariate with three-way 
and two-way interactions between FTND, trial arm and abstinence status. No significant 
interactions were found (ps>0.06). The main effect of FTND represented a 0.72 point 
increase in post-training attentional bias score for every one unit increase in FTND, 
however this failed to reach statistical significance (p=0.56, 95% CI=-1.74, 3.18). 
 
5.3.9.4 Pre-quit urge to smoke 
Baseline MPSS-C scores were included as a covariate in the model to determine whether 
pre-quit urge to smoke predicted post-training attentional bias scores. The analyses 
revealed no significant main effects or interactions; for every one unit increase in baseline 
MPSS-C score on a 7-point scale, attentional bias score decreased by 0.29 points (p=0.81, 
95% CI=-2.74, 2.15). 
 
5.3.10  Exploratory analyses of potential moderators of urge to smoke 
The most parsimonious model of MPSS-C scores was used in all exploratory analyses 
reported below. 
 
5.3.10.1 Demographic variables 
Participants’ age at randomisation and gender were added as covariates to the model of 
MPSS-C scores. Neither variable improved the fit of the model (χ2=0.70, p=0.70) and the 
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coefficients failed to reach statistical significance; there was only a 0.31 point decrease in 
MPSS-C scores in males compared to females (p=0.48, 95% CI=-1.16, 0.54) and a 0.02 
point decrease in MPSS-C score with every one year increase in age (p=0.37, 95% CI=-
0.05, 0.02). 
 
5.3.10.2 Nicotine dependence 
When FTND score was added as a covariate to the model of MPSS-C scores, no 
significant three-way or two-way interactions involving FTND, trial arm and abstinence 
status were found; adding these interaction terms did not significantly improve the fit of 
the model (χ2=5.40, p=0.25). However, there was a statistically significant main effect of 
FTND, indicating that for every one unit increase in FTND score, MPSS-C scores 
increased by 0.22 (p=0.02, 95% CI=0.03, 0.40).  
 
5.3.10.3 Pre-quit attentional bias 
Baseline attentional bias score was included as a covariate in the parsimonious model of 
MPSS-C scores to predict the effect of pre-quit attentional bias on urges to smoke over 
time; three-way and two-way interactions between baseline attentional bias, trial arm and 
abstinence status were added but the coefficients derived from the model were non-
significant (ps>0.64). The final model indicated no statistically significant effect of 
baseline attentional bias score on MPSS-C scores (β=0.001, p=0.79, 95% CI=-0.02, 0.01). 
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5.3.11  Exploratory analyses of potential moderators of withdrawal 
Following the methods used in the exploratory analyses of urge to smoke (section 5.3.10), 
the most parsimonious model of MPSS-M was used in all exploratory analyses of 
withdrawal symptoms. 
 
5.3.11.1 Demographic variables 
Participant age at randomisation and gender were entered as covariates in the model of 
MPSS-M scores. Neither variable had any additional effect on the model; while the 
coefficients failed to reach statistical significance, MPSS-M scores increased by 0.37 
points in males (p=0.75, 95% CI=-1.86, 2.60) compared to females and decreased by 0.06 
with every one year increase in age (p=0.19, 95% CI=-0.15, 0.03). 
 
5.3.11.2 Nicotine dependence 
To examine the effect of nicotine dependence on withdrawal symptoms over time, FTND 
scores were added to the model of MPSS-M scores. No significant three-way or two way 
interactions between FTND, trial arm and abstinence status were found and were 
therefore removed from the model, as there was no improvement in fit (χ2=2.46, p=0.65). 
The final model indicated that there were no significant effects of FTND scores on 
MPSS-M scores (β=0.21, p=0.41, 95% CI=-0.29, 0.71). 
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5.3.11.3 Pre-quit attentional bias 
Baseline attentional bias scores were added to the model of MPSS-M scores; no 
significant three-way or two-way interactions between baseline attentional bias, trial arm 
and abstinence status were found (ps>0.63) and were subsequently discarded from the 
model.  The final model revealed that for every one unit increase in bias, MPSS-M scores 
decreased by 0.02 points, which failed to reach statistical significance (p=0.30, 95% CI=-
0.02, 0.06). 
 
5.3.12  Effects of attentional retraining on cue-induced craving 
5.3.12.1 VAS 
Mean VAS scores for the difference between pre and post cue exposure at baseline, four 
weeks, eight weeks and three months post-quit by trial arm are shown in Table 21. Across 
both groups at all time points, VAS craving scores were higher post cue exposure than pre 
cue exposure. The largest difference in VAS pre and post cue exposure scores was found 
at pre-training in both groups; thereafter the difference scores were small and similar 
across groups.  
 
 
 
 
 
 
 
  CHAPTER 5 
 
 
181 
 
Table 21. Mean (95%CI) VAS difference scores for craving pre-training and post-
training at 4 weeks, 8 weeks and 3 months post-quit by trial arm 
  
Attentional 
retraining           
(n=58) 
Control           
(n=58)         
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
VAS difference  pre-
training 4.47 (24.99) 5.93 (26.78) -1.46 -0.31 0.76 (-10.94, 8.02) 
VAS difference  post-
training +4 week 1.81 (17.82) 0.74 (11.04) 1.07 0.35 0.73 (-5.05, 7.19) 
VAS difference  post-
training +8 week 0.26 (12.07) 0.60 (11.62) -0.34 -0.13 0.90 (-5.45, 4.77) 
VAS difference  post-
training 3 months 1.66 (13.89) 0.88 (8.37) 0.78 0.31 0.76 (-4.26, 5.82) 
 
Figure 30 depicts mean VAS difference scores by trial arm and abstinence status. 
Abstainers in the AR group had a higher mean difference in VAS craving pre and post 
cue exposure than the control group across all time points. The mean difference in VAS 
craving scores among non-abstainers was generally lower than that found in abstainers 
across both groups. 
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Figure 30. Mean VAS difference scores by trial arm and abstinence status from quit 
day to 3 months (n=116) 
 
The fully specified mixed-effects model of VAS difference scores did not contain any 
significant three-way or two-way interactions between trial arm, abstinence status and 
time (Appendix 31); following backward elimination of all non-significant interactions, 
only the main effects of trial arm, abstinence status and time remained in the model. 
Model comparisons indicated no significant loss in the log-likelihood between the fully 
specified model and the parsimonious model (χ2=3.54, p=0.83). 
 
Linear combinations of the coefficients from the parsimonious model indicated a small 
non-significant 0.22 point reduction in VAS craving difference scores in the AR group 
compared to the control group (p=0.93, 95% CI=-5.06, 4.60; Figure 31). The comparison 
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by abstinence status revealed that VAS difference scores were significantly higher in 
abstainers than non-abstainers (β=5.21, p=0.04, 95% CI=0.32, 10.10). 
 
Figure 31. Predicted VAS difference scores for craving (95% CI) by trial arm and 
abstinence status from one week prior to quit day to 3 months post-quit 
 
5.3.13  Other cognitive processing bias measures 
5.3.13.1 Baseline Stroop bias 
Participants across the sample did respond in the predicted direction and were slower to 
colour-name smoking-related pictures than neutral pictures (mean difference=4.87). 
However, a one-sample t-test against zero indicated that this difference was not 
significant at baseline (t[117]=0.87, p=0.39).  
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5.3.13.2 Effects of attentional retraining on pictorial Stroop bias 
Mean Stroop bias RT scores by trial arm are shown in Table 22. A one-way between 
groups ANCOVA adjusted for pre-training Stroop bias scores was performed to assess 
group differences in Stroop bias at four weeks post-quit. No significant differences were 
found between groups in post-training Stroop bias scores (F[2,85]=0.25, p=0.62). 
Similarly, when a 2 x 2 between-groups ANCOVA was performed with abstinence status 
included, there were no significant main effects or interactions (Fs<0.22, ps>0.67).  
 
Table 22. Pre-training and post-training Stroop bias scores at 4 weeks, 8 weeks and 3 
months by trial arm 
  
Attentional 
retraining           
(n=60) 
Control           
(n=58)         
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 834.18 (154.70) 801.36 (131.75) 32.81 1.24 0.22 (-19.66, 85.29) 
  RT for neutral stimuli 824.28 (160.09) 801.70 (129.31) 22.58 0.84 0.40 (-30.59, 75.75) 
  Attentional bias 9.90 (62.85)  -0.34 (59.07) 10.24 0.91 0.36 (-12.02, 32.49) 
Post-training +4 week 
        RT for smoking stimuli 838.78 (133.46) 792.64 (148.86) 40.56 1.53 0.13 (-13.69, 105.97) 
  RT for neutral stimuli 837.34 (144.91) 796.77 (148.39) 46.14 1.30 0.20 (-21.62, 102.75) 
  Attentional bias 1.45 (55.13)  -4.13 (39.96) 5.58 0.55 0.59 (-14.72, 25.87) 
Post-training +8 week 
        RT for smoking stimuli 828.30 (145.87) 807.18 (148.40) 21.11 0.66 0.51 (-42.39, 84.62) 
  RT for neutral stimuli 830.97 (150.90) 822.55 (143.45) 8.42 0.26 0.79 (-55.20, 72.04) 
  Attentional bias  -2.67 (45.09)  -15.37 (64.44) 12.70 1.06 0.29 (-11.17, 36.56) 
Post-training 3 months 
        RT for smoking stimuli 838.52 (129.66) 810.33 (148.92) 28.20 0.92 0.36 (-33.08, 89.48) 
  RT for neutral stimuli 834.04 (139.65) 793.86 (138.86) 40.17 1.31 0.20 (-21.06, 101.40) 
  Attentional bias 4.49 (58.60) 16.46 (63.19) -11.97 -0.89 0.38 (-38.74, 14.79) 
RT - reaction time (milliseconds) 
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Among abstainers only, Stroop bias scores were higher in the AR group than the control 
group post-training (β=9.18, p=0.50, 95% CI=-17.47, 35.83), while in non-abstainers, bias 
scores were 0.94 points less in the AR group compared to the control group (p=0.96, 95% 
CI=-34.86, 32.98; see Figure 32). 
 
 
Figure 32. Stroop bias scores (ms) with 95% CI by abstinence status in the 
attentional retraining group (n=60) and control group (n=58) 
 
5.3.13.3 Effects of attentional retraining on pictorial Stroop bias – imputed dataset  
The ANCOVA reported in section 5.3.13.2 was re-run using imputed Stroop RT scores 
for missing values; however there was no significant difference in Stroop bias scores at 
four weeks post-quit between trial arms (F[2,93]=0.06, p=0.80) or with abstinence status 
added as an additional variable and interaction (F[4,91]=0.26, p=0.62). 
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5.3.14     Effects of attentional retraining on trained ‘old’ stimuli on the visual probe 
task 
Mean RT scores for attentional bias on trained stimuli only are presented in Table 23. To 
examine attentional retraining effects on trained stimuli only, a one-way between groups 
ANCOVA adjusted for pre-training attentional bias scores was performed on the stimuli 
that were used during training sessions only. This was initially carried out with the 
inclusion of trial arm, followed by an interaction with abstinence status. The ANCOVA 
revealed no significant differences between groups (F[2,81]=0.16, p=0.85) or by 
abstinence status (F[4,79]=0.40, p=0.81). 
 
In analyses of abstainers only, attentional bias scores were 2.62 points lower in the AR 
group compared to the control group for trained stimuli, although this failed to reach 
statistical significance (p=0.80, 95% CI=-23.15, 17.90). Across non-abstainers only, the 
difference was larger in the AR group compared to the control group but again, the size of 
this effect was small and did not reach statistical significance (β=-6.52, p=0.62, 95% CI=-
32.24, 19.21; Figure 33). 
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Table 23. Pre-training and post-training attentional bias scores for trained stimuli 
only at 4 weeks, 8 weeks and 3 months by trial arm 
  
Attentional 
retraining           
(n=58) 
Control           
(n=58)         
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 684.52 (156.11) 680.40 (139.19) 4.12 0.15 0.88 (-50.28, 58.52) 
  RT for neutral stimuli 668.30 (199.91) 686.63 (139.88) -18.32 -0.58 0.57 (-81.43, 44.79) 
  Attentional bias 6.84 (27.50) 6.23 (47.59) 0.60 0.08 0.93 (-13.69, 14.90) 
Post-training +4 week 
        RT for smoking stimuli 681.96 (132.69) 651.81 (139.61) 30.14 1.03 0.31 (-28.30, 88.59) 
  RT for neutral stimuli 680.68 (129.51) 654.82 (142.83) 25.86 0.88 0.38 (-32.54, 84.27) 
  Attentional bias  -1.27 (35.00) 3.01 (37.13) -4.28 -0.55 0.58 (-19.76, 11.20) 
Post-training +8 week 
        RT for smoking stimuli 670.09 (125.25) 649.50 (117.71) 20.59 0.79 0.48 (-30.97, 72.15) 
  RT for neutral stimuli 669.27 (121.70) 648.02 (115.96) 21.24 0.84 0.77 (-29.18, 71.66) 
  Attentional bias  -0.82 (35.59)  -1.48 (35.09) 0.65 0.09 0.42 (-14.33, 15.64) 
Post-training 3 months 
        RT for smoking stimuli 681.42 (159.52) 664.85 (135.85) 16.57 0.51 0.62 (-48.70, 81.84) 
  RT for neutral stimuli 686.46 (157.51) 668.40 (139.48) 18.06 0.55 0.59 (-47.44, 83.57) 
  Attentional bias 5.05 (35.14) 3.55 (29.37) 1.50 0.21 0.84 (-12.77, 15.77) 
RT - reaction time (milliseconds) 
 
 
Figure 33. Attentional bias scores (ms) for trained stimuli only with 95% CI by 
abstinence status in the attentional retraining group (n=58) and control group 
(n=58) 
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5.3.15  Effects of attentional retraining on untrained ‘novel’ stimuli on the visual 
probe task 
Mean RT scores for attentional bias on untrained stimuli only are presented in Table 24. 
We examined retraining effects on untrained stimuli only in a one-way between groups 
ANCOVA adjusted for pre-training attentional bias scores. The ANCOVA revealed no 
significant differences between groups (F[2,81]=2.26, p=0.11) but a significant effect was 
found when abstinence status was included with an interaction with trial arm 
(F[4,79]=2.51, p=0.05). 
 
Across abstainers only, attentional bias scores were 2.84 points lower post-training in the 
AR group compared to the control group, although this was not statistically significant 
(p=0.79, 95% CI=-23.81, 18.13). On the other hand in non-abstainers, attentional bias 
scores were significantly lower by 41.76 points in the AR group than the control group 
(p=0.002, 95% CI=-68.34, -15.18; Figure 34). 
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Table 24. Pre-training and post-training attentional bias scores for untrained stimuli 
only at 4 weeks, 8 weeks and 3 months by trial arm 
  
Attentional 
retraining           
(n=58) 
Control           
(n=58)         
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 686.83 (154.97) 690.22 (124.51) -3.39 -0.13 0.90 (-55.10, 48.32) 
  RT for neutral stimuli 659.22 (201.89) 694.04 (132.41) -34.83 -1.10 0.27 (-97.30, 27.65) 
  Attentional bias  -4.88 (33.09) 3.83 (38.45) -8.71 -1.31 0.19 (-21.90, 4.49) 
Post-training +4 week 
        RT for smoking stimuli 694.65 (134.84) 655.91 (136.04) 38.74 1.32 0.61 (-19.47, 96.95) 
  RT for neutral stimuli 686.21 (122.65) 663.44 (146.65) 22.77 0.78 0.32 (-34.98, 80.52) 
  Attentional bias  -8.45 (38.64) 7.53 (37.04) -15.97 -1.95 0.42 (-32.27, 0.32) 
Post-training +8 week 
        RT for smoking stimuli 675.57 (137.62) 666.50 (124.37) 9.07 0.32 0.75 (-46.60, 64.74) 
  RT for neutral stimuli 676.84 (130.75) 653.76 (118.33) 23.09 0.87 0.39 (-29.83, 76.01) 
  Attentional bias 1.28 (35.00)  -12.74 (38.62) 14.02 1.79 0.08 (-1.58, 29.63) 
Post-training 3 months 
        RT for smoking stimuli 684.51 (151.78) 674.58 (142.37) 9.94 0.31 0.76 (-54.81, 74.68) 
  RT for neutral stimuli 680.42 (157.66) 669.19 (136.44) 11.23 0.72 0.73 (-53.71, 76.16) 
  Attentional bias  -4.10 (50.19)  -5.39 (45.70) 1.29 0.85 0.90 (-19.84, 22.42) 
RT - reaction time (milliseconds) 
 
 
Figure 34. Attentional bias scores (ms) for untrained stimuli only with 95% CI by 
abstinence status in the attentional retraining group (n=58) and control group 
(n=58) 
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5.3.16  Identification of group allocation 
Self-reported data on group allocation were missing from two participants at follow up, 
excluding those who had dropped out of the study and were lost-to-follow up after 
randomisation. Data were therefore available for 92 participants. Figure 35 illustrates 
participant responses as a percentage within each group. Most participants in the AR 
group correctly identified that they had received training (58.7%). In the control group, 
the majority of participants incorrectly identified that they had received training or were 
unsure of their allocation (71.7%). 
 
Kappa was used to measure the degree of agreement between the number of correct 
responses to group allocation and actual allocation; overall there was marginal agreement 
(Kappa=0.13, p=0.03). 
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Figure 35. Self-reported responses (%) to group allocation by trial arm (n=92) 
 
5.3.17 Observational analysis: association between attentional bias, craving and 
withdrawal symptoms at baseline 
To examine whether the visual probe task measure of attentional bias correlated with 
craving and withdrawal measures at baseline, Pearson’s correlations were performed 
between baseline attentional bias scores, MPSS-C scores, MPSS-M scores and VAS score 
for the item “craving a cigarette” on all participants. There was a positive correlation 
between MPSS-C and VAS craving measures (r=+0.23, p<0.05) and between MPSS-C 
and MPSS-M scores (r=+0.40, p<0.001), but none of these measures correlated with 
attentional bias scores (ps>0.77). 
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5.3.18 Observational analysis: attentional bias associations with measures of 
dependence and clinical outcomes 
 
To facilitate interpretation of the coefficients derived from the linear regression analyses 
presented below, the coefficients were multiplied by 100. 
 
5.3.18.1 Associations with nicotine dependence 
There were no significant associations between attentional bias measured by the visual 
probe task or Stroop task and markers of dependence. On the visual probe task measure, 
FTND decreased by 0.20 (p=0.77, 95% CI=-1.60, 1.19) and cigarettes per day decreased 
by 4 (p=0.17, 95% CI=-9.74, 1.70) with every 100 unit increase in bias score. On the 
Stroop task measure, FTND decreased by 0.02 (p=0.95, 95% CI=-0.66, 0.71) and 
cigarettes per day decreased by 1 (p=0.47, 95% CI=-1.77, 3.79) with every 100 unit 
increase in bias score.  
 
5.3.18.2 Associations with urge to smoke 
There were no significant associations between attentional bias measured by the visual 
probe task or Stroop task and urge to smoke. A mixed-effects model of MPSS-C scores 
with an interaction between attentional bias and period of quit attempt (to delineate pre-
quit from post-quit) indicated no significant main effects or interactions (ps>0.41). We 
found a 0.30 point non-significant increase in MPSS-C with every 100 unit increase in 
bias score (p=0.59, 95% CI=-0.98, 1.74). Similarly, using the Stroop task measure in a 
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mixed-effects model of MPSS-C scores, there was a 0.50 point non-significant increase in 
MPSS-C with every 100 unit increase in bias score (p=0.12, 95% CI=-0.13, 1.18). 
 
5.3.18.3 Associations with withdrawal symptoms 
There were no significant associations between attentional bias measured by the visual 
probe task or Stroop task and severity of withdrawal mood symptoms. Similar to the 
analysis of MPSS-C scores in section 5.3.18.2, a mixed-effects model of MPSS-M scores 
indicated a 2.22 point non-significant reduction in pre-quit withdrawal symptoms with 
every 100 unit increase in bias scores (p=0.22, 95% CI=-5.77, 1.33). On the Stroop task, 
there was a 0.38 point non-significant increase in MPSS-M with every 100 unit increase 
in bias scores (p=0.66, 95% CI=-1.31, 2.07). 
 
5.3.18.4 Association with smoking abstinence at 4 weeks 
Over all participants, neither the visual probe task measure of attentional bias taken at 
baseline (OR=0.79, 95% CI=0.23, 2.74) nor Stroop bias measure (OR=1.15, 95% 
CI=0.63, 2.10) predicted four weeks abstinence. 
 
5.4 Discussion 
5.4.1 Summary of principal findings 
This study examined the efficacy of AR on attentional bias and smoking cessation 
outcomes in smokers attempting to stop smoking. The overall finding suggested that there 
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was no statistically significant effect of retraining on attentional bias, urge to smoke, 
withdrawal symptoms or abstinence rates in the AR group compared to the control group.  
 
There was no association between baseline attentional bias scores and baseline craving, 
although both MPSS-C and VAS craving measures correlated with each other. Similarly 
there was no association between baseline attentional bias scores and withdrawal scores, 
but one measure of craving (MPSS-C) correlated with withdrawal scores. 
 
Abstainers in the AR group had lower attentional bias scores post-training than those in 
the control group, but this was not statistically significant and the effect size was too 
small to be clinically meaningful. No significant differences in attentional bias scores 
were found between groups at follow-up. There was a non-significant reduction in MPSS-
C scores among abstainers in the AR group compared to the control group but again, 
these effects were negligible. This reduction was maintained at follow-up in abstainers. 
There was no difference between groups in withdrawal symptom profiles, although the 
AR group exhibited a non-significant increase in withdrawal over time, which was also 
observed at the follow-up time points. 
 
Abstinence rates were similar across both groups, indicating that AR had no effect on 
quitting. Moreover, the groups did not differ in time to first lapse. 
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We observed no retraining effects on cue-induced craving; the difference between pre and 
post cue exposure task ratings at each follow-up was only marginally smaller in the AR 
group compared to the control group. Overall, the difference in craving scores pre and 
post cue exposure was higher in abstainers than non-abstainers. 
 
Attentional retraining did not generalize to other measures of cognitive bias (the pictorial 
Stroop task) or to untrained ‘novel’ stimuli among abstainers on the visual probe task, 
although non-abstainers did show reductions in attentional bias. 
 
As found in current smokers in the earlier study, this sample of treatment-seekers did not 
exhibit an attentional bias at baseline. Moreover, retraining effects were not moderated by 
baseline attentional bias, i.e. the degree of attentional bias exhibited at baseline had no 
impact on post-training attentional bias scores, craving and withdrawal symptoms. 
Similarly, age, gender, FTND and pre-quit urge to smoke had little impact as potential 
moderators, although severity of nicotine dependence was moderately associated with 
urge to smoke and to a lesser degree, with attentional bias. 
 
Irrespective of retraining, neither attentional bias measure showed reliable associations 
with nicotine dependence nor any of the clinical outcomes measured in the study. The 
implications of these observational findings in relation to the trial results are discussed 
later in section 5.4.2. 
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5.4.2 The findings in the context of previous studies  
This study provides partial support for other tobacco-related retraining studies (Field et 
al., 2009b; McHugh et al., 2010) but not the Attwood et al. (2008) study. Attwood et al. 
(2008) found that attentional retraining significantly reduced attentional bias in their train-
to-avoid group, while in Field et al. (2009b), the reduction in bias only approached 
statistical significance.  
 
Crucially, both Attwood et al. (2008) and Field et al. (2009b) demonstrated that the 
current smokers in their studies exhibited an attentional bias at baseline, while participants 
in our study did not. Our findings therefore concur mostly with our earlier study (Chapter 
2) and McHugh et al. (2010), who found no attentional bias in their sample at baseline 
and no attentional retraining effects in those trained to avoid smoking cues. Of particular 
note is that attentional bias was normally distributed in our sample, with a large number 
of participants failing to show a bias towards smoking cues; in fact some showed a 
negative bias at baseline. This finding is perhaps more indicative of attentional bias in 
real-world settings with treatment-seeking populations, which is a departure from the 
unrepresentative samples typically recruited in the laboratory studies mentioned above. 
The implications of this are described in more detail in section 5.4.4. 
 
Arguably, the studies by Waters et al. (2003a, 2003c) are most relevant to the discussion 
of attentional bias in clinical populations. The first of these studies measured selective 
processing biases on the Stroop task while the second study used the visual probe task, 
both of which assessed smokers attempting to quit on nicotine patches or placebo patches. 
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Smokers across both studies showed a significant attentional bias towards smoking cues 
[64 ms bias in Waters et al. (2003a) and 3 ms bias in Waters et al. (2003c)]. A key 
difference in the design of the first study is that selective processing biases were measured 
on the first day of abstinence, unlike in Waters et al. (2003c) and this study where 
participants – though treatment seekers – were assessed in a non-deprived state. Across a 
handful of previous studies, participants have typically observed a period of abstinence 
prior to testing, e.g. for at least one hour in laboratory studies (Field et al., 2009b) or 
overnight in clinical studies (Powell et al., 2010). Indeed some investigators have found 
that nicotine deprivation level affects attentional bias (Field et al., 2004; Freeman et al., 
2012), whilst others have not (Canamar & London, 2012; Mogg & Bradley, 2002). For 
example, Field et al. (2004) assessed nicotine deprived and non-deprived smokers’ eye 
movements during a visual probe task and found that while both groups exhibited an 
attentional orienting towards smoking cues, deprivation increased the maintenance of 
gaze on smoking cues than neutral cues compared to those who were satiated. Although 
deprivation level did not appear to significantly affect bias on other measures in the Field 
et al. (2004) study, i.e. the direction of initial eye movement or visual probe task RTs at a 
stimulus duration of 2000 ms, a recent study demonstrated that abstinent smokers had 
faster RTs towards smoking cues than neutral cues compared to satiated smokers and non-
smoker controls on a visual probe task that employed a shorter stimulus duration of 250 
ms (Freeman et al., 2012). Aside from the need to clarify which measures are most 
sensitive to the measurement of attentional bias and the effects of nicotine deprivation, 
future investigations should consider the potential impact of deprivation state on 
attentional bias when measured in treatment-seeking populations. 
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While it may have been more difficult to detect retraining effects in a sample that did not 
show a significant attentional bias in the first instance, we also found that AR had little 
impact in those that did show a bias. It would seem that delivering AR in those identified 
with an a priori bias may still be insufficient to produce the desired change in attentional 
bias and smoking cessation outcomes. 
 
Attentional retraining had no apparent effects on urge to smoke, cue–induced craving and 
withdrawal symptoms. The lack of effect is consistent with findings of the earlier 
laboratory study and other tobacco and alcohol-related studies with a train-to-avoid 
manipulation (Field et al., 2009b; McHugh et al., 2010; Schoenmakers et al., 2007). 
Although there was some indication of a reduction in urge to smoke over time in 
abstainers in the AR group compared to the control group, the effects were negligible. 
The causal association between attentional bias and craving has been described as weak at 
best particularly in tobacco studies (Field et al., 2009a) and so these small effects are 
unsurprising. Previous retraining studies have only lent support for this causal association 
in one direction of change, i.e. by demonstrating that increases in attentional bias are 
associated with increases in urge to smoke (Attwood et al., 2008) or urge to drink (Field 
& Eastwood, 2005); however, most retraining studies have failed to demonstrate that 
decreases in attentional bias reduce craving across non-treatment seeking populations 
(Field et al., 2009b; McHugh et al., 2010) and critically, in clinical populations 
(Schoenmakers et al., 2010). Taken together, this study is the first to illustrate that 
attentional retraining on the visual probe task did not have a reliable effect on craving or 
withdrawal symptoms in treatment-seeking smokers. 
 
  CHAPTER 5 
 
 
199 
 
Additionally, this was the first study to demonstrate that AR had no effect on time to first 
lapse and relapse to smoking. Comparatively, alcohol retraining studies in clinical 
populations have found tentative evidence of retraining effects on clinical outcomes, e.g. 
Fadardi and Cox (2009) demonstrated that harmful drinkers reduced their weekly alcohol 
consumption over four sessions of being trained away from alcohol cues, with reductions 
maintained up to three months after the first session. Similarly, Schoenmakers et al. 
(2010) found that alcohol-dependent patients in a train-to-avoid group were discharged 
from treatment earlier and remained abstinent for longer in comparison to a control group. 
That said, it is worth noting that the lack of effects found on the behavioural outcomes in 
this study should be interpreted with some caution as this study was not powered to detect 
differences in abstinence. 
 
There are several issues relating to the procedural aspects of this study that are relevant to 
consider in the context of previous AR studies. Primarily, most attentional retraining 
protocols assess the effects of training immediately after the session in which it was 
delivered (Attwood et al., 2008; Field & Eastwood, 2005; Schoenmakers et al., 2007). In 
this study, to minimize participant burden, the first follow-up attentional bias assessment 
was carried out at least one week after the last training session. This time lag between 
training and assessment may have attenuated any immediate effects of retraining that 
might have occurred. That said, if attentional bias plays a role in the maintenance of 
addiction, the aim would be to observe global changes in attentional bias and not 
momentary changes and so any retraining effects would need to be maintained in the 
long-term. Our findings concur with those of Field et al. (2009b); although the authors 
found differential retraining effects by group immediately after training, these effects 
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dissipated the day after. Indeed, we found no evidence of group differences in attentional 
bias at any of the follow up assessments, and so we were unable to establish whether 
retraining effects were stable over time.  
 
Given the evident time lag between training and assessment, we might also question 
whether it was sufficient to deliver the training in weekly sessions. There is no evidence 
to date to inform the optimum number or regularity of training sessions in addiction-
related attentional retraining protocols. Daily sessions may be more efficacious although 
there are practical difficulties in delivering these within existing NHS stop smoking 
clinics, which follow a pattern of weekly visits as part of usual care. On the one hand, 
web-based training could be an alternative delivery system as patients could access the 
training program more readily from a remote location, for example, if they had a 
computer at home; however this method of delivering AR has yet to show efficacy in the 
treatment of social anxiety disorders, with most studies (Carlbring et al., 2012; Neubauer 
et al., 2013) failing to replicate the anxiety symptom reductions found in clinic-delivered 
sessions (Schmidt et al., 2009). The use of mobile technology appears to be a more 
promising way of delivering training (Kerst & Waters, 2013), which I discuss later in 
section 5.4.4.   
 
Like the number of training sessions, it is unclear whether enough training trials and 
picture pairs were used to produce the desired learning effect. To minimize effects of 
participant boredom, we limited the training to 192 trials per session, which was a 
significant departure from what has been used in previous tobacco-related retraining 
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studies; for example, Attwood et al. (2008) used 512 trials while Field et al. (2009b) used 
896 trials. In light of these comparisons, the use of fewer training trials could have 
compromised the effectiveness of training. In other psychopathologies however, multiple 
sessions of training consisting of 160 trials have been sufficient to reduce attentional bias 
and symptoms of social anxiety (Amir et al., 2009b; Schmidt et al., 2009). Comparisons 
made between other domains and addiction should be interpreted with caution though, 
because the mechanism of AR is likely to differ, as the neural pathways underlying 
attentional bias are thought to be different (Wiers & Stacy, 2006). 
 
We found that generalization of the learning effect may have occurred in non-abstainers 
in the AR group – but not in abstainers – as demonstrated by a reduction in bias towards 
stimuli that were not used during the training sessions. This could indicate that the 
number of picture pairs used was sufficient enough to produce a global effect rather than a 
stimuli-specific retraining effect on attentional bias. This effect has not been observed 
before in tobacco studies (Field et al., 2009b) but has been found in one alcohol study 
(Schoenmakers et al., 2010), but not others (Field et al., 2007b; Schoenmakers et al., 
2007). It is unclear why we found differential retraining effects for novel stimuli by 
abstinence status but we could consider that individual differences within subjects may 
have contributed to this effect. We should be cautious in our interpretation of the 
generalizability of training because this result was only found in sub-group analyses and 
the effect disappeared in the analysis by treatment group only, when the sample size was 
larger. Furthermore, the findings must be qualified because participants did not show 
retraining effects in response to stimuli that were used during the training sessions. If 
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there are retraining effects, a failure to observe a reliable reduction in attentional bias 
across all assessment stimuli indicates a lack of consistency in any effect. 
 
The finding that AR did not generalize to other task procedures is in line with previous 
studies (Field et al., 2007b; Field et al., 2009b; Schoenmakers et al., 2007). Correlations 
between attentional bias tasks are generally poor and may reflect the fact that different 
tasks measure different aspects of attentional processing (Mogg & Bradley, 2002). Thus, 
retraining on one task may not tap into the mechanism underlying attentional processing 
in another task. However, as participants did not show an attentional bias prior to training 
on the visual probe task or the pictorial Stroop task, generalization of any possible 
retraining effects are difficult to interpret in this study. 
 
I have thus far described how AR did not work as a preventative treatment for relapse in 
this study and discussed protocol design issues around why this might have been the case. 
The finding that attentional bias was not associated with indices of dependence, urge to 
smoke, withdrawal symptoms or relapse to smoking on neither task measure warrants 
consideration too. One interpretation may indeed be that smoking-related attentional bias 
is not an important phenomenon in the quitting process and therefore an unworthy target 
for intervention. However, this would go against much of the existing evidence reviewed 
in Chapter 1 on the value of attentional processing in addictive behaviours [see Field & 
Cox (2008) for a comprehensive review] and anecdotal evidence from drug users 
themselves who reflect on the ability of drug cues to capture their attention. What remains 
clear is that correlations between these constructs are often weak and that experimental 
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manipulation of one process does not always lead to a corresponding change in another. 
Instead we might consider that some processes like attentional bias and craving could 
have an altogether independent influence on smoking behaviour.  
 
Another plausible explanation for the lack of associations found could be because the task 
measures used in this study were not sensitive enough to assess attentional processing and 
any potential changes in bias. Coupled with the finding that the sample did not show a 
marked attentional bias at baseline, we are led to question whether indirect measures of 
cognitive bias like the visual probe task and Stroop task reliably and consistently tap into 
these processes. Lending weight to this explanation, Ataya et al. (2012a) conducted a 
study on the psychometric properties of visual probe and Stroop task measures of 
cognitive bias. The authors report on seven independent laboratory studies and concluded 
that both tasks showed poor internal reliability, particularly the visual probe task which 
had a smaller Cronbach’s alpha coefficient than the Stroop task (α=0.18 vs α=0.74, 
respectively) which was considered against a minimum accepted standard of 0.70 (Kline, 
1999).  
 
In response to this paper, Field and Christiansen (2012) argue that more direct measures 
of attention using eye-tracking methodology for example, may be more reliable than 
reaction time indices; their examination of one of their own studies on cannabis users 
(Field et al., 2006) indicated that the internal reliability of an eye-movement monitoring 
task was superior to that of a visual probe task delivered in parallel (α=0.71 vs α=0.53, 
respectively). Indeed the association between attentional bias and subjective craving has 
  CHAPTER 5 
 
 
204 
 
been noted as larger for direct measures than indirect measures of bias [r=0.36 vs r=0.18, 
respectively, see Field et al. (2009a)], further supporting the notion that direct measures 
may be more sensitive to indexing attentional bias than indirect measures.   
 
A second observation by Field and Christiansen (2012) is that participants may vary in the 
degree of responsiveness to particular stimuli used within each task, based on whether 
these stimuli bear any relevance to the individual. Some stimuli may therefore induce 
more bias than others; however when reaction time scores are averaged across all trials, 
the resultant bias may be small (Field & Christiansen, 2012). However, as Ataya et al. 
(2012b) allude to, it may be somewhat cumbersome and difficult to implement a tailored 
approach to stimulus selection, given the numerous factors that are likely to influence the 
salience of a cue, e.g. real-world contextual factors are not readily captured in stimuli 
used across existing studies. That said, investigators have now moved forward to identify 
more ecologically valid stimulus sets capable of evoking heightened motivational 
responses (Conklin et al., 2008; Conklin et al., 2010). For example, Conklin et al. (2010) 
had participants take pictures of their real-world smoking and non-smoking environments 
and compare them to generic environments in a cue exposure session. The difference in 
self-reported craving was larger for personalised stimuli than standard stimuli. However, 
personalisation of stimuli has not always produced greater attentional bias in other 
addictions. For example, Fridrici et al. (2013) found that alcohol-dependent patients 
neither showed a processing bias towards alcohol-related on a Stroop task nor showed 
increased interference for individualised alcohol-related words compared to generic 
alcohol-related words. Personalised pictorial stimuli may produce different results, and so 
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future investigations should still consider this as a potential way of increasing the 
reliability of cognitive bias measures.  
 
5.4.3 Strengths and limitations of the ARTS trial 
One of the strengths of this study is that it was the first translational study to examine the 
effects of tobacco-related attentional retraining in a clinical population. Prior 
investigations have only focused on non treatment-seeking smokers (Attwood et al., 2008; 
Field et al., 2009b; McHugh et al., 2010); the utility of AR procedures is most appropriate 
to assess in those wanting to modify their behaviour.  Secondly, this was the first study to 
assess the effects of multiple sessions of AR in smokers attempting to quit, as other 
studies only report on carrying out a single session [apart from the study by Kerst & 
Waters (2013) but the sample were current smokers].   
 
There are several limitations to consider. To avoid unblinding, we did not assess whether 
participants were aware of the training contingencies, i.e., if they could correctly identify 
a relationship between the location of the probe and picture type during the training 
sessions. Both cognitive bias tasks and ratings of craving and withdrawal could be 
susceptible to demand effects and so this was not assessed during the study. Previous AR 
studies that typically train and assess participants within a single session often ask 
participants about the training contingencies at the end of the session. As the last follow-
up session was approximately five months from the last training session, we considered 
that participants would not have been able to accurately recall if there was a relationship 
between the probe location and picture type, especially as they would have been 
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accustomed to the assessment version. We did, however, ask participants which group 
they thought they had been randomised to; mixed responses across both groups suggest 
no true knowledge of group allocation, with many participants stating that they had 
guessed their allocation. There is tentative evidence that retraining effects are mediated by 
contingency awareness; for example, increases in craving have been found in train-to-
attend groups only in those who were aware of being trained towards their drug of choice 
(Attwood et al., 2008; Field et al., 2007b). Many of the studies that have shown successful 
reductions in attentional bias and improvements in clinical outcomes have informed their 
participants of the principle behind training (Fadardi & Cox, 2009; Schoenmakers et al., 
2010). Awareness might increase engagement with the task too. Future studies that 
manipulate whether participants are contingency aware or not may shed light on the 
necessity of awareness and clarify the mechanisms that may underlie retraining effects. 
 
Another limitation of the study is that we did not control for or assess time since last 
cigarette at baseline. This may partly explain why we did not observe an attentional bias 
in the sample at baseline. It is possible that participants were satiated at the time of 
assessments, and as I have discussed in section 5.4.2, nicotine satiation may reduce or 
eliminate attentional bias and ratings of craving and withdrawal. Similarly, for those that 
lapsed between clinic sessions, we do not know how close to a training session a cigarette 
was smoked. We might speculate that if a positive association between attentional bias 
and craving exists (Field et al., 2009a) and attentional bias is somewhat mediated by 
nicotine deprivation level (Field et al., 2004), attentional bias and craving would be lower 
immediately after smoking. This would hypothetically reduce the likelihood of observing 
retraining effects if training was delivered immediately after a lapse occurred. That said, 
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the overall effect of AR on attentional bias appeared to be larger in non-abstainers than 
abstainers in the AR group compared to the control group, which perhaps undermines this 
argument.  
 
Finally, we did not record the actual day in which a lapse occurred and so the time to first 
lapse analysis may be somewhat inaccurate. Evidence indicates that lapses and relapse to 
smoking occur most commonly within the first eight days of a quit attempt (Hughes et al., 
2004a). Lapses in this study were reported by participants during weekly clinic visits, 
only to verify whether a lapse had occurred or not in the preceding week. Timeline 
follow-back procedures (TLFB) whereby participants use a calendar to indicate when a 
lapse occurred may have given a more accurate timing of lapse date (Brown et al., 1998), 
yet this method also has its own limitations by relying on participants to recall lapse days 
from memory. Again, EMA methods may obviate recall bias as lapses can be recorded as 
they happen, but these methods are only worthwhile if participants adhere to EMA 
protocols.  
 
5.4.4 Implications of the ARTS trial findings 
Based on the findings of this study, we are unable to advocate the use of AR procedures 
as a preventative treatment for relapse to smoking. The clinical value of such procedures 
for smoking cessation is limited, based on the lack of any consistent effects found and the 
confidence intervals exclude moderate sized effects. Until the measures for assessing 
attentional bias are validated and the design of the intervention is improved, it may be 
some time before we are able to ascertain the true potential of AR as a clinical tool.    
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In a broader sense, we are led to question whether laboratory methods are capable of 
addressing complex real-world processes (Ataya et al., 2012b). While the task measures 
used in these studies may require refinement, the population groups in which these 
measures are tested in may need consideration too. In the real-world, there is considerable 
variation in psychological, motivational and behavioural processes across populations 
(Henrich et al., 2010). However, laboratory studies typically recruit highly 
unrepresentative samples, often consisting of university students paid to take part in 
research. Indeed this is apparent in many of the tobacco and AR studies discussed here 
(Field et al., 2007b; McHugh et al., 2010). These studies typically employ models of acute 
abstinence where smokers, for example, only observe a temporary period of abstinence 
prior to a testing session and are subsequently aware of being able to smoke after a 
session. The perceived availability of a drug is thought to play an important role in 
moderating cue-induced craving and attentional bias (Field & Cox, 2008), insofar that 
both processes are enhanced by the opportunity to use a substance. Unlike smokers who 
know that there is an opportunity to smoke after a laboratory session, those seeking 
treatment for smoking cessation in clinics are less inclined to think this is as possible after 
a treatment session. This study was an attempt at validating the findings from previous 
laboratory studies by using a more representative sample that were seeking treatment and 
trying to quit, but it failed to confirm the earlier findings. We should therefore be cautious 
in generalizing data derived from laboratory studies on attentional bias while the 
translational value is still unclear. 
 
Since undertaking this trial, the study of attentional bias and AR in addictive behaviours 
has advanced to the use of mobile technology as both an assessment tool and delivery 
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system for training (Tiplady et al., 2009; Waters & Li, 2008). The use of portable 
electronic devices has several advantages over traditional methods. Firstly, it allows real-
time data capture using EMA to study cognitive and motivational processes that may 
underlie relapse (Shiffman et al., 2008). Arguably, it is unclear whether attentional bias is 
more or less prominent under certain conditions, e.g. depending on the time of day, or in 
particular circumstances, e.g. the proximity of someone smoking. Laboratory and clinical 
settings do not typically mimic the natural environment in which people experience 
smoking-related cognitions and fluctuating motivational states. In a recent EMA study, 
heroin-dependent patients in treatment completed cognitive bias and affect assessments 
on a hand-held device at random times during the day and during self-reported 
temptations to use drugs (Waters et al., 2012). The authors found that selective processing 
biases were elevated during temptation episodes compared to other times during the day, 
and in the one hour preceding a temptation. Extending on these findings, Marhe et al. 
(2013) assessed whether processing biases and craving were predictive of relapse using 
similar EMA methods in heroin addicts; they found that patients who relapsed had greater 
Stroop bias and higher levels of craving during temptation episodes than those who did 
not relapse. Taking these findings together, it appears that cognitive associations in 
relapse may be more decipherable using EMA techniques than the methods traditionally 
used within laboratory settings. If these methods are able to identify the particular 
circumstances in which people are most susceptible to relapse, this could bring about a 
more targeted intervention approach to such instances. 
 
Another advantage to the use of mobile technology in the study of attentional bias is that 
interventions like AR can be embedded within EMA. This approach not only enables 
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individuals to carry out training at any time of day, for example during temptation 
episodes when most at risk of smoking, but also obviates the time lag between training 
and assessments. At the time of writing, an EMA study (Kerst & Waters, 2013) examined 
the effects of daily AR on attentional bias in a sample of current smokers. The authors 
found that retraining delivered up to three times a day for seven days on a hand-held 
device reduced attentional bias towards smoking-related cues over time, in comparison to 
a control condition. However, this reduction in the AR group was only apparent after a 
few days. Attentional retraining also reduced cued craving following presentation of a 
picture with smoking and non-smoking features. Of particular note is that these retraining 
effects were not found in the laboratory session at the end of the study, which echoes the 
findings of this study. Again, this may be due to the time lag between training and 
laboratory assessments, implying that there are temporal effects of retraining. 
Alternatively, it may be that retraining effects are context-specific and more pronounced 
in the environment in which retraining occurs. As mentioned previously, further research 
using EMA methods and AR in a variety of contexts may shed light on any moderating 
effects of the environment. While it is remains to be seen if there is any clinical benefit of 
daily retraining using EMA methods, these findings do show some promise in the use of 
AR procedures delivered in a smoker’s natural environment.  
 
In summary, we conducted the first clinical trial of attentional retraining in smokers 
attempting smoking cessation. We found that multiple sessions of AR - delivered weekly 
in NHS stop smoking clinics - had no effect on attentional bias, craving, withdrawal 
symptoms or relapse in smokers. Furthermore, attentional bias was not associated with 
any clinical outcomes. Overall, there are no clinical benefits of AR procedures in 
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treatment-seeking smokers and they should not be used as a therapeutic intervention in 
their current form.
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CHAPTER 6: GENERAL CONCLUSIONS   
6.1  Summary of thesis 
The objective of the research outlined in this thesis was to develop, test and evaluate 
attentional retraining procedures in smokers. Underlying this objective was the aim of 
increasing our understanding on the phenomenon of attentional bias and its relation to 
other motivational processes and clinical outcomes in smoking cessation.  
 
I began with a laboratory study to pilot the length of an AR procedure for clinical use 
(Chapter 2); this study informed the design of a protocol for a clinical trial of AR in 
smokers attempting to quit (Chapter 3). I reported on the outcomes of the trial, firstly on 
the feasibility of delivering AR in a clinical setting and its acceptability to participants 
(Chapter 4) and secondly, on the efficacy of AR on attentional bias, craving, withdrawal 
symptoms and abstinence (Chapter 5). The purpose of this chapter is to provide an overall 
synthesis of this research and recommendations for future investigations. 
 
6.2 Summary of findings 
In the laboratory study described in Chapter 2, I examined the effect of varying the length 
of AR on attentional bias, subjective craving, mood and withdrawal in a sample of current 
smokers. The aim of this study was to gauge how much training was acceptable for 
participants to carry out in a single session, without ceding efficacy. I found that AR, 
delivered on a modified visual probe task with either a short, medium or long block of 
training did not significantly reduce attentional bias when compared to a control 
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condition. Similarly I did not observe reliable retraining effects on craving, mood or 
withdrawal measured after training and following cue-exposure. The likelihood of making 
an error during training became greater as the block length increased, suggesting that it 
became more difficult for participants to attend to the task as the length of training 
increased. Furthermore, the efficacy of training appeared to reduce as more errors were 
made. No effects were observed on an additional cognitive bias task measure. 
Unexpectedly, the sample did not show an attentional bias at baseline, which may in part 
explain the lack of retraining effects observed. There was some indication that for those 
who had an attentional bias from the outset, post-training attentional bias was less in the 
trained group than the control group.  
 
Based on the findings of the laboratory study alone, I was unable to unequivocally 
establish the optimal amount of training to deliver in the clinical trial of AR described in 
Chapter 3. I reasoned that even though retraining effects were not apparent at any length 
of training in the laboratory study, two blocks of training - with a break in between - were 
likely to be acceptable to patients and practical to deliver in a stop smoking clinic. Rather 
than increasing the number of training trials within each session, delivering multiple 
sessions was preferred as evidence from previous retraining studies that used more than 
one session had shown clinically relevant effects (Amir et al., 2009a; Schoenmakers et al., 
2010). 
 
Following on from the laboratory study, I conducted a double-blind randomised 
controlled trial of AR in smokers who attempted to quit using NHS stop smoking 
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services. Five sessions of attentional retraining or placebo training were delivered weekly 
in clinic using a modified visual probe task. I examined the feasibility and acceptability of 
the trial by looking at the processes involved in carrying out the study and how well the 
intervention was received by patients (Chapter 4). Delays with NHS regulatory approvals 
and difficulties with recruitment were the main practical barriers of delivering the study. I 
randomised 119 participants into the trial, which was less than the 200 participants 
anticipated. The first stage of patient recruitment via GP practice invitation letters was 
poor and so the strategy was revised. Methods used to improve recruitment included 
increasing the number of sites to include community venues as well as GP practices, 
targeting a new population group from a database of smokers and using online 
advertising; the combination of these approaches did improve the number of recruits but 
the target sample could not be reached within the timescale of the trial. Although these 
practical barriers prevailed, attendance at clinic sessions were high, as were the number of 
retraining sessions completed. Drop out was approximately equal across groups and was 
mainly due to a quit attempt abandonment. Taken together, the intervention was feasible 
to deliver within stop smoking clinics, despite problems with general recruitment, which 
were unrelated to the attentional retraining.   
 
Most participants found the AR procedure easy to understand and carry out. However, 
some participants felt that the length of training was too long and that the task induced 
boredom; thus, irrespective of the efficacy of AR, it is important to take into account such 
factors as they may deter smokers from using these procedures as a treatment during 
smoking cessation.  
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I reported on the efficacy of the intervention in Chapter 5, but found little evidence that 
AR affected attentional bias, urge to smoke, withdrawal symptoms, abstinence rates and 
time to first lapse. Attentional bias scores were marginally and non-significantly lower in 
those who received AR than PT, but the effects were too small to be clinically 
meaningful. Similarly, urge to smoke was lower among abstainers who received AR than 
PT, but again, these effects were negligible and not significant. I failed to observe any 
retraining effects on withdrawal symptoms, where in fact, a marginal increase was found 
in those who received AR than PT. The fact that the intervention had no impact on 
quitting or time to first lapse, indicates that AR had no real impact on preventing relapse 
to smoking in this sample of treatment-seekers.  
 
These findings echo those of the earlier laboratory study, where I found that AR had little 
effect on attentional bias, subjective outcomes and behavioural outcomes. Similarly 
across both studies, I found that AR on the modified visual probe task did not generalize 
to the Stroop task. This is consistent with findings from previous studies, where retraining 
on one cognitive bias task has not shown effects on another (Field et al., 2007b; Field et 
al., 2009b; Schoenmakers et al., 2007). I found some tentative evidence that 
generalization of AR occurred in relation to novel stimuli in the ARTS study, however 
these findings are exploratory in nature given that a decrease in attentional bias towards 
untrained stimuli was only found in non-abstainers and did not extend to trained stimuli. 
Unlike some previous studies, the observational findings from the ARTS study indicated 
that attentional bias was not related to several indices of dependence or clinical outcomes, 
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meaning that participants with higher levels of attentional bias at baseline did not 
necessarily have higher levels of dependence, craving or withdrawal. Furthermore, 
attentional bias did not predict abstinence whether measured by the visual probe task or 
the Stroop task. Coupled with the finding that AR failed to produce any corresponding 
changes in attentional bias on craving – in neither the laboratory study nor the clinical 
trial - the research findings discussed here therefore do not support a causal role of 
attentional bias on craving. 
 
Perhaps most crucial to this discussion is the finding that attentional bias was not evident 
in the sample of treatment-seekers recruited to the ARTS study. This was also found in 
the earlier laboratory study with smokers and has been reported elsewhere (McHugh et 
al., 2010). I reasoned that retraining effects might be stronger in those exhibiting an 
attentional bias from the outset; this was true of smokers in the laboratory study, but not 
of treatment-seekers in the clinical study.   
 
In the sections that follow, I will provide some of my own reflections and 
recommendations for the study of attentional bias and attentional retraining, based on the 
collective findings of the research presented in this thesis.  
 
6.3 Reflections 
It is important to first consider some of the possible reasons why attentional bias was not 
associated with any subjective or behavioural outcomes in either of my studies, in light of 
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the propositions outlined in Chapter 1. At the same time, it is necessary to understand 
why I found no effect of AR on these aforementioned outcomes.  
 
6.3.1 Attentional bias – is it causally related to addiction? 
Many of the theoretical models discussed in section 1.3.1 make predictions that drug-
related cues capture the attention of drug users automatically and that processes like 
craving may be interrelated and subsequently influence drug use (Franken, 2003; 
Robinson & Berridge, 2001; Ryan, 2002). Although some evidence from correlational 
studies indicates that attentional bias is associated with craving, drug use and relapse (see 
section 1.5), these studies do not reveal anything about the causal role of attentional bias 
in addiction. Furthermore, the number of tobacco studies investigating this relationship, 
particularly in treatment-seeking or abstaining smokers is scarce.  
 
Studies that experimentally manipulate attentional bias including the studies conducted 
here, provide the best evidence of causality. In the studies reviewed in section 1.4.2, most 
were able to manipulate attentional bias either towards or away from smoking or alcohol-
related cues, but corresponding effects on subjective outcomes like craving were weak. 
Moreover, a relationship between attentional bias and craving has only been found in 
train-to-attend manipulations and mainly observed in certain groups, e.g. male 
participants only (Attwood et al., 2008) and those aware of the experimental 
contingencies (Field et al., 2007b). My studies, like all previous investigations involving 
train-to-avoid manipulations, found no evidence of a relationship between attentional bias 
and craving. 
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The evidence here and in other AR studies leads us to believe that attentional bias and 
craving are unrelated constructs; however one possible reason why I found no association 
could be because of difficulties in measuring both attentional bias and craving. I found no 
evidence of attentional bias in the study on smokers (Chapter 2) or treatment-seekers 
(Chapter 5) but we know that drug-users have exhibited attentional bias in many other 
studies (section 1.3.2). Indirect task measures - the visual probe task and the pictorial 
Stroop task - were used in both studies to assess attentional bias, although as I discussed 
in section 5.4.4, some investigators suggest that these measures may not be reliable 
(Ataya et al., 2012a). Similarly, there is much contention over the measurement of craving 
(Sayette et al., 2000; Tiffany & Wray, 2012). For example, self-report measures such as 
the QSU and MPSS rely on a smoker’s ability to recognise and recall their experiences of 
craving. Nevertheless, if craving had been measured accurately even with a poor 
measurement of attentional bias, a retraining effect on craving would still be apparent had 
the intervention been successful. This view is reinforced by evidence from 
pharmacotherapy trials, where medication effects appear to be mediated through craving 
measured by similar measures (West et al., 2008). Altogether, the same argument holds 
for other variables where I found no associations and an absence of retraining effects on 
attentional bias, withdrawal symptoms, lapses and relapse outcomes. 
 
Another point worth considering is that the studies conducted in this thesis focused on the 
measurement of maintained attentional bias rather than biases in the initial orienting of 
attention. As I discussed in section 1.3.2.2, these two subcomponents of attention may 
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have state-like or trait-like qualities. Similarly, as I discussed in section 1.4, craving may 
also be regarded as both state and trait phenomena. I speculated that maintained 
attentional bias may be a state-like construct and arises in situations of high cravings, 
while the initial orienting of attention may be a more persistent trait-like construct. Based 
on this premise, one might expect to see an association between maintained attentional 
bias and episodic cravings, particularly in treatment-seeking or abstinent smokers who are 
likely to experience high cravings when deprived of nicotine for example. In my clinical 
trial however, this may have been difficult to detect as participants were tested in a 
satiated state when maintained attentional bias was not evident. That said, participants in 
the earlier laboratory study were tested in a nicotine deprived state, yet the sample again 
did not exhibit maintained attentional bias at baseline and no associations with craving 
were found. Based on these studies alone, it is unclear whether certain states impact on 
attentional bias and associations with craving, given that there were several differences in 
smoking dependence and levels of nicotine deprivation across and within the studies that 
complicated this investigation. Understanding the extent to which both the initial 
orienting of attention and maintained attention resonates in smokers and the 
circumstances in which they might be found, may help clarify these issues.       
 
Alternatively, an association between attentional bias, craving and my other clinical 
outcomes may not have been found for other reasons. It could be that the AR intervention 
was effective but the study lacked statistical power to detect an intervention effect. 
Indeed, I did not reach the desired number of participants required according to my 
sample size calculations. Another reason could be that the AR intervention was not 
effective in its current form but still has the potential to work if modifications to the 
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design are made (see section 6.3.2.1). Alternatively, it could be that AR simply did not 
function as a way of changing attentional bias and smoking behaviour, which altogether 
obviates an investigation of any causal relationship. 
 
In light of the considerations above, I believe it is difficult to draw conclusions on 
whether attentional bias is causally related to addiction. Given that attentional bias was 
not related to any key variables associated with tobacco addiction in my studies indicates 
that it could be a by-product of addiction rather than a causal agent, as suggested by some 
investigators (Hogarth & Duka, 2006). However, before any definitive conclusions are 
drawn, it is important to ascertain whether the measures we are using are in fact reliably 
and accurately measuring attentional bias and other processes. Secondly, we need to 
establish whether modifications to the design of AR procedures are required in order for 
retraining effects to occur. Only then can we determine the true nature of a relationship 
between attentional bias and addiction. 
 
6.3.1.1 Recommendations: improving the precision of measurements 
Using better techniques to measure cognitive biases and refining existing procedures are 
ways of increasing the accuracy of attentional bias assessments. We might also uncover 
processes that would have otherwise gone undetected. Additionally, by making 
methodological improvements we increase the precision by which we measure attentional 
retraining effects on attentional bias. For example, direct measures, such as eye-tracking, 
are considered as more ecologically reliable indexes of attention than indirect measures 
(Field & Cox, 2008). Eye-tracking can be used to measure both the initial orienting of 
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attention and maintenance of attention, providing a method of investigating the extent to 
which different components of attentional bias can be considered as state-like or trait-like 
constructs. In conjunction with indirect measures, direct measures may be able to tap into 
these attentional processes more readily. 
 
While direct measures may be more able to detect attentional bias if it is present, indirect 
measures are more practical and, as I have shown in Chapter 4, feasible to deliver in a 
clinic setting. The visual probe task and Stroop task are most often used for assessing and 
modifying attentional bias and so further work is warranted on refining and improving the 
reliability of these measures.  
 
One way of increasing the reliability of the Stroop and visual probe task assessments 
could be to use more ecologically valid stimuli, i.e. pictures that participants are more 
accustomed to seeing in their everyday environment. As in Conklin et al. (2010), it may 
be worthwhile if participants took pictures of their real-world smoking and non-smoking 
environments to use as stimulus material in the visual probe task or Stroop task. 
 
Another way of increasing the precision of measurements could be with the use of EMA 
methods. Administering the visual probe task or Stroop task on a hand-held device in a 
smoker’s natural environment may be more capable of assessing attentional bias and 
naturally occurring processes like craving and withdrawal as they happen. It is plausible 
that smokers do not necessarily experience the same cognitions and motivations in a 
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laboratory or clinical setting as their natural environment. EMA could capture times in 
which smokers might be more prone to show attentional bias, or experience craving and 
withdrawal, for example in response to real-world smoking cues. Although, understanding 
what type of cues trigger these processes depends somewhat on a smoker’s ability to 
report that they have attended to particular cues. There are numerous cues in the 
environment that a smoker will be less consciously aware of that could influence 
attentional bias, craving and withdrawal processes, but these would remain difficult to 
capture using EMA methods.  
 
While different tasks appear to measure different aspects of attention depending on the 
time of assessment, it may be worthwhile to shorten the duration of stimulus 
presentations. Both studies conducted here used a stimulus onset asynchrony (SOA) of 
500 ms, which is likely to reflect the maintenance of attention rather than the initial 
orienting of attention as discussed in section 1.3.2.2. The initial orienting of attention can 
only be captured at shorter stimulus durations, for example, of less than 200 ms [e.g. Field 
et al. (2009b) demonstrated that smokers exhibited attentional bias at an SOA of 50 ms], 
or by using direct measures such as eye tracking to measure the initial direction of eye 
movements (Field et al., 2004; Mogg et al., 2003). While the participants in my study did 
not show maintained attentional bias, it may be possible that attentional bias was present 
at the initial orientation stage. Speculatively, it could be that attentional bias at the earlier 
stages of attentional processing is more strongly associated with craving and relapse than 
later stages, although Field et al. (2009b) did not find an association between attentional 
bias and urge to smoke at an SOA of 50 ms.   
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Finally, it is important to consider the timing of attentional bias assessments in a 
treatment-seeking population. Although the sample in my clinical trial were recruited 
during a time in which they were thinking of stopping smoking, they were in fact tested in 
a satiated state when attentional bias may have been low. As discussed in section 1.3.2.2, 
biases in maintained attention –the principal measure in my clinical trial – may be 
regarded as a state-like construct which means that these slower attentional processes may 
only transpire in certain situations, e.g. when nicotine deprived. This may in part explain 
why I did not observe an attentional bias in the sample at baseline and the lack of 
association between attentional bias and my clinical outcome measures. Testing 
participants during the baseline period while they are still smoking and again on the first 
day of abstinence might address these questions. 
 
6.3.2 Attentional retraining procedures – are they effective in treatment-seeking 
smokers? 
On balance, a likely explanation of why I found no associations and no attentional 
retraining effects is that the intervention simply did not work. The intervention did not 
change cognitive bias processes or smoking behaviour overall. Considering all of the 
evidence discussed in section 1.4.2, it is clear that AR procedures designed to train 
attention away from smoking-related cues have not led to reductions in craving or led to 
reliable changes in other indices of smoking behaviour. Unlike the improvement in 
clinical symptoms found in clinically anxious patients or delayed relapse outcomes found 
in alcohol-dependent patients (section 1.7), I found no similar effects of AR in treatment-
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seeking smokers. As the first study to test the efficacy of a tobacco-related AR procedure 
in a clinical population, I believe that there is no direct clinical benefit of AR procedures 
for smokers, as they currently stand.  
   
Both studies followed the basic design of the AR procedures of previous tobacco-related 
retraining studies (Attwood et al., 2008; Field et al., 2009b; McHugh et al., 2010). As 
mentioned in the section above, the efficacy of AR could have been undermined by 
design issues. Although participants in the clinical study completed the majority of 
training sessions and the intervention was generally well received, some participants still 
were bored during the task probably due to its repetitive nature. As such, participants may 
not have been effectively trained if they were not attending to the task. Clearly, these 
laboratory-based procedures still require refinement and adaptation if they are intended 
for clinical use. 
 
6.3.2.1 Recommendations: modify the design of attentional retraining procedures  
It is worth noting that AR has been successful on reducing time to relapse in alcohol-
dependent patients who were given positive feedback on performance and instructed to 
set goals to improve future performance (Schoenmakers et al., 2010). It is plausible that 
these additional interactive features of retraining work in two ways; positive feedback 
provides encouragement that the task is being performed well, while goal setting might 
increase engagement through motivation to meet certain targets. It could be speculated 
that both techniques could enhance the efficacy of retraining by increasing the likelihood 
of participants attending to a task. Individual learning curves could be inspected to 
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examine adherence over the course of a session to establish whether these techniques are 
worthwhile.    
 
The number of training trials used in my studies may have been insufficient to produce a 
retraining effect; all other addiction-related retraining studies have employed more than 
double the 192 trials used in my clinical trial. I initially reasoned that multiple sessions 
might offset the need to increase the number of training trials within each session, 
although this assumption may have been wrong. Another way of delivering a higher 
‘dose’ of training would be to increase the frequency of training and deliver sessions in a 
shorter period of time; indeed this method has been successful in producing the predicted 
changes in attentional bias in non-treatment seeking smokers (Kerst & Waters, 2013).  
 
Finally, as discussed in section 6.3.1.1, if attentional bias was present during the initial 
orientation stage of attention, it would be important to design an AR procedure that could 
target this early stage of attentional processing. I adopted an SOA of 500 ms to measure 
and train participants in my studies but this SOA is unlikely to assess and change biases 
exhibited at the initial orientation stage. Considering that biases in the initial orienting of 
attention may be regarded as more of a consistent trait in drug users than maintained 
attentional bias, these processes may in fact be less amenable to change using AR 
procedures. Prior to developing an experimental manipulation to tackle these early 
attentional processes, it is necessary to establish if they are in fact important in the 
maintenance of addictive behaviours as they have not been studied as extensively as later 
processes.  
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6.4 Closing statements 
The aim of this thesis was to further our understanding of attentional bias and AR 
procedures in smokers. Firstly, a causal role of attentional bias in tobacco addiction is 
unsupported by the empirical studies reported in this thesis. Secondly, while AR 
procedures are feasible to deliver within NHS SSS, they are of no real benefit to smokers 
attempting to stop smoking.  
 
In the context of previous studies, although some relate attentional bias to craving and 
relapse, the association between constructs is often weak and the findings are mixed. 
Overall, there is a lack of empirical research investigating this relationship, particularly in 
the case of smokers. On this basis, I believe that it is premature to conclude that 
attentional bias has no role in tobacco addiction. Instead, I agree with Ataya et al. (2012b) 
and believe that we are faced with the challenge of knowing that attentional bias exists in 
drug-users - be that in certain individuals or groups - but we may not necessarily have the 
right measures to consistently and reliably assess it. I would suggest that we turn our 
attention to improving the ways we measure cognitive processes, in order to better 
understand how they might relate to drug-taking behaviour.  
 
As a clinical intervention, previous research in alcohol and anxiety indicates that the use 
of AR procedures lead to successful treatment effects in clinical populations. In marked 
contrast, my clinical trial revealed that AR does not reduce attentional bias, craving, 
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withdrawal symptoms or relapse in smokers seeking to quit. Altogether, there is not 
enough evidence on the efficacy of these procedures in the treatment of addictive 
behaviours, as only one other randomised controlled trial has investigated the effect of 
AR in alcohol abusers. It is clear that AR procedures for smokers should not be used in 
their current form and that both the assessment and any intervention to modify attentional 
bias needs improvement prior to any further investigation on their clinical value.  
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8 APPENDICES 
 
Appendix 1. Laboratory study participant information sheet 
 
INFORMATION SHEET  
Attentional Bias Retraining among Cigarette Smokers  
You are being invited to take part in a research study because you are a cigarette smoker who 
smokes at least 5 cigarettes per day. Before you decide, it is important for you to understand why 
the research is being done and what it would involve. Please take time to read the following 
information carefully and discuss it with friends, relatives or your GP if you wish. Ask us if there 
is anything that is not clear or if you would like more information. Take time to decide whether or 
not you wish to take part.  
 
What is this study about?  
This is a study to measure the effects of exposure to smoking-related pictures on subsequent 
cravings for cigarettes.  
 
Why have I been chosen?  
You are a cigarette smoker, aged 18 to 40. You should smoke at least 5 cigarettes per day, and 
should not be using other illicit drugs (except cannabis).  
 
Do I have to take part?  
Participation in the study is entirely voluntary. It is up to you to decide whether or not to do this. 
If you do decide to take part, we would ask you to sign a consent form and give you a copy of this 
information sheet and the consent form to keep. If you decide to take part you are still free to 
withdraw from the study at any time. If you decide not to take part, or to withdraw, you do not 
have to give a reason, nobody would be upset.  
 
What would happen if I took part?  
You would first give a breath sample to confirm your smoking status, and then complete some 
short questionnaires. You would then be asked to complete a computer-based reaction time task, 
during which you would be presented with smoking-related and neutral pictures.  
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Next, you would be presented with a series of smoking cues, and be asked to rate your mood and 
craving for cigarettes.  
 
You would then be given another computer-based reaction time task. After this you would have 
the opportunity to ask questions about the study, and the hypotheses that we are testing.  
 
What are my responsibilities?  
We would ask you to avoid smoking for 12 hours prior to the study. This would be confirmed by a 
breath sample when you arrive for testing, and if you were found to have smoked in the past 12 
hours we would have to re-schedule your visit.  
 
What are the risks of taking part?  
You might experience moderate cravings for cigarettes during and immediately after the 
experiment, but we do not expect these effects to last very long.  
 
How would I benefit from participating?  
You would not benefit from taking part. However, you would be reimbursed for your participation 
(£10 total).  
 
How would we use the results of the research?  
These results may eventually be published in a scientific journal, and may also be reported at 
scientific meetings.  
 
Why is this study useful?  
Understanding the effects of smoking-related cues on cravings for cigarettes is important in 
helping to explain why people smoke. We are attempting to understand more about how the 
impact of smoking-related cues differs between people and across situations.  
 
Would I be able to know the results of the experiment?  
We won’t be giving out individual results of the study, since all the data would be kept entirely 
confidential and anonymous. However, you would have the opportunity to ask questions about the 
study once you had taken part.  
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Would my taking part in this study be kept confidential?  
All data collected in this study would remain confidential and would be available only to research 
staff directly involved in the study. It would not be possible to identify you by name from any 
aspect of reporting for this research study.  
 
Other information  
Your participation in the study is voluntary. Should you decide to take part, you would be asked to 
sign a consent form.  
 
If you have any questions at any time about the study, please do not hesitate to contact the 
research team at the Department of Experimental Psychology at the address provided.  
 
Main contacts:  
Miss Rachna Begh 
  
  
 
Dr Marcus Munafò  
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Appendix 2. Laboratory study consent form 
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Appendix 3. Laboratory study questionnaire 
UNIVERSITY OF BRISTOL 
Department of Experimental Psychology  
8 Woodland Road  
University of Bristol 
Bristol 
BS8 1TN 
CRF 
PARTICIPANT 
STUDY DAY 
Study: Attentional bias retraining among cigarette smokers. 
 
Ethics Number: 040310491C 
 
Principal Investigator: 
Dr Marcus Munafò 
 
Investigators: 
Dr Angela Attwood 
Miss Rachna Begh 
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Please mark one answer for each question. 
 
1. How soon after you wake up do you smoke your first cigarette? 
 
 Within 5 minutes 
 6-30 minutes 
 31-60 minutes 
 After 60 minutes 
 
2. How many cigarettes / day do you smoke? 
 10 or less 
 11-20 
 21-30 
 31 or more 
 
3. Do you find it difficult to refrain from smoking in places where it is forbidden e.g. in 
church, at the library, in cinema, etc.? 
 Yes 
 No 
 
4. Do you smoke more frequently during the first hours after waking than during the rest 
of the day? 
 Yes 
 No 
 
5. Do you smoke if you are so ill that you are in bed most of the day? 
 Yes 
 No 
 
6. Which cigarette would you hate most to give up? 
 The first one in the morning 
 Any other 
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A number of statements which people have used to describe themselves are given below.  
Read each statement and then blacken in the appropriate circle to the right of the 
statement to indicate how you feel right now, that is, at this moment.  There are no right 
or wrong answers. 
 
Do not spend too much time on any one statement but give the answer which seems to 
describe your present feelings best. 
 
 
 
 
 
 
 
1. I feel calm                                    
2. I feel secure                                   
3. I am tense                                    
4. I feel strained                                   
5. I feel at ease                                   
6. I feel upset                                   
7. I am presently worrying over possible misfortunes                              
8. I feel satisfied                                   
9. I feel frightened                                   
10. I feel comfortable                                   
11. I feel self-confident                                  
12. I feel nervous                                   
13. I am jittery                                   
14. I feel indecisive                                   
15. I am relaxed                                   
16. I feel content                                   
17. I am worried                                   
18. I feel confused                                   
19. I feel steady                                   
20. I feel pleasant                                   
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A number of statements which people have used to describe themselves are given below.  
Read each statement and then blacken in the appropriate circle to the right of the 
statement to indicate how you generally feel.  There are not right or wrong answers. 
 
Do not spend too much time on any one statement but give the answer which seems to 
describe how you generally feel. 
 
 
 
 
 
 
 
 
1. I feel pleasant                                   
2. I feel nervous and restless                                  
3. I feel satisfied with myself                                 
4. I wish I could be as happy as others seem to be                               
5. I feel like a failure                                   
6. I feel rested                                   
7. I am “calm, cool and collected”                                 
8. I feel that difficulties are piling up                                
9. I worry too much over things that don’t really matter                              
10. I am happy                                   
11. I have disturbing thoughts                                 
12. I lack self-confidence                                  
13. I feel secure                                   
14. I make decisions easily                                  
15. I feel inadequate                                   
16. I am content                                   
17. Unimportant thoughts bother me                                 
18. I can’t put disappointments out of my mind                               
19. I am a steady person                                  
20. I become tense as I think over recent concerns                               
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Indicate how much you agree or disagree with each of the following statements by 
placing a single checkmark along each line between STRONGLY DISAGREE and 
STRONGLY AGREE.  The closer you place your checkmark to one end or the other 
indicates the strength of your agreement or disagreement.  
 
We are interested in how you are thinking and feeling right now as you are filling out 
the questionnaire. 
 
 
1. I have a desire for a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
2. Nothing would be better than smoking a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
3. If it were possible, I probably would smoke now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
4. I could control things better right now if I could smoke. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
5. All I want right now is a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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6. I have an urge for a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
7. A cigarette would taste good right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
8. I would do almost anything for a cigarette now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
9. Smoking would make me less depressed. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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Using a vertical line, please mark on each scale how you feel in your current mood 
(i.e., right now). 
 
 
Happy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Drowsy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Depressed 
Extremely       Not at all 
l————————————————————I 
 
 
 
Anxious 
Extremely       Not at all 
l————————————————————I 
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Energetic 
Extremely       Not at all 
l————————————————————I 
 
 
 
Irritable 
Extremely       Not at all 
l————————————————————I 
 
 
 
Craving a Cigarette 
Extremely       Not at all 
l————————————————————I 
 
 
Please do not turn over until you are 
instructed to do so 
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A number of statements which people have used to describe themselves are given below.  
Read each statement and then blacken in the appropriate circle to the right of the 
statement to indicate how you feel right now, that is, at this moment.  There are no right 
or wrong answers. 
 
Do not spend too much time on any one statement but give the answer which seems to 
describe your present feelings best. 
 
 
 
 
 
 
 
 
1. I feel calm                                    
2. I feel secure                                   
3. I am tense                                    
4. I feel strained                                   
5. I feel at ease                                   
6. I feel upset                                   
7. I am presently worrying over possible misfortunes                              
8. I feel satisfied                                   
9. I feel frightened                                   
10. I feel comfortable                                   
11. I feel self-confident                                  
12. I feel nervous                                   
13. I am jittery                                   
14. I feel indecisive                                   
15. I am relaxed                                   
16. I feel content                                   
17. I am worried                                   
18. I feel confused                                   
19. I feel steady                                   
20. I feel pleasant                                   
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Indicate how much you agree or disagree with each of the following statements by 
placing a single checkmark along each line between STRONGLY DISAGREE and 
STRONGLY AGREE.  The closer you place your checkmark to one end or the other 
indicates the strength of your agreement or disagreement.  
 
We are interested in how you are thinking and feeling right now as you are filling out 
the questionnaire. 
 
 
1. I have a desire for a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
2. Nothing would be better than smoking a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
3. If it were possible, I probably would smoke now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
4. I could control things better right now if I could smoke. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
5. All I want right now is a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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6. I have an urge for a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
7. A cigarette would taste good right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
8. I would do almost anything for a cigarette now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
9. Smoking would make me less depressed. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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Using a vertical line, please mark on each scale how you feel in your current mood 
(i.e., right now). 
 
 
Happy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Drowsy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Depressed 
Extremely       Not at all 
l————————————————————I 
 
 
 
Anxious 
Extremely       Not at all 
l————————————————————I 
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Energetic 
Extremely       Not at all 
l————————————————————I 
 
 
 
Irritable 
Extremely       Not at all 
l————————————————————I 
 
 
 
Craving a Cigarette 
Extremely       Not at all 
l————————————————————I 
 
 
Please do not turn over until you are 
instructed to do so 
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A number of statements which people have used to describe themselves are given below.  
Read each statement and then blacken in the appropriate circle to the right of the 
statement to indicate how you feel right now, that is, at this moment.  There are no right 
or wrong answers. 
 
Do not spend too much time on any one statement but give the answer which seems to 
describe your present feelings best. 
 
 
 
 
 
 
 
 
21. I feel calm                                    
22. I feel secure                                   
23. I am tense                                    
24. I feel strained                                   
25. I feel at ease                                   
26. I feel upset                                   
27. I am presently worrying over possible misfortunes                              
28. I feel satisfied                                   
29. I feel frightened                                   
30. I feel comfortable                                   
31. I feel self-confident                                  
32. I feel nervous                                   
33. I am jittery                                   
34. I feel indecisive                                   
35. I am relaxed                                   
36. I feel content                                   
37. I am worried                                   
38. I feel confused                                   
39. I feel steady                                   
40. I feel pleasant                                   
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Indicate how much you agree or disagree with each of the following statements by 
placing a single checkmark along each line between STRONGLY DISAGREE and 
STRONGLY AGREE.  The closer you place your checkmark to one end or the other 
indicates the strength of your agreement or disagreement.  
 
We are interested in how you are thinking and feeling right now as you are filling out 
the questionnaire. 
 
 
1. I have a desire for a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
2. Nothing would be better than smoking a cigarette right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
3. If it were possible, I probably would smoke now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
4. I could control things better right now if I could smoke. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
5. All I want right now is a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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6. I have an urge for a cigarette. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
7. A cigarette would taste good right now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
8. I would do almost anything for a cigarette now. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
 
9. Smoking would make me less depressed. 
 
 STRONGLY DISAGREE ___: ___: ___: ___: ___: ___: ___STRONGLY AGREE 
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Using a vertical line, please mark on each scale how you feel in your current mood 
(i.e., right now). 
 
 
Happy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Drowsy 
Extremely       Not at all 
l————————————————————I 
 
 
 
Depressed 
Extremely       Not at all 
l————————————————————I 
 
 
 
Anxious 
Extremely       Not at all 
l————————————————————I 
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Energetic 
Extremely       Not at all 
l————————————————————I 
 
 
 
Irritable 
Extremely       Not at all 
l————————————————————I 
 
 
 
Craving a Cigarette 
Extremely       Not at all 
l————————————————————I 
 
 
Thank you – you are nearly at the end 
of the experiment! 
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Appendix 4. Laboratory study debriefing sheet 
DEBRIEFING SHEET 
Attentional Bias Retraining among Cigarette Smokers  
Thank you for taking part in this experiment. The aims of the project are two-fold: to 
reassess whether the experimental manipulation of attentional bias influences subsequent 
cue reactivity to smoking cues in cigarette smokers and to explore whether the amount of 
attentional bias manipulation affects the degree of cue reactivity exhibited. 
Attentional bias, where images and objects that have become associated over time with 
drug use tend to “capture” ones attention, are thought to be an important component of 
addiction which predict relapse to drug use. For example, people addicted to nicotine tend 
to notice smoking-related words and pictures more quickly than those who are not.  
It is possible to experimentally manipulate the extent to which people either focus their 
attention on, or away from, such words and pictures. Our original study found that 
experimentally-induced attentional bias for smoking-related cues was associated with 
greater subsequent cue-induced craving compared to induced attentional bias for neutral 
cues. In this study, we are reassessing this relationship by comparing 2 groups, where: 
  
a) Participants have their attention trained towards neutral cues because the appearance of 
the probe during the reaction time task is more likely to occur in the location of a neutral 
picture. This is the training group. 
b) Participants don’t have their attention trained towards any particular cues because the 
appearance of the probe during the reaction time task occurs in the location of the 
smoking-related and neutral pictures with equal frequency. This is the placebo training 
group. 
 
We are also investigating whether manipulating the length of training has an effect on 
attentional bias and cue reactivity. In each group, a third of participants either receive a 
low dose, medium dose or high dose of training/placebo training. The allocation of 
participants to training/placebo training and one of the three groups is random, and we 
won’t break the code which identifies which participants were in which condition until the 
study is complete.  
 
This research will hopefully enable us to better understand the biological basis of 
addiction, and reassess the link between attentional bias and craving for cigarettes. We 
may also be able to better understand the impact of different amounts of attentional 
retraining on attentional bias and reactivity to smoking-related cues. We are also 
interested in measures of mood and personality, since these may help us to understand 
why no two smokers are the same. This research may eventually lead to novel treatments 
for nicotine dependence.  
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MacLeod, C. et al. (2002). Selective attention and emotional vulnerability: assessing the 
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Appendix 5. Pre-training and post-training attentional bias scores by group and 
block length allocation  
a) Pre-training and post-training attentional bias scores by allocation to short block 
length 
  
Attentional 
retraining  
(n=11) Control  (n=12) 
    
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 624.23 (93.03) 638.88 (81.22) -14.65 -0.4 0.69 (-90.21, 60.91) 
  RT for neutral stimuli 638.50 (93.76) 629.54 (67.48) 8.96 0.27 0.80 (-61.41, 79.33) 
  Attentional bias 14.27 (68.46) -9.33 (33.25) 23.61 1.07 0.30 (-22.42, 69.63) 
Post-training 
        RT for smoking stimuli 636.68 (161.45) 596.04 (109.40) 40.64 0.70 0.49 (-81.58, 162.86) 
  RT for neutral stimuli 644.68 (162.17) 600.38 (103.09) 44.31 0.77 0.45 (-76.63, 165.24) 
  Attentional bias 8.00 (37.29) 4.33 (33.23) 3.67 0.25 0.81 (-26.91, 34.25) 
Change score attentional 
bias -6.27 (84.48) 13.67 (55.60) -19.94 -0.67 0.51 (-81.43, 41.55) 
RT - reaction time (milliseconds) 
 
b) Pre-training and post-training attentional bias scores by allocation to medium block 
length 
  
Attentional 
retraining 
(n=13) Control (n=10) 
    
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 697.15 (102.71) 719.15 (180.83) -22.00 -0.37 0.72 (-145.83, 101.84) 
  RT for neutral stimuli 685.61 (100.62) 730.05 (181.20) -44.43 -0.75 0.46 (-167.70, 78.83) 
  Attentional bias -11.54 (30.43) 10.90 (31.47) -22.44 -1.73 0.09 (-49.45, 4.58) 
Post-training 
        RT for smoking stimuli 617.23 (112.01) 638.75 (113.22) -21.52 -0.46 0.65 (-119.96, 76.92) 
  RT for neutral stimuli 616.12 (109.06) 664.70 (151.75) -48.58 -0.90 0.38 (-161.51, 64.34) 
  Attentional bias -1.12 (27.06) 25.95 (53.33) -27.07 -1.59 0.13 (-62.46, 8.33) 
Change score attentional 
bias 10.42 (51.34) 15.05 (61.25) -4.63 -0.20 0.85 (-53.44, 44.18) 
RT - reaction time (milliseconds) 
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c) Pre-training and post-training attentional bias scores by allocation to long block 
length 
  
Attentional 
retraining  
(n=8) Control (n=13) 
    
  M (SD) M (SD) 
Mean 
difference t p 95% CI 
Pre-training 
        RT for smoking stimuli 650.81 (183.53) 678.58 (114.43) -27.76 -0.43 0.67 (- 163.02, 107.49) 
  RT for neutral stimuli 665.00 (205.23) 682.42 (118.42) -17.42 -0.25 0.81 (-164.26, 129.41) 
  Attentional bias 14.19 (51.75) 3.85 (47.13) 10.34 0.47 0.64 (-35.63, 56.32) 
Post-training 
        RT for smoking stimuli 567.81 (101.09) 584.42 (88.81) -16.61 -0.40 0.70 (-104.57, 71.35) 
  RT for neutral stimuli 590.75 (125.04) 580.08 (92.18) 10.67 0.23 0.82 (-88.54, 109.88) 
  Attentional bias 22.94 (31.16) -4.35 (48.00) 27.28 1.43 0.17 (-12.76, 67.33) 
Change score attentional 
bias 8.75 (56.28) -8.19 (44.19) 16.94 0.77 0.45 (-29.14, 63.02) 
RT - reaction time (milliseconds) 
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Appendix 6. Normal probability plots for QSU-Brief and VAS multi-level models 
a) Example plot of residuals for fully specified model of QSU-Brief scores 
 
b) Example plot of residuals for fully specified model of VAS scores 
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Appendix 7. Box plots illustrating the distribution of QSU-Brief scores and VAS 
craving scores by group, block length and time 
a) Box plot of QSU-Brief scores 
 
Plot headings follow the format [group, block length, time] where control=0, attentional retraining=1; 
short block length=1, medium block length=2, long block length=3; baseline=1, pre-exposure=2, post-
exposure=3 
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b) Box plot of VAS craving scores 
 
Plot headings follow the format [group, block length, time] where control=0, attentional retraining=1; 
short block length=1, medium block length=2, long block length=3; baseline=1, pre-exposure=2, post-
exposure=3 
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Appendix 8. Mean (95% CI) change in QSU-brief scores from baseline to pre-
exposure and post-exposure in the attentional retraining group and control group by 
block length 
a) Mean (95% CI) change in QSU-brief scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the short 
block length 
 
b) Mean (95% CI) change in QSU-brief scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the medium 
block length 
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c) Mean (95% CI) change in QSU-brief scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the long 
block length 
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Appendix 9. Mean (95% CI) change in VAS craving scores from baseline to pre-
exposure and post-exposure in the attentional retraining group and control group by 
block length 
a) Mean (95% CI) change in VAS craving scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the short 
block length 
 
b) Mean (95% CI) change in QSU-brief scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the medium 
block length 
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c) Mean (95% CI) change in QSU-brief scores from baseline to pre-exposure and 
post-exposure in the attentional retraining group and control group at the long 
block length 
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Appendix 10. Published ARTS trial protocol 
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Appendix 11. GP practice invitation letter to participants 
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Appendix 12. Patient information sheet 
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Appendix 13. Telephone screening form for eligibility into the ARTS trial 
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Appendix 14. Patient consent form for the ARTS trial 
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Appendix 15. Clinical procedure for ARTS trial 
THE UNIVERSITY OF BIRMINGHAM 
ARTS STUDY 
Clinical Procedure 
 
 
 
Contents 
Recruitment ........................................................................................   03 
Session 1 .......................................................................................    06 
Session 2 .....................................................................................      08 
Session 3 ....................................................................................       11 
Session 4-6 ........................................... .........................................       13 
Session 7 ....................................................................................       15 
Session 8 ...................................................................................        17 
Session 9 .....................................................................................      19 
Session 10 ........................................................................................   21
A double blind randomised controlled trial of attentional bias retraining in 
cigarette smokers attempting smoking cessation (ARTS).  This document 
outlines the study procedures from the initial approach to the final 
assessment session. 
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Recruitment 
Summary of recruitment process 
 
1 
 
Brief patient about ARTS and study procedures 
 
2 
 
Check eligibility (pg 3-4 of CRF) 
 
3 
 
Medical History Form (pg 5 of CRF) 
 
4 
 
Concomitant medication form (pg 6 of CRF) 
 
3 
 
Consent Form (in folder) 
 
4 
 
Patient Information Form (in folder) 
 
5 
 
Proceed to first session 
 
Recruitment  
Participating practices will write to patients on their list who meet the eligibility 
criteria inviting them to take part in the study.  Those who are interested will call 
the trial coordinator, who will give them a summary of what the trial involves and 
run a quick screening checklist.  Those who are happy to go ahead will be book 
an appointment to see one of the trial nurses and a patient information sheet will 
be posted out.  
1. The potential patient will already have read the patient information sheet.  
Brief the patient about the study and procedures working through the 
information sheet.   
2. If they are still interested check their eligibility using the CRF.  Every 
patient will have a CRF.  The study will be recruiting current smokers who 
1. Male or female aged 18 years or over. 
2. Smokes at least 10 cigarettes per day or has a value of 10 parts 
per million (ppm) for exhaled carbon monoxide (CO). 
3. Have normal or corrected-to-normal vision. 
4. Show evidence of a signed and dated informed consent 
document indicating that s/he has been informed of all aspects 
of the study and consents to participate and be randomised to 
either group. 
5. Be able and willing to complete all study procedures. 
 
Smokers are non-eligible if they: 
 
1. A medical condition that prevents them seeing the computerised 
images properly, attending to the task, or pressing the keyboard 
  APPENDICES 
 
 
309 
 
buttons on the computer accurately, or completing any other 
study procedures. 
2. Are currently using other nicotine replacement therapy (NRT), 
bupropion, nortriptyline, mecamylamine, reserpine, or 
varenicline, or undergoing any treatment for tobacco 
dependence (e.g. acupuncture) that they are not willing to cease 
using to use study medication. 
3. Have taken part in other medicinal trials in the last 3 months or 
are doing so during study participation. 
4. Have previously had severe skin reactions to nicotine patches or 
severe eczema or other skin diseases that make patch use 
hazardous or undesirable. 
5. Severe acute or chronic medical or psychiatric condition or 
previously diagnosed clinically important renal or hepatic 
disease, which may increase the risk associated with study 
participation or may interfere with the interpretation of study 
results and, in the judgment of the investigator, would make the 
patient inappropriate for entry into this study. 
 
 
Check that the main inclusion / exclusion criteria are met by assessment form on 
pages 3 to 4 of the CRF.  
Note 
If the criteria are not met then give the patient an explanation of why we are 
unable to include them in the study and refer them on to their local stop smoking 
service.  Send the incomplete CRF to the trial manager so we can keep a log of 
numbers of patients seen but not recruited. 
3. Fill in the medical history form on page 5 of the CRF. 
 
4. Fill in the concomitant medication form on page 6 of the CRF. 
 
5. If eligibility criteria are met and the patients decide to progress ask them to 
read, sign and date the informed consent form.  This is completed in 
triplicate; one copy goes to the patient, one sent to the research team 
and one to be kept in case file at the Practice.    
Note 
If the patient does not wish to provide consent, send the CRF without smokers 
contact details to the trial manager so the research team can keep a log of 
number of patients seen but not recruited.   
 
6. Fill in the patient information form. 
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7. Provided the individual is happy to do so, proceed with the first session. 
Session 1 
-2 weeks (pre-quit) 
Summary of session 1 
 
1 
 
Stop smoking support: Contact 1 (No NRT to be given on this day) 
 
2 
 
Patient fills ARTS study baseline questionnaire, week -2 (in folder) 
 
3 
 
Fill in the first part of Visit 1 CRF (pg 7) 
 
3 
 
Visual probe task (on laptop) 
 
4 
 
Explain and issue electronic diary  
 
5 
 
Pictorial Stroop task (on laptop) 
 
6 
 
Book next appointment (ARTS online system) 
 
7 
 
Data entry of Baseline CRF (Baseline visit 1 on ARTS online system) 
 
1. Carry out first session of the stop smoking programme.  Carbon monoxide 
monitoring begins in this session and will be recorded at each visit during 
the trial.  During this session a quit date must be set for two weeks time.  
No NRTs to be given on this day.  
 Introduce stop smoking programme 
 Fill in stop smoking registration form 
 CO monitoring: Ask the patient to provide a carbon monoxide 
reading.  Refer to CO monitors instructions for correct use.  Allow 
the patients a couple of attempts if practice is needed. 
 Discuss NRTs (in particular the nicotine patch which will be used in 
the trial) 
 Set quit date 
 
2. Give the patient the baseline questionnaire to fill (ARTS study baseline 
questionnaire week -2) 
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3. Visual probe task on the laptop.  Refer to visual probe task guide Appendix 
1.  
The patient has the opportunity to do a practice version of the task which is 
in the ‘Practice visual probe task’ folder. For the practice version, enter the 
subject number as 0, as data from the practice version is not required. The 
practice version is continuous, so you will have to abort the task for the 
patient when they are happy to do the real visual probe task.  
To abort the practice task, press the control, alt and shift key at the same 
time.  
Continue on to setting up the visual probe task (Appendix 1).There is a 
break after 8 minutes of the task should the patient need one. This task is 
expected to take 16 minutes in total.   
 
4. Talk to the patient about the electronic diary. Refer to Appendix xx for 
guidance in setting up the electronic diary and play the video file named 
‘Electronic diary instructions’ on the laptop. While the video is playing, turn 
the diary on and follow the instructions on the screen. Give the patient the 
electronic dairy, a charger and a copy of the ARTS instruction booklet.  
The patient will have to sign a contract on the diary on receipt of the diary.  
The contract ‘ARTS electronic diary sign out form’ will be in your resource 
pack. Keep a log of this on the ARTS electronic diary tracking form (also in 
your resource pack). 
 
5. Pictorial Stroop task on the laptop.  Refer to pictorial Stroop task guide 
Appendix 2.  
Again, there is a practice version of the task in the ‘Practice Stroop task’ 
folder if the patient requires a practice-run (you will have to abort this task 
using the same procedure above). Run the Pictorial Stroop task. There are 
three breaks during the task should the patient need them. This task is 
expected to take approximately 12 minutes in total. 
 
6. Book the next appointment for one week’s time using the ARTS online 
system and print this out for patient.  Patients need to come to the next 
session without having smoked for at least an hour.  Find out from the 
patient their preferred way of being sent reminders about appointments 
(text, email or phone call). 
7. Log on to the ARTS online system and enter CRF data (named baseline 
visit 1) https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 2 
-1 week (pre-quit) 
Summary of session 2 
 
1 
 
Complete the next section of the CRF (pg 8)  
 
2 
 
Upload data from electronic diary 
 
3 
 
Patient fills ARTS study questionnaire, week -1 (in folder) 
 
4 
 
Cue exposure task 
 
5 
 
Carry out randomisation on ARTS online system 
 
6 
 
Training - Part 1   
 
7 
 
Behavioural support (one week supply of NRT to be given on this day in 
preparation for quit day) 
 
8 
 
Training - Part 2 
 
9 
 
Data entry of CRF on ARTS online system (visit -1) 
 
10 
 
Book next appointment 
 
1. Complete the next section of the CRF.  Page 8, visit 2, -1 week prequit.  
Confirm consent and ensure that the patient still meets the inclusion 
criteria. 
 
2. Upload data from the electronic diary using guidelines in Appendix 6.  
Return the electronic diary to patient.  Encourage patient to record all 
cigarettes they smoke and respond to prompts if compliance is low. 
 
3. Give the patient the ARTS week -1 questionnaire to fill. Patient to fill in 
questions 1-3 and Time 1 pre cue exposure task question and stop where 
it says break. 
 
4. Cue exposure task – please refer to cue exposure task guide (Appendix 3).  
For this task you will have a cigarette, a lighter and a box.  Play the sound 
file named 'Cue exposure voiceover’ from the laptop which will give 
instructions on the task. After the task the patient completes the last page 
of the questionnaire, Time 2 post cue exposure task question.   
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5. Log on to the ARTS online system https://www.pc-crtu.bham.ac.uk/ARTS/ 
and navigate to the ‘Patients’ tab and click on ‘Randomise’. Find the 
patient in the list to bring up their details by clicking on ‘View’. Click ‘Finish’ 
to randomise the patient. The system will indicate whether the patient is 
randomised to ‘Training A’ or ‘Training B’. Write down which group the 
patient is randomised to on page 1 of the CRF.  
Explain to the patient that they will be randomised in this session. They will 
either be in the intervention arm and receive attentional bias retraining or 
be in the control group and receive control training.  They will continue to 
receive behavioural support and nicotine patches regardless of which arm 
they are randomised to. The patient should be made aware the 
randomisation process is computerised and that they cannot choose the 
group they will be allocated to and neither they nor the research team / 
nurse would know the group they are allocated to.  
 
6. Training part 1 
Set up the training for the patient on the laptop. Click on the ‘Training A’ 
folder if the patient has been randomised to the group ‘Training A’ or click 
on the ‘Training B’ folder if the patient has been randomised to the group 
‘Training B’. Refer to the training guide for information on how to run the 
program (Appendix 4).  This will run for about 16 minutes. Training is split 
into two parts, Part 1 and Part 2. There is a break in between the two parts 
and this will be indicated on the screen.  
 
7. Provide behavioural support after Part 1 of training.  
 Confirm quit date of next week with patient in this session. 
 C0 readings taken 
 NRT patches to be given in this session.  
 Explain how nicotine patch use works 
“When you smoke, nicotine is absorbed rapidly from the smoke and travels 
to the brain where it attacks the brain’s motivation system. This causes 
your brain to pay attention to what was happening just before the nicotine 
got to your brain- which was smoking a cigarette. If you repeat this 
process, your brain will come to expect it’s hit of nicotine in particular times 
or places when you would usually smoke. This is automatic learning and is 
nothing to do with what you want to happen or feel.  When you try to stop 
smoking, your brain’s motivation system will send a message which you 
feel as a craving, particularly when you are in places where you would 
normally have smoked. These cravings can be very strong and they are 
the main reason people fail to quit smoking in the early days. Eventually 
they will go away as your brain’s motivation forgets, but this can take 
weeks or months. If you put on a nicotine patch, your cravings will not be 
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as strong and there is more chance you will be  able to avoid smoking.  
The longer you go without smoking, the more chance you have of making 
it as a non-smoker. Wearing the patch will help you get there. Does that 
make sense to you?” 
 Encourage and emphasise how important regular use is. 
 
 Dispense one week’s worth of medication to start use the day prior to 
quit day (or from the morning of quit day).   
 
 Give advice on where to put the patch (any area of hairless skin 
excluding the breasts). 
 
 Ask whether the patient has questions about patch use or NRT and 
reassure the patient about the use of the patch. 
 
When you are ready, instruct the patient to resume with Part 2 of training 
on the laptop. 
 
8. Training part 2 
Continue with the second part of training on the laptop for patients. 
9. Book the next appointment using the ARTS online system and print out for 
patient.   
 
10. Log on to the ARTS online system and enter CRF data (named visit -1) 
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 3 
0 Week (quit day) 
Summary of session 3 
 
1 
 
Fill out next section of CRF (pg 9) 
 
2 
 
Patient fills ARTS study questionnaire, week 0 (in folder) 
 
2 
 
Upload data from electronic diary 
 
3 
 
Training - Part 1   
 
4 
 
Behavioural support (One weeks supply of NRT to be given) 
 
5 
 
Training - Part 2 
 
6 
 
Data entry on ARTS online system – week 0 
 
7 
 
Book next appointment 
 
1. Fill out the next section of the CRF, page 9. 
 
2. Upload the data from electronic diary using guidelines in Appendix 6.  
Encourage patient to use diary if compliance is low. 
 
3. Training part 1 
Set up the training for the patient on the laptop. Check which group the 
patient was randomised to (either Training A or Training B) which you 
wrote down on page 1 of the CRF from the previous session. 
 
4. Provide behavioural support after Part 1 of training.  
 Today is quit day; emphasise the not a puff rule.   
 Check that the participant has their patch on.  
 Check for any concerns and worries about the medication. 
 Emphasise how important regularly using the patch is.  If necessary 
explain how the patch works. 
 It is important the person knows that lapsing is ‘not an option’, but if 
they do, it is even more important that s/he uses the patch.  Lapsing on 
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a patch is less likely to lead to relapse and it is perfectly safe to smoke 
while on a patch. 
 CO reading 
 Dispense one week’s medication. 
 
5. Training part 2 
Continue with the second part of training on the laptop for patients 
 
6. Book the next appointment using the ARTS online system and print out for 
patient.   
 
7. Log on to the ARTS online system and enter CRF data (named visit 0) 
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 4-6 
+1 week, +2 week, +3 weeks post-quit  
Summary of session 4-6 
 
1 
 
Fill in next session of CRF (session 4 pg. 10, session 5 pg 12, session 6 
pg 14) 
 
2 
 
Patient fills ARTS study questionnaire, week +1/week +2/week +3 (in 
folder) 
 
3 
 
Upload data from electronic diary 
 
4 
 
Training part 1 
 
5 
 
Behavioural support (One weeks supply of NRT to be given) 
 
6 
 
Training part 2 
 
7 
 
Book next appointment 
 
8 
 
Data entry of CRF on ARTS online system  
 
1. Fill out the next section of the CRF - Page 10 for session 4, page 12 for 
session 5 and page 14 for session 6. 
 
2. Give the patient the appropriate questionnaire to fill (week +1, +2, +3). 
 
3. Upload the data from electronic diary using guidelines in Appendix 6.  
Encourage patient to use diary if compliance is low. 
 
4. Training part 1 
Set up the training for the patient on the laptop. Check which group the 
patient was randomised to (either Training A or Training B) which you 
wrote down on page 1 of the CRF. 
 
5. Behavioural support 
 Check that the participant has their patch on.  
 Check for any concerns and worries about the medication. 
 Emphasise how important regularly using the patch is.  If necessary 
explain how the patch works. 
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 It is important the person knows that lapsing is ‘not an option’, but if 
they do, it is even more important that s/he uses the patch.  Lapsing on 
a patch is less likely to lead to relapse and it is perfectly safe to smoke 
while on a patch. 
 CO reading 
 Dispense one week’s medication. 
If the patient has abandoned their quit attempt, their next visit will be at 
+12 weeks and +24 weeks follow up sessions.  They will need to return the 
electronic diaries and sign them back in.  They will receive £15 on 
returning the phones if they drop out of the study before visit 8. 
 
6. Training part 2 
Continue with the second part of training on the laptop for patients. 
 
7. Book the next appointment using the ARTS online system and print out for 
patient.   
 
8. Log on to the ARTS online system and enter CRF data  
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 7  
+4 weeks post quit day 
Summary of session 7 
 
1 
 
Complete the next section of the CRF (pg 16) 
 
2 
 
Patient fills first part of ARTS study questionnaire, week +4 (in folder) 
 
3 
 
Upload data from electronic diary 
 
4 
 
Visual Probe task 
 
5 
 
Behavioural support (Three weeks supply of NRT to be given) 
 
6 
 
Pictorial Stroop task  
 
7 
 
Cue exposure task 
 
8 
 
Book next appointment 
 
9 
 
Data entry of Week +7 CRF on ARTS online system (Visit 7) 
 
1. Complete the next session of the CRF(page 16). 
 
2. Patient fills ARTS week + 4 questionnaire in folder.  Patient to fill in 
questions 1-3 and stop where it says break. 
 
3. Upload the data from electronic diary.  The patient will use the dairy for 
one more week.  The next appointment is in four weeks so patient to keep 
the diary off after one week and return it with the charger at their next 
appointment in four weeks time. 
 
4. Visual probe task 
To be set up on laptop for patient.  There is a break after 8 minutes should 
the patient need one. This is expected to last for approximately 16 
minutes. 
 
5. Behavioural support: this is the final behavioural support session. Give the 
patients their final set of patches to last them for 4 weeks.  
 Check that the participant has their patch on.  
 Check for any concerns and worries about the medication. 
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 Emphasise how important regularly using the patch is.  If necessary 
explain how the patch works. 
 It is important the person knows that lapsing is ‘not an option’, but if 
they do, it is even more important that s/he uses the patch.  Lapsing on 
a patch is less likely to lead to relapse and it is perfectly safe to smoke 
while on a patch. 
 CO reading 
 Dispense three  week’s medication 
 Consider whether to reduce the dose of the nicotine patch.  If in doubt 
do not reduce the dose. 
 
6. Pictorial Stroop task 
To be set up on laptop for patient.  There are three breaks during the task 
should the patient need them. This task is expected to take approximately 
12 minutes in total. 
 
7. Cue exposure task  
Patient to return to filling in ARTS week +4 questionnaire, Time 1, pre cue 
exposure task question. Set up cue exposure task (cigarette, lighter and a 
box), play the sound file named 'Cue exposure voiceover’ from the laptop.  
After the task, the patient completes the last page of the questionnaire, 
Time 2 post cue exposure task question.   
 
8. Book next appointment for 4 weeks on ARTS online system. 
 
9. Log on to the ARTS online system and enter CRF data  
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 8 
+8 weeks post quit day 
Summary of session 8 
 
1 
 
Complete first part of CRF (Pg 18) 
 
2 
 
Patient fills ARTS study questionnaire, week +8 (in folder)  
 
3 
 
Visual probe task 
 
4 
 
CO measurement 
 
5 
 
Pictorial Stroop task 
 
6 
 
Cue exposure task 
 
7 
 
Patient fills ARTS patient satisfaction questionnaire (in folder) 
 
8 
 
Upload data from electronic diary, collect electronic diary + make 
payment 
 
9 
 
Book next appointment for 4 weeks on ARTS online system 
 
10 
 
Data entry of week +8 CRF on ARTS online system 
 
1. Complete first part of CRF (Page 18). 
 
2. Patient fills ARTS week +8 questionnaire.  After the first section patient to 
break for visual probe task (to be set up on laptop). 
 
3. Set up visual probe task on laptop. There is a break after 8 minutes should 
the patient need one. This is expected to last for approximately 16 
minutes. 
 
4. CO measurement. 
 
5. Set up pictorial Stroop task for patient on laptop. There are three breaks 
during the task should the patient need them. This task is expected to take 
approximately 12 minutes in total. 
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6. Patient to refer back to questionnaire and fill in Time 1, pre cue exposure 
task question. Set up cue exposure task (cigarette, lighter and a box), play 
the sound file named 'Cue exposure voiceover’ from the laptop.  After the 
task, the patient completes the last page of the questionnaire, Time 2 post 
cue exposure task question.   
 
7. Patient fills in ARTS patient satisfaction questionnaire. 
 
8. Upload data from the electronic diary.  The patient has now finished using 
the phone and it must be returned at this stage. Check overall 
compliance (refer to electronic diary guidance Appendix xx).  If patient 
has 60% compliance or above, pay £75.  If patient has less than 60% 
compliance pay £40. The patient must sign for receipt of payment. Use the 
payment form.  Sign the phone back in.  Return the phone to trial 
coordinator. 
9. Book next appointment using ARTS online system.  The next appointment 
is due in four weeks. 
10. Log on to the ARTS online system and enter CRF data  
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 9 
+12 weeks post quit day 
Summary of session 9 
 
1 
 
Complete first part of the CRF(Pg 20) 
 
2 
 
Patient fills ARTS study questionnaire, week +12 (in folder)  
 
3 
 
Visual probe task 
 
4 
 
CO measurement 
 
5 
 
Pictorial Stroop task 
 
6 
 
Cue exposure task 
 
7 
 
Pay patient £15 
 
8 
 
Book next appointment 
 
9 
 
Data entry of Week +12 CRF on ARTS online system 
 
1. Complete the first part of the CRF (page 20). 
 
2. Give the patient the ARTS week +12 questionnaire to fill, up to where the 
first break is indicated. 
 
3. Set up visual probe task. There is a break after 8 minutes should the 
patient need one. This is expected to last for approximately 16 minutes. 
 
4. CO measurement. 
 
5. Set up pictorial Stroop task on laptop. There are three breaks during the 
task should the patient need them. This task is expected to take 
approximately 12 minutes in total. 
 
6. Patient to refer back to questionnaire and fill in Time 1, pre cue exposure 
task question. Set up cue exposure task (cigarette, lighter and a box), play 
the sound file named 'Cue exposure voiceover’ from the laptop.  After the 
task, the patient completes the last page of the questionnaire, Time 2 post 
cue exposure task question.   
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7. Pay patient £15, let patient sign on receipt for the money. 
 
8. Book next appointment for 12 weeks time, and print out to patient.  Agree 
with patient way of reminding them of the appointment nearer the date. 
 
9. Log on to the ARTS online system and enter CRF data  
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Session 10 
+24 weeks post quit day 
Summary of session 10 
 
1 
 
Complete first part of CRF (Pg 22) 
 
2 
 
Patient fills ARTS study questionnaire, week +24 (in folder)  
 
3 
 
Visual probe task 
 
4 
 
CO measurement 
 
5 
 
Pictorial Stroop task 
 
6 
 
Cue exposure task 
 
7 
 
Final visit – pay patient £15 and thank patient 
 
8 
 
Data entry of Week +24 CRF on ARTS online system 
 
 
1. Complete the first part of the CRF (Page 22) 
 
2. Give the patient the ARTS week +24 questionnaire to fill, up to where the 
first break is indicated. 
 
3. Set up visual probe task. There is a break after 8 minutes should the 
patient need one. This is expected to last for approximately 16 minutes. 
 
4. CO measurement 
 
5. Set up pictorial Stroop task on laptop. There are three breaks during the 
task should the patient need them. This task is expected to take 
approximately 12 minutes in total. 
 
6. Patient to refer back to questionnaire and fill in Time 1, pre cue exposure 
task question. Set up cue exposure task (cigarette, lighter and a box), play 
the sound file named 'Cue exposure voiceover’ from the laptop.  After the 
task, the patient completes the last page of the questionnaire, Time 2 post 
cue exposure task question.   
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7. Pay patient £15, let patient sign on receipt for the money.  This is the final 
session.  Thank patient for taking part in the study. 
 
8. Log on to the ARTS online system and enter CRF data  
https://www.pc-crtu.bham.ac.uk/ARTS/ 
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Appendix 1: Visual probe task guide 
Appendix 2: Pictorial Stroop task guide 
Appendix 3: Cue exposure task guide 
Appendix 4: Training guide 
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Appendix 1:  Visual Probe Task 
N.B. This only applies for the baseline visit (week -2), +4 week visit, +8 week visit, +12 
week and +24 week visit. 
1. Double-click on the Visual Probe Task folder on the desktop.  Double-click on the 
file name ‘Visual probe task’ (make sure this is the E-run 2.0 Script File) 
 
 
2. After you have clicked on the ‘Visual probe task’ icon, the following box will 
appear on the screen. Please type in the patient ID as the subject number, e.g if the 
patient ID is 0005, type in the number ‘5’ in the box. 
 
3. Type in the Session number, e.g. if this is the baseline visit (week -2 visit), type 
the number  ‘1’, or if this is the week -1 visit, type the number  ‘2’, or for week 0 
quit day visit, type ‘3’ and so on. 
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4. Type in the patient’s age. 
 
5. Specify whether the patient is male or female by clicking on one of the options. 
 
 
 
 
 
 
 
 
 
 
 
 
6. Check the information you have entered. If the information is correct, click ‘Yes’ 
and proceed on to the instructions page. If any of the information is incorrect, 
click ‘No’, which will take you back to the beginning. 
 
 
 
7. The instructions screen looks like this. When the patient is ready to proceed they 
should press any key to start. 
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8. The patient will see this screen at the end of the session. 
 
 
  APPENDICES 
 
 
331 
 
Appendix 2:  Pictorial Stroop Task 
N.B. This only applies for the baseline visit (week -2), +4 week visit, +8 week visit, +12 
week and +24 week visit. 
1. Double-click on the Pictorial Stroop Task folder on the desktop.  Double-click on 
the file name ‘Pictorial Stroop task’ (make sure this is the E-run 2.0 Script File) 
 
 
2. After you have clicked on the ‘Pictorial Stroop task’ icon, the following box will 
appear on the screen. Please type in the patient ID as the subject number, e.g if the 
patient ID is 0005, type in the number ‘5’ in the box. 
 
3. Type in the Session number, e.g. if this is the baseline visit (week -2 visit), type 
the number  ‘1’, or if this is the week -1 visit, type the number  ‘2’, or for week 0 
quit day visit, type ‘3’ and so on. 
 
 
 
4. Type in the patient’s age. 
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5. Specify whether the patient is male or female by clicking on one of the options. 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Check the information you have entered. If the information is correct, click ‘Yes’ 
and proceed on to the instructions page. If any of the information is incorrect, 
click ‘No’, which will take you back to the beginning. 
 
 
 
The instructions screen looks like this. When the patient is ready to proceed they should 
press any key to start. 
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7. There is a break in the middle of the task should the patient need a break.  Please 
instruct the patient to proceed by pressing any key to continue. 
 
 
 
8. The patient will see this screen at the end of the session. 
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Appendix 3:  Cue exposure task 
N.B. This only applies for week –1 visit, +4 week visit, +8 week visit, +12 week and +24 
week visit. 
 
 
1. In the equipment given to you, you will have a cigarette, a lighter and a box. Place 
the cigarette and lighter under the box, without the patient seeing you do this. 
Place the box in front of the patient 
 
2. Ask the patient to fill in ‘Time 1’ of the patient questionnaire. Time 1 looks like 
this: 
 
 
Time 1 
 
Using a vertical line, please mark on the scale how much you are feeling the urge to 
smoke right now. 
Urge to smoke 
 
Extremely       Not at all 
I————————————————————I 
 
BREAK 
Please do not turn over until you are instructed to do so 
 
3. At the break, play the sound file named ‘Cue exposure voiceover’. These are 3 
minute instructions. The patient will hear the following instructions.  
 
 
N.B. At no point will the patient be allowed to light or smoke the cigarette. 
 
00:00 
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Do not touch anything until instructed to do so. Please sit quietly and relax for one 
minute. 
 
01:00 
Please lift-up the box in front of you and place it to the side. 
(Patient obeys) 
 
01:15 
Pick-up the cigarette and hold the cigarette in which ever hand is comfortable.  
 (Patient holds the cigarette) 
 
01:30 
Pick-up the lighter with your other hand. Hold the cigarette in front of you and hold 
the lighter. 
(Patient picks up the lighter) 
 
01:45 
Hold the cigarette at a downward angle in front of you while continuing to hold the 
lighter in your other hand.  
(Patient obeys) 
 
02:15 
Put the lighter down on the table. Hold the cigarette in your hand as you usually would.  
 (Patient obeys) 
 
02:30 
Look at the cigarette. Imagine what it would be like to be smoking the cigarette. 
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(Patient obeys) 
 
02:45 
Please put the cigarette down. Cover the cigarette and the lighter with the box. 
 (Patient does so) 
 
03 :00 
(Exposure ends) 
 
 
 
4. Ask the patient to fill in ‘Time 2’ of the patient questionnaire. Time 2 looks like this: 
 
Time 2 
 
Using a vertical line, please mark on the scale how much you are feeling the urge to 
smoke right now. 
 
Urge to smoke 
 
Extremely       Not at all 
I————————————————————I 
 
 
Thank you very much for completing this questionnaire 
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Appendix 4:  Training 
N.B.  This only applies to week -1 visit, week 0 quit day visit, +1 visit, +2 visit, +3 visit 
and + 4 visit. 
1. Double-click on the Training folder on the desktop.  Double-click on the file name 
‘Training’ (make sure this is the E-run 2.0 Script File) 
 
 
2. After you have clicked on the ‘Training’ icon, the following box will appear on 
the screen. Please type in the patient ID as the subject number, e.g if the patient ID 
is 0005, type in the number ‘5’ in the box. 
 
3. Type in the Session number, e.g.  if this is the week -1 visit, type the number  ‘2’, 
or for week 0 quit day visit, type ‘3’ and so on. 
 
 
 
 
4. Type in the patient’s age. 
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5. Specify whether the patient is male or female by clicking on one of the options. 
 
 
 
 
 
 
 
 
 
 
 
 
6. Check the information you have entered. If the information is correct, click ‘Yes’ 
and proceed on to the instructions page. If any of the information is incorrect, 
click ‘No’, which will take you back to the beginning. 
 
 
 
7. The instructions screen looks like this. When the patient is ready to proceed they 
should press any key to start. 
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8. At the end of the first block, the patient will come to a screen which looks like 
this.  
 
 
9. After the patient has had a break and is ready to resume with the second part of the 
task, ask the patient to press any key to continue. A screen like this will appear. 
 
 
 
10. The patient will see this screen at the end of the session. 
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Appendix 16. Case report form for ARTS trial 
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Appendix 17. Baseline questionnaire  
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Appendix 18. Example of Mood and Physical Symptoms Scale (MPSS) questionnaire 
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Appendix 19. Example of visual analogue scale (VAS) used to measure urge to 
smoke pre and post cue exposure task 
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Appendix 20. Question on knowledge of group allocation in +4 week questionnaire 
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Appendix 21. Patient satisfaction questionnaire 
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Appendix 22. Stimuli used during assessment and training tasks 
 
Picture-pair 1     Picture-pair 2                  Picture-pair 3 
 
Picture-pair 4      Picture-pair 5       Picture-pair 6 
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Picture-pair 7     Picture-pair 8                  Picture-pair 9 
 
Picture-pair 10    Picture-pair 11     Picture-pair 12 
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Picture-pair 13    Picture-pair 14                 Picture-pair 15 
 
 
Picture-pair 16    Picture-pair 17     Picture-pair 18 
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Appendix 23. Letter of ethics approval for ARTS trial
 
  APPENDICES 
 
 
390 
 
Appendix 24. ARTS posters  
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Appendix 25. Facebook campaign 
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Appendix 26. Observed and predicted MPSS-C scores over time in each trial arm 
and by abstinence status 
a) Observed and predicted MPSS-C scores in attentional retraining group 
abstainers 
 
b) Observed and predicted MPSS-C scores in control group abstainers 
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c) Observed and predicted MPSS-C scores in attentional retraining group non-
abstainers 
 
 
 
 
d) Observed and predicted MPSS-C scores in control group non-abstainers 
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Appendix 27. Predicted MPSS-C scores over time by trial arm and abstinence status 
(for fixed part of model only) 
a) Predicted MPSS-C scores with main effects of time, time squared, trial arm and 
abstinence status 
 
b) Predicted MPSS-C scores with main effects of time, time squared, time cubed trial 
arm and abstinence status 
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Appendix 28. Mixed-effects models of MPSS-C scores over time by trial arm and weekly abstinence status 
  Model 1 Model 2 Model 3 Model 4 Model 5 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Fixed effects 
            Time 0.91 0.50 -1.39 0.01 -1.30 0.01 -1.28 0.01 -1.22 0.01 
  Time² -0.17 0.34 0.13 0.02 0.13 0.02 0.13 0.02 0.13 0.02 
  Treatment arm₁ 2.89 0.38 -0.32 0.80 0.52 0.55 0.32 0.68 0.71 0.11 
  Abstinence status₂ 5.13 0.06 0.37 0.70 0.94 0.22 0.79 0.27 0.77 0.28 
Intercept 8.48 
 
12.18 
 
11.84 
 
11.89 
 
11.70 
 Interactions 
            Time x Abstinence status -3.34 0.03 -0.45 0.06 -0.60 0.001 -0.60 0.001 -0.60 0.001 
  Time x Treatment arm -1.67 0.38 0.34 0.26 0.12 0.52 0.10 0.54 
    Treatment arm x Abstinence status -2.98 0.44 0.88 0.54 -0.31 0.61 
      Time x Treatment arm x Abstinence status 2.04 0.35 -0.33 0.35 
        Time² x Abstinence status 0.37 0.06 
          Time² x Treatment arm 0.26 0.27 
          Time² x Treatment arm x Abstinence status -0.30 0.27 
        Random effects 
            Participant ID, intercept (SD) 1.70 
 
1.71 
 
1.71 
 
1.73 
 
1.72 
  -2*log likelihood -1038.18   -1039.97   -1040.40   -1040.53   -1040.72   
Model 1: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x 
treatment arm x abstinence status, time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status  
Model 2: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x treatment arm, time x abstinence status, time x 
treatment arm x abstinence status 
Model 3: craving score by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm  
Model 4: craving score by time, time², treatment arm, abstinence status and interaction terms time x abstinence status, time x treatment arm    
Model 5: craving score by time, time², treatment arm, abstinence status and interaction terms time x abstinence status 
₁ Reference category is control group, ₂Reference category is non-abstainers
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Appendix 29. Observed and predicted MPSS-M scores over time in each trial arm 
and by abstinence status 
a) Observed and predicted MPSS-M scores in attentional retraining group 
abstainers 
 
 
 
 
b) Observed and predicted MPSS-M scores in control group abstainers 
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c) Observed and predicted MPSS-M scores in attentional retraining group non-
abstainers 
 
 
 
 
d) Observed and predicted MPSS-M scores in control group non-abstainers 
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Appendix 30. Predicted MPSS-M scores over time by trial arm and abstinence status 
(for fixed part of model only) 
a) Predicted MPSS-M scores with main effects of time, time squared, trial arm and 
abstinence status 
 
b) Predicted MPSS-M scores with main effects of time, time squared, time cubed trial 
arm and abstinence status 
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Appendix 31. Mixed-effects models of change in VAS craving scores over time by trial arm and abstinence status 
  Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
Variable 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Regression 
coefficient  p 
Fixed effects 
              Time -0.80 0.56 -1.46 0.04 -1.18 0.08 -1.15 0.08 -1.36 0.03 -1.36 0.03 
  Time² 0.03 0.74 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.08 0.07 0.08 
  Treatment arm₁ -8.36 0.14 -8.17 0.08 -4.85 0.24 -4.54 0.21 -4.64 0.20 -0.23 0.93 
  Abstinence status₂ 2.90 0.61 0.51 0.92 3.79 0.36 3.75 0.37 1.17 0.74 5.21 0.04 
Intercept 5.54 
 
6.62 
 
4.95 
 
4.80 
 
6.11 
 
3.90 
 Interactions 
              Treatment arm x Abstinence status 13.82 0.08 14.34 0.03 7.87 0.11 7.94 0.10 8.05 0.10 
    Time x Abstinence status -1.21 0.50 0.10 0.84 -0.39 0.25 -0.39 0.25 
      Time x Treatment arm 0.74 0.70 0.61 0.23 0.05 0.88 
        Time x Treatment arm x Abstinence status -0.77 0.76 -1.00 0.14 
          Time² x Abstinence status 0.09 0.45 
            Time² x Treatment arm -0.01 0.94 
            Time² x Treatment arm x Abstinence status -0.01 0.93 
          Random effects 
              Participant ID, intercept (SD) 9.03 
 
8.96 
 
8.73 
 
8.72 
 
8.52 
 
8.81 
  -2*log likelihood -1598.56   -1599.06   -1600.12   -1600.13   -1600.77   -1602.10   
Model 1: VAS difference scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status, time² x abstinence status, time² x treatment arm, time² x treatment arm x abstinence status 
Model 2: VAS difference scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm, time x treatment arm x 
abstinence status 
Model 3: VAS difference scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status, time x treatment arm   
Model 4: VAS difference scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status, time x abstinence status  
Model 5: VAS difference scores by time, time², treatment arm, abstinence status and interaction terms treatment arm x abstinence status    
Model 6: VAS difference scores by time, time², treatment arm, abstinence status   
₁ Reference category is attentional retraining group, ₂Reference category is abstainers 
